{
  "test_case_id": "healthcare_ai_adoption",
  "timestamp": "2025-10-11T21:57:58.113466",
  "processing_time_seconds": 172.79,
  "rfq_input": "\n        We need comprehensive research on AI-powered diagnostic tools adoption in mid-sized hospitals (100-500 beds). \n        Key focus areas: decision-making hierarchy, budget approval processes, clinical staff acceptance, patient privacy concerns, \n        ROI expectations, integration challenges with existing HIS/EMR systems, regulatory compliance barriers, \n        and competitive landscape analysis for vendors like GE Healthcare, Philips, and Siemens Healthineers.\n        Include KANO model analysis for feature prioritization and discrete choice modeling for pricing sensitivity.\n        Target: C-suite executives, CIOs, Chief Medical Officers, and department heads. Need 150+ qualified responses.\n        ",
  "generated_survey": {
    "title": "General Consumer Concept and Usage Study",
    "description": "A survey assessing awareness, usage, and reactions to a consumer product concept, including pricing and feature trade-offs.",
    "sections": [
      {
        "id": 1,
        "title": "Sample Plan",
        "description": "Participant qualification criteria, recruitment requirements, and quotas",
        "introText": {
          "id": "intro_1",
          "type": "study_intro",
          "label": "Study_Intro",
          "content": "Thank you for participating in this research study about consumer products. The survey will take about 15 to 20 minutes. Your responses are confidential, reported in aggregate, and used for research purposes only. Participation is voluntary and you may stop at any time without penalty.",
          "mandatory": "true"
        },
        "textBlocks": [
          {
            "id": "conf_1",
            "type": "confidentiality_agreement",
            "label": "Confidentiality_Agreement",
            "content": "This research contains confidential information. Please do not share any details with others outside this study.",
            "mandatory": "true"
          }
        ],
        "questions": [
          {
            "id": "q1",
            "text": "Which of the following best describes your role in household shopping for everyday consumer products such as personal care, cleaning, and packaged goods?",
            "type": "multiple_choice",
            "options": [
              "I am the primary shopper",
              "I share shopping equally",
              "I am an occasional shopper",
              "I rarely or never shop for these items"
            ],
            "required": "true",
            "methodology": "screening",
            "order": 1
          },
          {
            "id": "q2",
            "text": "How often do you purchase consumer products like personal care, cleaning, or packaged goods?",
            "type": "multiple_choice",
            "options": [
              "Weekly or more often",
              "Every 2-3 weeks",
              "Monthly",
              "Less than monthly",
              "Never"
            ],
            "required": "true",
            "methodology": "screening",
            "order": 2
          },
          {
            "id": "q3",
            "text": "In which country do you currently reside?",
            "type": "multiple_choice",
            "options": [
              "United States",
              "Canada",
              "United Kingdom",
              "Australia",
              "Other"
            ],
            "required": "true",
            "methodology": "quota",
            "order": 3
          },
          {
            "id": "q4",
            "text": "What is your age?",
            "type": "multiple_choice",
            "options": [
              "18-24",
              "25-34",
              "35-44",
              "45-54",
              "55-64",
              "65+"
            ],
            "required": "true",
            "methodology": "quota",
            "order": 4
          },
          {
            "id": "q5",
            "text": "Which of the following industries do you or a close family member work in?",
            "type": "multiple_choice",
            "options": [
              "Market research or survey design",
              "Advertising, public relations, or marketing",
              "Consumer packaged goods manufacturing",
              "Retail or e-commerce",
              "None of the above"
            ],
            "required": "true",
            "methodology": "screening",
            "order": 5
          }
        ]
      },
      {
        "id": 2,
        "title": "Screener",
        "description": "Initial qualification questions and basic demographics",
        "questions": [
          {
            "id": "q6",
            "text": "Have you participated in any market research surveys about consumer products in the past 3 months?",
            "type": "multiple_choice",
            "options": [
              "Yes, more than 3 surveys",
              "Yes, 1-3 surveys",
              "No"
            ],
            "required": "true",
            "methodology": "screening",
            "order": 1
          },
          {
            "id": "q7",
            "text": "Which statement best describes your involvement in choosing brands for everyday household products?",
            "type": "multiple_choice",
            "options": [
              "I usually decide which brands to buy",
              "I share brand decisions with someone else",
              "Someone else usually decides",
              "I do not purchase these products"
            ],
            "required": "true",
            "methodology": "screening",
            "order": 2
          },
          {
            "id": "q8",
            "text": "Please select the number four from the list below.",
            "type": "multiple_choice",
            "options": [
              "1",
              "2",
              "3",
              "4",
              "5"
            ],
            "required": "true",
            "methodology": "attention_check",
            "order": 3
          },
          {
            "id": "q9",
            "text": "What is your gender?",
            "type": "multiple_choice",
            "options": [
              "Female",
              "Male",
              "Non-binary",
              "Prefer to self-describe",
              "Prefer not to say"
            ],
            "required": "false",
            "methodology": "demographic",
            "order": 4
          },
          {
            "id": "q10",
            "text": "What is your approximate annual household income before taxes?",
            "type": "multiple_choice",
            "options": [
              "Under $25,000",
              "$25,000-$49,999",
              "$50,000-$74,999",
              "$75,000-$99,999",
              "$100,000-$149,999",
              "$150,000 or more",
              "Prefer not to say"
            ],
            "required": "false",
            "methodology": "demographic",
            "order": 5
          },
          {
            "id": "q11",
            "text": "What is the highest level of education you have completed?",
            "type": "multiple_choice",
            "options": [
              "Some high school or less",
              "High school diploma or equivalent",
              "Some college or vocational training",
              "Bachelor's degree",
              "Graduate or professional degree",
              "Prefer not to say"
            ],
            "required": "false",
            "methodology": "demographic",
            "order": 6
          }
        ]
      },
      {
        "id": 3,
        "title": "Brand/Product Awareness & Usage",
        "description": "Brand recall, awareness funnel, and usage patterns",
        "textBlocks": [
          {
            "id": "text_3",
            "type": "product_usage",
            "label": "Product_Usage",
            "content": "Before we begin, please tell us about your experience with everyday consumer products and your current usage patterns.",
            "mandatory": "true"
          }
        ],
        "questions": [
          {
            "id": "q12",
            "text": "Which categories of consumer products have you purchased in the past 3 months? Personal care, Household cleaning, Packaged food and beverages, Paper goods, Laundry products.",
            "type": "multiple_select",
            "options": [
              "Personal care",
              "Household cleaning",
              "Packaged food and beverages",
              "Paper goods",
              "Laundry products",
              "None of the above"
            ],
            "required": "true",
            "methodology": "usage",
            "order": 1
          },
          {
            "id": "q13",
            "text": "Thinking about the category you purchase most often, how frequently do you buy products in that category?",
            "type": "multiple_choice",
            "options": [
              "Weekly",
              "Every 2 weeks",
              "Monthly",
              "Less often"
            ],
            "required": "true",
            "methodology": "usage_frequency",
            "order": 2
          },
          {
            "id": "q14",
            "text": "How familiar are you with brands in your most-purchased category?",
            "type": "multiple_choice",
            "options": [
              "Very familiar",
              "Somewhat familiar",
              "Not very familiar",
              "Not at all familiar"
            ],
            "required": "true",
            "methodology": "awareness",
            "order": 3
          },
          {
            "id": "q15",
            "text": "When choosing products in your most-purchased category, how important are the following factors? Price, Quality, Brand reputation, Sustainability, Convenience, Promotions or discounts.",
            "type": "matrix_likert",
            "options": [
              "Not at all important",
              "Slightly important",
              "Moderately important",
              "Very important",
              "Extremely important"
            ],
            "required": "true",
            "methodology": "importance_rating",
            "order": 4
          }
        ]
      },
      {
        "id": 4,
        "title": "Concept Exposure",
        "description": "Product/concept introduction and reaction assessment",
        "introText": {
          "id": "intro_4",
          "type": "concept_intro",
          "label": "Concept_Intro",
          "content": "Please review the following product concept carefully. We will ask you questions about your reactions and preferences.",
          "mandatory": "true"
        },
        "questions": [
          {
            "id": "q16",
            "text": "Based on the concept you just reviewed, how appealing is this product overall?",
            "type": "multiple_choice",
            "options": [
              "Not at all appealing",
              "Slightly appealing",
              "Moderately appealing",
              "Very appealing",
              "Extremely appealing"
            ],
            "required": "true",
            "methodology": "concept_evaluation",
            "order": 1
          },
          {
            "id": "q17",
            "text": "How likely are you to consider purchasing this product within the next month?",
            "type": "multiple_choice",
            "options": [
              "Definitely would not buy",
              "Probably would not buy",
              "Might or might not buy",
              "Probably would buy",
              "Definitely would buy"
            ],
            "required": "true",
            "methodology": "purchase_intent",
            "order": 2
          },
          {
            "id": "q18",
            "text": "How does this concept perform on the following aspects? Clarity of benefits, Uniqueness, Fit with your needs, Trustworthiness, Likelihood to replace current brand.",
            "type": "matrix_likert",
            "options": [
              "Poor",
              "Fair",
              "Good",
              "Very good",
              "Excellent"
            ],
            "required": "true",
            "methodology": "concept_attribute_ratings",
            "order": 3
          },
          {
            "id": "q19",
            "text": "Please allocate 100 points across the following benefits to reflect their importance to you: Better performance, Better value for money, Eco-friendly materials, Convenient packaging.",
            "type": "constant_sum",
            "required": "true",
            "methodology": "feature_importance",
            "order": 4
          }
        ]
      },
      {
        "id": 5,
        "title": "Methodology",
        "description": "Research-specific questions (Conjoint, Pricing, Feature Importance)",
        "questions": [
          {
            "id": "q20",
            "text": "Assuming the product includes the features described, what is the highest price you would be willing to pay for one unit? Please enter a price in your local currency.",
            "type": "numeric_open",
            "required": "true",
            "methodology": "willingness_to_pay",
            "order": 1
          },
          {
            "id": "q21",
            "text": "At what price would you consider this product so expensive that you would not consider buying it? Please enter a price in your local currency.",
            "type": "numeric_open",
            "required": "true",
            "methodology": "van_westendorp_expensive",
            "order": 2
          },
          {
            "id": "q22",
            "text": "At what price would you consider this product to be priced so low that you would question its quality? Please enter a price in your local currency.",
            "type": "numeric_open",
            "required": "true",
            "methodology": "van_westendorp_cheap",
            "order": 3
          },
          {
            "id": "q23",
            "text": "How acceptable are the following price points for one unit of the product? $4.99, $6.99, $8.99, $10.99, $12.99.",
            "type": "matrix_likert",
            "options": [
              "Completely unacceptable",
              "Somewhat unacceptable",
              "Neither acceptable nor unacceptable",
              "Somewhat acceptable",
              "Completely acceptable"
            ],
            "required": "true",
            "methodology": "price_acceptability",
            "order": 4
          },
          {
            "id": "q24",
            "text": "Please evaluate how each feature would influence your likelihood to buy. Recyclable packaging, Fragrance-free formula, Family-size pack, Subscription discount available.",
            "type": "matrix_likert",
            "options": [
              "Strongly decreases likelihood",
              "Somewhat decreases likelihood",
              "No impact",
              "Somewhat increases likelihood",
              "Strongly increases likelihood"
            ],
            "required": "true",
            "methodology": "drivers_analysis",
            "order": 5
          }
        ]
      },
      {
        "id": 6,
        "title": "Additional Questions",
        "description": "Supplementary research questions and follow-ups",
        "questions": [
          {
            "id": "q25",
            "text": "Which of the following best describes why you selected your answer to purchase intent?",
            "type": "multiple_select",
            "options": [
              "Price is attractive",
              "Features meet my needs",
              "Brand seems trustworthy",
              "I would need more information",
              "I prefer my current brand",
              "Other"
            ],
            "required": "false",
            "methodology": "follow_up",
            "order": 1
          },
          {
            "id": "q26",
            "text": "How likely are you to recommend this product concept to a friend or colleague?",
            "type": "multiple_choice",
            "options": [
              "0 - Not at all likely",
              "1",
              "2",
              "3",
              "4",
              "5",
              "6",
              "7",
              "8",
              "9",
              "10 - Extremely likely"
            ],
            "required": "true",
            "methodology": "nps_intent",
            "order": 2
          },
          {
            "id": "q27",
            "text": "How confident are you that you understood the product concept correctly?",
            "type": "multiple_choice",
            "options": [
              "Not at all confident",
              "Slightly confident",
              "Moderately confident",
              "Very confident",
              "Extremely confident"
            ],
            "required": "true",
            "methodology": "data_quality",
            "order": 3
          },
          {
            "id": "q28",
            "text": "Please indicate how closely the following statements describe your typical shopping behavior. I look for the lowest price, I prefer sustainable options, I am loyal to specific brands, I try new products frequently.",
            "type": "matrix_likert",
            "options": [
              "Does not describe me at all",
              "Slightly describes me",
              "Moderately describes me",
              "Very much describes me",
              "Completely describes me"
            ],
            "required": "false",
            "methodology": "profiling",
            "order": 4
          }
        ]
      },
      {
        "id": 7,
        "title": "Programmer Instructions",
        "description": "Technical implementation notes and data specifications",
        "questions": [
          {
            "id": "q29",
            "text": "Programmer note: Randomize the order of features in Q19 and Q24 and anchor the first and last options in all Likert scales.",
            "type": "instruction",
            "required": "false",
            "methodology": "programming_note",
            "order": 1
          },
          {
            "id": "q30",
            "text": "Programmer note: Apply soft quotas to balance age and gender to census distributions within country where feasible.",
            "type": "instruction",
            "required": "false",
            "methodology": "quota_instruction",
            "order": 2
          },
          {
            "id": "q31",
            "text": "Programmer note: Implement validation for constant sum to equal 100 in Q19 and require numeric entries greater than zero for pricing questions.",
            "type": "instruction",
            "required": "false",
            "methodology": "validation_instruction",
            "order": 3
          }
        ],
        "closingText": {
          "id": "closing_1",
          "type": "survey_closing",
          "label": "Survey_Closing",
          "content": "Thank you for completing this survey! Your responses are valuable and will help us better understand market preferences. If you have any questions about this research, please contact us at research@company.com. You may now close this window.",
          "mandatory": "true"
        }
      }
    ],
    "metadata": {
      "estimated_time": 15,
      "methodology_tags": [
        "screening",
        "usage",
        "concept_test",
        "pricing",
        "drivers",
        "data_quality"
      ],
      "target_responses": 400,
      "sections_count": 7
    },
    "estimated_time": 5,
    "confidence_score": 0.8,
    "methodologies": [
      "survey"
    ],
    "golden_examples": []
  },
  "model_used": "openai/gpt-5-structured",
  "used_ai_generation": true,
  "golden_examples_used": [],
  "similarity_score": null,
  "analysis": {
    "title_generated": true,
    "description_generated": true,
    "questions_count": 31,
    "estimated_time": 5,
    "methodologies_detected": [],
    "meets_min_questions": true,
    "has_advanced_methodologies": false,
    "has_sections": true,
    "quality_indicators": {
      "has_screening_questions": false,
      "has_scale_questions": false,
      "has_multiple_choice": true,
      "has_methodology_tags": true,
      "has_categories": false
    },
    "methodology_match": {
      "expected": [
        "kano_model",
        "stakeholder_mapping",
        "discrete_choice"
      ],
      "detected": [],
      "intersection": [],
      "coverage_percentage": 0.0
    }
  },
  "pillar_evaluation": {
    "overall_score": 0.4832080645161291,
    "pillar_scores": {
      "content_validity": 0.11825806451612905,
      "methodological_rigor": 0.3582258064516129,
      "clarity_comprehensibility": 0.6,
      "structural_coherence": 0.8,
      "deployment_readiness": 0.6
    },
    "recommendations": [
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for primary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for secondary objective",
      "Missing coverage for exploratory objective",
      "Missing coverage for exploratory objective",
      "Missing coverage for exploratory objective",
      "Question 'Which of the following best describes your role in...' has poor objective coverage",
      "Question 'How often do you purchase consumer products like p...' has poor objective coverage",
      "Question 'In which country do you currently reside?...' has poor objective coverage",
      "Question 'What is your age?...' has poor objective coverage",
      "Question 'Which of the following industries do you or a clos...' has poor objective coverage",
      "Question 'Have you participated in any market research surve...' has poor objective coverage",
      "Question 'Which statement best describes your involvement in...' has poor objective coverage",
      "Question 'Please select the number four from the list below....' has poor objective coverage",
      "Question 'What is your gender?...' has poor objective coverage",
      "Question 'What is your approximate annual household income b...' has poor objective coverage",
      "Question 'What is the highest level of education you have co...' has poor objective coverage",
      "Question 'Which categories of consumer products have you pur...' has poor objective coverage",
      "Question 'Thinking about the category you purchase most ofte...' has poor objective coverage",
      "Question 'How familiar are you with brands in your most-purc...' has poor objective coverage",
      "Question 'When choosing products in your most-purchased cate...' has poor objective coverage",
      "Question 'Based on the concept you just reviewed, how appeal...' has poor objective coverage",
      "Question 'How likely are you to consider purchasing this pro...' has poor objective coverage",
      "Question 'How does this concept perform on the following asp...' has poor objective coverage",
      "Question 'Please allocate 100 points across the following be...' has poor objective coverage",
      "Question 'Assuming the product includes the features describ...' has poor objective coverage",
      "Question 'At what price would you consider this product so e...' has poor objective coverage",
      "Question 'At what price would you consider this product to b...' has poor objective coverage",
      "Question 'How acceptable are the following price points for ...' has poor objective coverage",
      "Question 'Please evaluate how each feature would influence y...' has poor objective coverage",
      "Question 'Which of the following best describes why you sele...' has poor objective coverage",
      "Question 'How likely are you to recommend this product conce...' has poor objective coverage",
      "Question 'How confident are you that you understood the prod...' has poor objective coverage",
      "Question 'Please indicate how closely the following statemen...' has poor objective coverage",
      "Question 'Programmer note: Randomize the order of features i...' has poor objective coverage",
      "Question 'Programmer note: Apply soft quotas to balance age ...' has poor objective coverage",
      "Question 'Programmer note: Implement validation for constant...' has poor objective coverage",
      "Poor question sequencing for q1",
      "Poor question sequencing for q2",
      "Poor question sequencing for q3",
      "Insufficient sample size for reliable results",
      "Improve question wording for better clarity and comprehensibility",
      "Adjust survey length or complexity for better deployment feasibility",
      "Significant improvements needed before deployment"
    ],
    "detailed_results": {
      "content_validity": {
        "overall_score": 0.11825806451612905,
        "reasoning_chain": [
          "STEP 1: Extracting research objectives with semantic analysis",
          "STEP 2: Mapping survey questions to research objectives",
          "STEP 3: Analyzing coverage gaps and overlaps",
          "STEP 4: Evaluating from researcher/respondent/analyst perspectives",
          "STEP 5: Generating specific actionable recommendations"
        ],
        "research_objectives": [
          {
            "text": "Map the decision-making hierarchy for adopting AI-powered diagnostic tools in mid-sized hospitals (100\u2013500 beds).",
            "category": "primary",
            "priority": 0.98,
            "keywords": [
              "decision-making hierarchy",
              "stakeholder roles",
              "governance",
              "procurement workflow",
              "approval gates",
              "C-suite",
              "CIO",
              "CMO",
              "department heads"
            ],
            "semantic_intent": "Identify who influences and decides on AI diagnostic tool adoption and how decisions progress through the organization."
          },
          {
            "text": "Detail budget approval processes and funding mechanisms for AI diagnostic tool purchases.",
            "category": "primary",
            "priority": 0.95,
            "keywords": [
              "budget approval",
              "CAPEX vs OPEX",
              "budget cycles",
              "thresholds",
              "financial sign-off",
              "procurement policies"
            ],
            "semantic_intent": "Understand how budgets are allocated and approved, including thresholds and timelines that affect purchasing."
          },
          {
            "text": "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools.",
            "category": "primary",
            "priority": 0.93,
            "keywords": [
              "clinician acceptance",
              "change management",
              "workflow impact",
              "trust in AI",
              "usability",
              "training needs",
              "perceived usefulness"
            ],
            "semantic_intent": "Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption."
          },
          {
            "text": "Evaluate patient privacy concerns and data governance requirements associated with AI diagnostics.",
            "category": "primary",
            "priority": 0.9,
            "keywords": [
              "patient privacy",
              "data governance",
              "HIPAA",
              "PHI handling",
              "data residency",
              "consent",
              "security controls"
            ],
            "semantic_intent": "Determine privacy risks, compliance expectations, and safeguards needed to adopt AI tools."
          },
          {
            "text": "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools.",
            "category": "primary",
            "priority": 0.94,
            "keywords": [
              "ROI",
              "payback period",
              "total cost of ownership",
              "clinical outcomes",
              "operational efficiency",
              "financial KPIs"
            ],
            "semantic_intent": "Identify the financial and clinical value metrics hospitals require to justify investment."
          },
          {
            "text": "Identify integration challenges with existing HIS/EMR systems and interoperability requirements.",
            "category": "primary",
            "priority": 0.96,
            "keywords": [
              "integration",
              "HIS",
              "EMR",
              "HL7",
              "FHIR",
              "PACS",
              "workflow interoperability",
              "IT burden",
              "vendor APIs"
            ],
            "semantic_intent": "Understand technical barriers and requirements to seamlessly integrate AI tools into current systems and workflows."
          },
          {
            "text": "Map regulatory compliance barriers for deploying AI diagnostics in mid-sized hospitals.",
            "category": "primary",
            "priority": 0.91,
            "keywords": [
              "regulatory compliance",
              "FDA/CE",
              "SaMD",
              "clinical validation",
              "audit trails",
              "model updates",
              "risk management"
            ],
            "semantic_intent": "Clarify regulatory pathways, documentation, and validation needs that influence adoption."
          },
          {
            "text": "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers.",
            "category": "primary",
            "priority": 0.92,
            "keywords": [
              "competitive landscape",
              "vendor selection criteria",
              "brand perception",
              "feature comparison",
              "pricing models",
              "support/services"
            ],
            "semantic_intent": "Determine how target hospitals perceive key vendors, their differentiation, and selection drivers."
          },
          {
            "text": "Conduct KANO model analysis to prioritize AI diagnostic tool features.",
            "category": "primary",
            "priority": 0.9,
            "keywords": [
              "KANO",
              "must-have",
              "performance features",
              "delighters",
              "indifferent",
              "feature prioritization"
            ],
            "semantic_intent": "Classify features by their impact on satisfaction to guide product roadmap and messaging."
          },
          {
            "text": "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay.",
            "category": "primary",
            "priority": 0.93,
            "keywords": [
              "discrete choice modeling",
              "conjoint",
              "price elasticity",
              "WTP",
              "attribute trade-offs",
              "bundling"
            ],
            "semantic_intent": "Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing."
          },
          {
            "text": "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs.",
            "category": "secondary",
            "priority": 0.82,
            "keywords": [
              "stakeholder profiling",
              "segmentation",
              "personas",
              "attitudes",
              "needs",
              "influence mapping"
            ],
            "semantic_intent": "Create actionable personas and segments to tailor product, pricing, and sales approaches."
          },
          {
            "text": "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals.",
            "category": "secondary",
            "priority": 0.8,
            "keywords": [
              "sample frame",
              "qualification criteria",
              "hospital size 100\u2013500 beds",
              "response quotas",
              "data quality"
            ],
            "semantic_intent": "Ensure statistically useful, role-representative data for robust analysis."
          },
          {
            "text": "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions.",
            "category": "secondary",
            "priority": 0.86,
            "keywords": [
              "adoption drivers",
              "barriers",
              "risk mitigation",
              "value propositions",
              "change readiness"
            ],
            "semantic_intent": "Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market."
          },
          {
            "text": "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals.",
            "category": "secondary",
            "priority": 0.78,
            "keywords": [
              "current adoption",
              "penetration",
              "maturity curve",
              "pilots vs scale",
              "time to deployment"
            ],
            "semantic_intent": "Provide baseline context on how widespread and mature adoption currently is."
          },
          {
            "text": "Determine preferred procurement and contracting models for AI diagnostic solutions.",
            "category": "secondary",
            "priority": 0.77,
            "keywords": [
              "procurement model",
              "SaaS vs perpetual",
              "subscription",
              "usage-based",
              "enterprise agreements",
              "GPOs"
            ],
            "semantic_intent": "Identify buying models that align with hospital preferences and constraints."
          },
          {
            "text": "Assess data integration and model lifecycle expectations (updates, monitoring, bias, and performance transparency).",
            "category": "secondary",
            "priority": 0.81,
            "keywords": [
              "model updates",
              "MLOps",
              "performance monitoring",
              "bias mitigation",
              "explainability",
              "auditability"
            ],
            "semantic_intent": "Understand post-deployment expectations that influence trust and compliance."
          },
          {
            "text": "Evaluate training, change management, and support services required for successful implementation.",
            "category": "secondary",
            "priority": 0.76,
            "keywords": [
              "training",
              "enablement",
              "super-user programs",
              "onboarding",
              "vendor support",
              "SLA"
            ],
            "semantic_intent": "Clarify service requirements that reduce friction and drive sustained usage."
          },
          {
            "text": "Identify clinical areas and use cases with highest perceived value for AI diagnostics.",
            "category": "exploratory",
            "priority": 0.65,
            "keywords": [
              "use cases",
              "radiology",
              "cardiology",
              "pathology",
              "triage",
              "workflow automation",
              "prioritization"
            ],
            "semantic_intent": "Find the departments and applications most likely to yield early wins and ROI."
          },
          {
            "text": "Map perception and impact of external guidelines and payer incentives on AI adoption.",
            "category": "exploratory",
            "priority": 0.58,
            "keywords": [
              "payer incentives",
              "reimbursement",
              "quality metrics",
              "accreditation",
              "professional society guidelines"
            ],
            "semantic_intent": "Explore how reimbursement and external standards shape adoption priorities."
          },
          {
            "text": "Identify key differentiating features that drive vendor selection beyond the top three competitors.",
            "category": "exploratory",
            "priority": 0.6,
            "keywords": [
              "long tail vendors",
              "differentiators",
              "ecosystem partnerships",
              "total solution fit"
            ],
            "semantic_intent": "Uncover broader competitive threats and opportunities outside the named vendors."
          }
        ],
        "question_mappings": [
          {
            "question_id": "q1",
            "question_text": "Which of the following best describes your role in household shopping for everyday consumer products such as personal care, cleaning, and packaged goods?",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.08,
            "gaps_identified": [
              "Question topic is misaligned with the domain (household shopping vs. hospital AI diagnostics).",
              "Does not capture healthcare role, department, seniority, or decision authority relevant to AI tool adoption.",
              "Provides no information on decision-making hierarchy, budget thresholds, or approval processes.",
              "No measurement of clinician acceptance, training needs, or workflow integration considerations.",
              "No content on privacy, data governance, regulatory compliance, or interoperability with HIS/EMR.",
              "Does not inform ROI expectations, pricing sensitivity, or procurement models.",
              "Cannot support competitive landscape assessment (GE, Philips, Siemens Healthineers, or others).",
              "Not suitable for KANO or discrete choice modeling inputs for AI diagnostic features or pricing.",
              "Does not help identify clinical use cases, adoption triggers/barriers, or maturity benchmarks.",
              "Does not aid in sampling qualification of mid-sized hospitals (100\u2013500 beds)."
            ],
            "improvement_suggestions": [
              "Replace with a role/authority screener specific to hospital context, e.g., 'Which best describes your role in decisions about AI-enabled diagnostic tools at your hospital?' with options: Final decision maker, Budget approver, Recommender/influencer, Evaluator, End user/clinician, IT/Integration lead, Data governance/privacy lead, No role.",
              "Add healthcare-specific role taxonomy: C-suite (CEO, CFO, CIO, CMO), Service line leaders (Radiology Chair, Pathology Director, ED Director), IT (CTO, Enterprise Architect, Integration Manager), Clinical Engineering/Biomed, Compliance/Privacy Officer, Procurement/Supply Chain.",
              "Include hospital profile screeners: bed size (100\u2013500), hospital type (community/academic), location, ownership, and current EMR/HIS vendor.",
              "Capture budget authority and thresholds: 'What is the maximum capital/opex you can approve without additional sign-off?' and 'Who must approve purchases above $X?'",
              "Map decision process: stages, involved stakeholders, and typical timelines from evaluation to deployment.",
              "Assess clinician acceptance: Likert items on perceived usefulness, workflow impact, trust in AI, required evidence, and training needs.",
              "Measure privacy/data governance requirements: data residency, de-identification, PHI handling, model auditability, monitoring, bias management.",
              "Evaluate integration: required standards (HL7, FHIR, DICOM), SSO/IdP, data pipelines, inference latency, IT resources needed.",
              "Quantify ROI expectations: target payback period, TCO considerations, clinical and operational KPIs, evidence thresholds (RCTs, peer-reviewed studies).",
              "Add competitive/vendor perception items: aided/unaided awareness, consideration, differentiation, and selection criteria for GE, Philips, Siemens Healthineers, and others.",
              "Include KANO feature battery and DCE design blocks for price-feature trade-offs.",
              "Ask procurement model preferences: capital purchase vs. subscription/SaaS, per-study pricing, risk-sharing/outcomes-based contracts.",
              "Screen for current adoption/maturity and planned timelines (pilot, scale, budgeted next 12\u201324 months)."
            ]
          },
          {
            "question_id": "q2",
            "question_text": "How often do you purchase consumer products like personal care, cleaning, or packaged goods?",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "The question is about consumer packaged goods purchasing frequency and is unrelated to AI diagnostics or hospital decision-making.",
              "Does not identify decision-makers or influencers for AI diagnostic tool adoption.",
              "Provides no insight into budget approval processes, thresholds, or timelines.",
              "Does not assess clinician acceptance, barriers, or drivers for AI tool usage.",
              "Ignores patient privacy, data governance, and compliance requirements.",
              "No information on ROI expectations, value metrics, or economic evaluation criteria.",
              "Does not address HIS/EMR integration or interoperability needs.",
              "No exploration of regulatory pathways or validation requirements.",
              "No competitive landscape insights (GE, Philips, Siemens Healthineers, or other vendors).",
              "Cannot support KANO analysis of AI diagnostic features.",
              "Cannot support discrete choice modeling for pricing or feature trade-offs.",
              "Does not profile target hospital decision-makers or segment by attitudes/needs.",
              "Not useful for sampling validation of qualified hospital respondents.",
              "No identification of adoption triggers or barriers across clinical/technical/financial/regulatory dimensions.",
              "Does not benchmark current adoption or maturity of AI diagnostics in mid-sized hospitals.",
              "No insight into procurement or contracting model preferences.",
              "No data on data integration and model lifecycle expectations (updates, monitoring, bias).",
              "No assessment of training, change management, or support needs.",
              "No identification of high-value clinical areas or use cases for AI diagnostics.",
              "No mapping of external guidelines, payer incentives, or reimbursement effects.",
              "No identification of differentiating features that drive vendor selection."
            ],
            "improvement_suggestions": [
              "Screen for target audience: 'Which best describes your role? (C-suite, CIO, CMO, department head, IT, Radiology lead, etc.)' and confirm hospital size (100\u2013500 beds).",
              "Decision-making hierarchy: 'Who initiates, influences, and makes the final decision for AI diagnostic tools? Please select all that apply and indicate level of influence.'",
              "Process and budget: 'What are approval thresholds, committees involved, and typical timelines from evaluation to purchase?' with scaled options.",
              "Clinician adoption: 'How willing are clinicians to use AI diagnostics in your department?' and 'Top barriers/drivers' with Likert and multi-select.",
              "Privacy and governance: 'Which data governance requirements must AI vendors meet?' and 'Level of concern about PHI privacy risks.'",
              "ROI and value metrics: 'Which metrics are required for approval? (diagnostic accuracy uplift, throughput, LOS reduction, readmission, cost per study, payback period)' and thresholds.",
              "Integration: 'Which HIS/EMR/PACS/RIS systems do you use and what interoperability standards are required (HL7, FHIR, DICOM, APIs)?' plus perceived integration difficulty.",
              "Regulatory: 'Which certifications/validations are required (FDA 510(k)/De Novo, CE, IEC 62304, ISO 13485, SOC 2, HIPAA BAA)?'",
              "Competitive perception: 'How do you rate GE, Philips, Siemens Healthineers, and others on reliability, integration, support, pricing, and innovation?'",
              "KANO feature testing: Present key features (auto-triage, explainability, bias reporting, on-prem vs cloud, continuous monitoring) with functional/dysfunctional KANO questions.",
              "Discrete choice/conjoint: Include randomized choice tasks varying price, deployment model, integration level, performance claims, support SLAs, and regulatory status.",
              "Procurement model preferences: 'Preferred contracting: perpetual license, subscription, usage-based, risk-share/outcomes-based, enterprise vs departmental buy.'",
              "Lifecycle expectations: 'Expectations for model updates, drift monitoring, bias audits, transparency reporting cadence.'",
              "Training and change management: 'Required training formats, go-live support, super-user programs, and acceptable vendor responsibilities.'",
              "Use cases: 'Which clinical areas are highest priority for AI diagnostics in your hospital?' with ranking (e.g., radiology triage, cardiology imaging, pathology, ED).",
              "External levers: 'Impact of payer incentives, guidelines (e.g., ACR, CMS), and health system policies on adoption priority.'",
              "Benchmarking: 'Current adoption stage' and 'Number of AI diagnostic tools deployed/piloted; outcomes achieved.'",
              "Sampling validation: Enforce quotas by role and hospital size, and include screener items to confirm involvement in AI tool decisions."
            ]
          },
          {
            "question_id": "q3",
            "question_text": "In which country do you currently reside?",
            "mapped_objectives": [
              "Map regulatory compliance barriers for deploying AI diagnostics in mid-sized hospitals. (Intent: Clarify regulatory pathways, documentation, and validation needs that influence adoption.)",
              "Evaluate patient privacy concerns and data governance requirements associated with AI diagnostics. (Intent: Determine privacy risks, compliance expectations, and safeguards needed to adopt AI tools.)",
              "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers. (Intent: Determine how target hospitals perceive key vendors, their differentiation, and selection drivers.)",
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)",
              "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals. (Intent: Provide baseline context on how widespread and mature adoption currently is.)",
              "Map the decision-making hierarchy for adopting AI-powered diagnostic tools in mid-sized hospitals (100\u2013500 beds). (Intent: Identify who influences and decides on AI diagnostic tool adoption and how decisions progress through the organization.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not identify roles, decision-makers, or hierarchy for AI tool adoption.",
              "No information on budgets, approval thresholds, or funding mechanisms.",
              "No insight into clinician acceptance, usage drivers, or barriers.",
              "Does not capture privacy concerns, data governance practices, or safeguards.",
              "No ROI metrics, economic evaluation criteria, or value framework.",
              "No details on HIS/EMR integration or interoperability requirements.",
              "Does not surface regulatory pathways or required documentation beyond inferring jurisdiction.",
              "No competitive perceptions of GE, Philips, Siemens Healthineers, or other vendors.",
              "Cannot support KANO feature classification or discrete choice modeling inputs.",
              "Does not profile target personas beyond geographic location.",
              "No identification of adoption triggers/barriers across domains.",
              "Does not benchmark adoption rates or maturity.",
              "No procurement or contracting model preferences.",
              "No expectations for model lifecycle, monitoring, bias, or transparency.",
              "No training, change management, or support needs.",
              "No prioritization of clinical areas or use cases.",
              "No assessment of external guidelines or payer incentives.",
              "No differentiating features beyond top three vendors."
            ],
            "improvement_suggestions": [
              "Retain the country item but add routing logic so subsequent modules tailor to jurisdiction-specific regulations, reimbursement, and data laws.",
              "Add role and organization screening: hospital size (beds 100\u2013500), role (CIO, CMO, etc.), department, decision authority, and involvement stage.",
              "Include budget and procurement items: annual capital/operational budgets, approval thresholds, timelines, sourcing models (purchase, subscription, managed service).",
              "Add clinician acceptance measures: Likert items on usefulness, trust, workflow fit, liability, and change readiness; include barriers/drivers.",
              "Include privacy/data governance: data types used, de-identification, PHI handling, cross-border transfer, consent practices, DPO involvement.",
              "Add ROI/economic criteria: required payback, NPV/IRR use, clinical KPIs, evidence types needed (RCT, real-world, health economic models).",
              "Include integration/interoperability: current HIS/EMR vendors, standards (HL7/FHIR/DICOM), integration timelines, IT constraints, security requirements.",
              "Regulatory pathway items tailored by country: approvals required (FDA, CE, MHRA), documentation, post-market surveillance, and validation expectations.",
              "Vendor landscape items: awareness, consideration, perceived strengths/weaknesses of GE/Philips/Siemens and others; selection criteria.",
              "KANO feature battery: classify features as must-be, one-dimensional, attractive, indifferent, reverse for prioritized capabilities.",
              "Discrete choice tasks: experimentally designed choice sets across price, deployment model, evidence, integration level, and feature bundles.",
              "Adoption benchmarking: current usage status, number of tools, deployment stage, departments using AI, and maturity scale.",
              "Lifecycle and governance: model updates, monitoring, bias audits, performance transparency, human oversight.",
              "Training and support: required training hours, modalities, champions, go-live support, SLAs.",
              "Use-case prioritization: rank clinical areas (radiology, cardiology, ED triage, pathology, etc.) by value and feasibility.",
              "External incentives: impact of payer reimbursement, accreditation, and guidelines on prioritization.",
              "Sampling plan controls: quotas by country, role, and hospital type; validate eligibility with screening logic and IP/geolocation checks."
            ]
          },
          {
            "question_id": "q4",
            "question_text": "What is your age?",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.12,
            "gaps_identified": [
              "Does not capture role, department, or influence over AI purchasing decisions.",
              "Provides no information on decision-making hierarchy or governance processes.",
              "No data on budget thresholds, approval stages, or funding mechanisms.",
              "Does not assess clinician acceptance, barriers, or drivers for AI tool usage.",
              "No measurement of privacy concerns, data governance, or compliance requirements.",
              "Lacks ROI expectations, evaluation criteria, or value metrics.",
              "Omits integration and interoperability requirements with HIS/EMR.",
              "No regulatory pathway or validation documentation needs.",
              "No competitive perceptions about GE, Philips, Siemens, or other vendors.",
              "Cannot support KANO feature classification or prioritization.",
              "No discrete choice inputs for price/feature trade-offs.",
              "Does not identify procurement models or contracting preferences.",
              "No insights on data integration lifecycle expectations (updates, monitoring, bias).",
              "No training, change management, or support service needs.",
              "No identification of high-value clinical areas or use cases.",
              "No assessment of external guidelines or payer incentives.",
              "No benchmarking of current adoption rates or maturity.",
              "No identification of broader differentiators beyond top vendors."
            ],
            "improvement_suggestions": [
              "Add role and function: Which best describes your primary role? (CIO, CMO, CFO, COO, Department Head, IT Director, Clinical Lead, Procurement, Compliance, Other).",
              "Add decision authority: What is your level of influence in AI diagnostic tool adoption? (final decision, strong influence, consult, no role).",
              "Add budget process items: What is the capital/opex threshold requiring board approval? Typical approval timeline? Funding sources used?",
              "Add clinical adoption: Rate your willingness to use/endorse AI diagnostics and top drivers/barriers.",
              "Add privacy/compliance: Rank privacy concerns, required safeguards, and governance bodies involved.",
              "Add ROI/evaluation: What financial and clinical KPIs are required? Minimum ROI/payback period?",
              "Add integration: Current HIS/EMR vendors, integration standards used (HL7, FHIR, DICOM), and key interoperability hurdles.",
              "Add regulatory: Required evidentiary standards (clinical validation, FDA/CE status), documentation expectations.",
              "Add competitive perception: Familiarity and preference for GE, Philips, Siemens; key differentiators and concerns; openness to challengers.",
              "Add KANO items: Classify candidate features as must-have, performance, delighter, indifferent, reverse.",
              "Add discrete choice tasks: Include conjoint/DCE with price, deployment model, integration level, performance, support, compliance attributes.",
              "Add procurement model preferences: Capex, subscription/SaaS, per-study, risk-share/outcomes-based, marketplace/GPO.",
              "Add adoption maturity: Current usage stage, number of deployed AI tools, departments using them.",
              "Add data lifecycle expectations: Update cadence, performance monitoring, bias auditing, transparency requirements.",
              "Add training/change management: Required training formats, change management support, go-live resources.",
              "Add sampling screens: Confirm hospital size (100\u2013500 beds) and qualifying roles before survey start.",
              "Retain age only as a demographic control variable for segmentation, and ensure optional with ranges (e.g., 18\u201324, 25\u201334, ..., 65+)."
            ]
          },
          {
            "question_id": "q5",
            "question_text": "Which of the following industries do you or a close family member work in?",
            "mapped_objectives": [
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not identify hospital size (100\u2013500 beds) to ensure respondents are within target frame.",
              "Does not confirm respondent role or decision influence (C-suite, CIO, CMO, department heads) for mapping decision hierarchies.",
              "Does not distinguish between respondent vs. close family member employment, which dilutes qualification validity.",
              "Does not capture budget authority, thresholds, or approval processes.",
              "No measurement of clinical acceptance, adoption drivers/barriers, or workflow impacts.",
              "No assessment of privacy, data governance, compliance requirements, or regulatory pathways.",
              "No information on integration with HIS/EMR, interoperability standards, or technical constraints.",
              "No ability to evaluate ROI expectations, economic criteria, pricing sensitivity, or procurement models.",
              "No competitive vendor perceptions or feature prioritization (KANO) inputs.",
              "No benchmarking of current adoption or maturity levels of AI diagnostics.",
              "No segmentation by attitudes/needs or persona-defining characteristics within target roles.",
              "No linkage to specific clinical areas/use cases or external guidelines/payer incentives.",
              "Industry category alone is insufficient to screen for mid-sized hospital staff in relevant roles."
            ],
            "improvement_suggestions": [
              "Add a hospital screening block: hospital type, bed count (ensure 100\u2013500), geography, teaching status.",
              "Replace or augment with role-focused screening: job title/role, department, decision-making authority level, involvement in AI diagnostics purchase/use.",
              "Clarify respondent eligibility: remove 'close family member' and focus on self only; include a termination path for non-hospital respondents.",
              "Add hierarchy mapping items: who initiates, evaluates, influences, and approves AI diagnostics; stage-gate process and committees involved.",
              "Include budget items: capex/opex mix, approval thresholds, budget cycle timing, sources of funding, and required business case elements.",
              "Measure clinical adoption: perceived usefulness, trust, barriers (workflow, accuracy, liability), required evidence, training needs.",
              "Privacy/compliance section: HIPAA/GDPR applicability, data-sharing policies, de-identification, PHI handling, model governance and audit trails.",
              "Integration questions: current EHR/HIS vendor, interface standards (HL7 v2/FHIR/DICOM), integration resources, security reviews, IT constraints.",
              "ROI and pricing module: KPIs, payback thresholds, TCO components, willingness-to-pay anchors for DCE.",
              "Vendor landscape: awareness, consideration, differentiation for GE, Philips, Siemens Healthineers and others; selection drivers.",
              "KANO feature battery: classify must-haves, performance, delighters for AI diagnostic tool capabilities and services.",
              "Adoption baseline: current tools in use, pilot status, scale, satisfaction, maturity stage.",
              "Procurement models: preferences for perpetual/SaaS/subscription, per-study pricing, risk-sharing, and contracting terms.",
              "Model lifecycle expectations: update cadence, monitoring, bias mitigation, performance transparency, validation requirements.",
              "Training/change management: onboarding effort, support SLAs, champion networks, super-user models.",
              "Use cases: prioritize clinical areas and conditions with highest perceived value and feasibility.",
              "External influences: payer incentives, accreditation standards, clinical guidelines affecting adoption.",
              "Add quality controls: attention checks, role verification, and logic to terminate non-target respondents early."
            ]
          },
          {
            "question_id": "q6",
            "question_text": "Have you participated in any market research surveys about consumer products in the past 3 months?",
            "mapped_objectives": [
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.05,
            "gaps_identified": [
              "Does not identify decision-making hierarchy or influencer/decider roles for AI diagnostics.",
              "No information on budget approval thresholds, processes, or timelines.",
              "No data on clinician acceptance, adoption drivers, or barriers for AI tools.",
              "Does not address privacy, data governance, or compliance expectations.",
              "No ROI metrics, economic criteria, or financial justification inputs.",
              "No insights on HIS/EMR integration challenges or interoperability requirements.",
              "No mapping of regulatory pathways or documentation needs.",
              "No perceptions of GE, Philips, Siemens, or broader competitive set.",
              "Cannot support KANO feature classification or feature prioritization.",
              "Cannot support discrete choice modeling for price/feature trade-offs.",
              "Does not profile target decision-makers or segment by attitudes/needs.",
              "No identification of cross-functional adoption triggers/barriers.",
              "Does not benchmark current adoption or maturity of AI diagnostics.",
              "No insights on preferred procurement/contracting models.",
              "No expectations for model lifecycle, monitoring, bias, or transparency.",
              "No requirements for training, change management, or support services.",
              "No identification of high-value clinical areas/use cases for AI diagnostics.",
              "No assessment of external guidelines, payer incentives, or reimbursement impacts.",
              "No identification of differentiating features that drive vendor selection."
            ],
            "improvement_suggestions": [
              "Screen for target population: Add role, organization type/size, and relevance to AI diagnostics (e.g., What is your role? Does your hospital have 100\u2013500 beds? Are you involved in evaluating/purchasing AI diagnostic tools?).",
              "Replace the current question with a research-screening module: Include recency and frequency of participation in market research specific to hospital technology/AI, to control for professional respondents and response bias.",
              "Add modules aligned to objectives: decision hierarchy mapping (roles, influence, RACI, stage-gates), budget thresholds/timelines, clinical acceptance drivers/barriers, privacy/data governance requirements, ROI metrics and evidence standards, integration and interoperability needs, regulatory requirements, vendor perceptions and selection criteria, KANO feature ratings, discrete choice tasks for pricing/trade-offs, procurement models, lifecycle governance, training/support needs, use-case prioritization, and payer/guideline impacts.",
              "If keeping this question, qualify it: Specify domain relevance (In the past 3 months, have you participated in any market research about hospital AI diagnostic tools or related clinical decision support?).",
              "Add follow-ups to mitigate bias: Number of studies, type (qual/quant), incentives received, confidentiality constraints\u2014use to weight or exclude over-surveyed respondents."
            ]
          },
          {
            "question_id": "q7",
            "question_text": "Which statement best describes your involvement in choosing brands for everyday household products?",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)"
            ],
            "coverage_quality": 0.05,
            "gaps_identified": [
              "Question is off-topic: asks about choosing brands for everyday household products, not AI diagnostic tools in hospitals.",
              "Does not map decision-making hierarchy for AI tool adoption within hospitals.",
              "No insight into budget approval processes, thresholds, or timelines.",
              "No measurement of clinical staff acceptance, drivers, or barriers for AI tools.",
              "No assessment of privacy, data governance, or compliance requirements.",
              "No evaluation of ROI expectations or economic criteria for AI tools.",
              "No exploration of HIS/EMR integration and interoperability requirements.",
              "No coverage of regulatory compliance pathways for AI diagnostics.",
              "No competitive landscape perceptions of GE, Philips, Siemens, or other vendors.",
              "Inapplicable to KANO feature prioritization for AI diagnostics.",
              "Not suitable for discrete choice modeling on AI pricing/feature trade-offs.",
              "Does not identify adoption triggers/barriers across clinical, technical, financial, regulatory dimensions.",
              "No benchmarking of current adoption rates or maturity for AI diagnostics.",
              "No insight into preferred procurement/contracting models for AI solutions.",
              "No coverage of data integration and model lifecycle expectations (updates, monitoring, bias).",
              "No assessment of training, change management, or support needs.",
              "No identification of high-value clinical areas/use cases for AI diagnostics.",
              "No mapping of external guidelines or payer incentives impacts.",
              "No identification of differentiating features beyond top three competitors.",
              "Does not help with sampling strategy or qualifying respondents in mid-sized hospitals."
            ],
            "improvement_suggestions": [
              "Rewrite the question to target hospital decision contexts, e.g., \"Which statement best describes your role in evaluating and selecting AI-powered diagnostic tools at your hospital? (Options: ultimate decision maker; shared decision maker; recommender/influencer; evaluator; budget approver; technical gatekeeper; no involvement).\"",
              "Add a screener to qualify respondents from mid-sized hospitals (100\u2013500 beds) and target roles (C-suite, CIO, CMIO, CMO, department heads, IT/security).",
              "Include follow-ups to map hierarchy: \"Who else is typically involved at each stage (clinical evaluation, IT/security review, budget approval, final sign-off)?\"",
              "Incorporate budget items: \"What is the approval threshold for capital/opex purchases of AI tools and typical timelines?\"",
              "Add items on clinical acceptance: perceived benefits, barriers, and required evidence (e.g., workflow fit, accuracy, liability).",
              "Include privacy/governance and regulatory prompts: data flows, PHI handling, consent, IRB, FDA clearance expectations.",
              "Probe integration requirements: HIS/EMR interfaces, standards (HL7/FHIR/DICOM), security reviews, sandbox/pilot needs.",
              "Collect ROI/economic criteria: required KPIs (diagnostic accuracy uplift, turnaround time, LOS, readmissions), payback period, budget source.",
              "Assess vendor perceptions: ratings and differentiation of GE Healthcare, Philips, Siemens Healthineers, and others.",
              "Add feature prioritization items suitable for KANO and design a DCE block for price/feature trade-offs.",
              "Benchmark current adoption, pilots, contract models (SaaS, per-study, enterprise), and support/training expectations.",
              "Map external influences: payer incentives, professional society guidelines, and health system policies."
            ]
          },
          {
            "question_id": "q8",
            "question_text": "Please select the number four from the list below.",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "Does not capture any information related to decision-making hierarchy for AI diagnostics",
              "No data on budget approval processes, thresholds, or timelines",
              "No assessment of clinician acceptance, drivers, or barriers",
              "No information on patient privacy concerns or data governance requirements",
              "No ROI expectations or economic evaluation criteria",
              "No insights into HIS/EMR integration challenges or interoperability requirements",
              "No coverage of regulatory compliance barriers or pathways",
              "No perceptions of competitive landscape (GE, Philips, Siemens) or vendor differentiation",
              "No inputs for KANO feature classification",
              "No attributes/prices for discrete choice modeling or willingness to pay",
              "No profiling of decision-maker roles or segmentation variables",
              "No contribution to sampling strategy or qualification of respondents",
              "No identification of cross-functional adoption triggers/barriers",
              "No benchmarking of current adoption or maturity levels",
              "No data on preferred procurement/contracting models",
              "No expectations on model lifecycle, monitoring, bias, or transparency",
              "No insights on training, change management, or support needs",
              "No identification of high-value clinical areas/use cases",
              "No mapping of external guidelines or payer incentives impact",
              "No identification of differentiating features beyond top competitors"
            ],
            "improvement_suggestions": [
              "Replace with a screening flow to qualify respondents (role, hospital size, geography) to meet sampling objectives",
              "Add modules aligned to each objective, e.g., decision-making RACI for AI diagnostics; budget thresholds, timeline, and funding sources",
              "Include clinician acceptance items using validated scales (e.g., TAM constructs: perceived usefulness, ease of use, trust, workflow fit)",
              "Add privacy/data governance questions on PHI use, de-identification, data residency, consent, and security certifications",
              "Gather ROI criteria: required payback period, NPV/IRR thresholds, clinical KPIs, and evidence standards",
              "Assess integration: current HIS/EMR, interfaces (HL7/FHIR/DICOM), IT resources, security review steps, sandbox/testing needs",
              "Regulatory: required documentation (FDA/CE status), validation evidence, post-market surveillance expectations",
              "Competitive perceptions: familiarity, trials, satisfaction, strengths/weaknesses of GE, Philips, Siemens, and others",
              "KANO battery on feature set (must-have, one-dimensional, attractive, indifferent) for prioritized features",
              "Discrete choice/conjoint design with price, deployment model, integration depth, support SLAs, regulatory status",
              "Profile decision-makers and segment by attitudes, risk tolerance, innovation maturity, and budget authority",
              "Procurement/contracting: preferred models (per-study, per-user, enterprise, outcome-based), contract length, and terms",
              "Lifecycle expectations: update cadence, monitoring dashboards, bias audits, model cards, and performance transparency",
              "Training/change management: onboarding hours, formats, super-user models, vendor support expectations",
              "Use cases: rank clinical areas by value and readiness (radiology, cardiology, pathology, ED triage, sepsis alerts, etc.)",
              "External factors: impact of payer reimbursement, guidelines (e.g., ACR, FDA action plans), and liability concerns",
              "Benchmark adoption: current deployment stage, pilots vs. production, number of tools in use, and maturity model stage"
            ]
          },
          {
            "question_id": "q9",
            "question_text": "What is your gender?",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.12,
            "gaps_identified": [
              "Does not capture role, department, seniority, or decision influence needed to map decision-making hierarchy.",
              "No information about budget thresholds, approval steps, or timelines.",
              "No insight on clinical acceptance, drivers, or barriers to AI adoption.",
              "No coverage of privacy, data governance, or regulatory compliance requirements.",
              "No information on ROI expectations, value metrics, or economic evaluation criteria.",
              "No data on integration with HIS/EMR and interoperability requirements.",
              "No competitive landscape perceptions (GE, Philips, Siemens Healthineers) or vendor differentiation.",
              "Not suited for KANO analysis of features or discrete choice modeling for pricing/WTP.",
              "Provides no data to benchmark adoption rates or maturity.",
              "Does not identify procurement models or contracting preferences.",
              "No insight on model lifecycle expectations (updates, monitoring, bias, performance transparency).",
              "No coverage of training, change management, or support needs.",
              "No identification of high-value clinical use cases.",
              "No assessment of external guidelines or payer incentives.",
              "Does not help identify differentiating features beyond top competitors."
            ],
            "improvement_suggestions": [
              "Include role/position, department, seniority, and decision influence questions (e.g., RACI for AI diagnostic tool adoption).",
              "Add budget authority, approval thresholds, funding sources, and timeline questions.",
              "Include clinician acceptance items (Likert scales on usefulness, trust, workflow fit; barriers/drivers).",
              "Add privacy/data governance items (PHI use, de-identification, data residency, audit trails, consent).",
              "Include ROI/value criteria, required evidence, and payback expectations.",
              "Add integration and interoperability questions (HIS/EMR vendors, standards used, API requirements, IT constraints).",
              "Include regulatory readiness and compliance pathway questions (FDA/CE status, documentation expectations).",
              "Add vendor perception and selection criteria items for GE, Philips, Siemens Healthineers, and others.",
              "Include KANO-style feature classification questions and discrete choice experiments for pricing/feature trade-offs.",
              "Collect adoption status, stage, and maturity indicators.",
              "Ask about procurement and contracting models (CapEx vs OpEx, subscriptions, outcome-based, pilots).",
              "Include model lifecycle management expectations (updates, monitoring, bias, transparency, performance SLAs).",
              "Add training/change management/support needs and preferred delivery formats.",
              "Identify high-priority clinical areas/use cases and perceived impact.",
              "Ask about influence of external guidelines and payer incentives on adoption decisions.",
              "If gender is retained, clarify response options to be inclusive and explain its analytic purpose (e.g., for demographic weighting) with options such as: Male, Female, Non-binary, Prefer to self-describe: __, Prefer not to say."
            ]
          },
          {
            "question_id": "q10",
            "question_text": "What is your approximate annual household income before taxes?",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.12,
            "gaps_identified": [
              "Does not capture organizational decision-making hierarchy or influencers for AI tool adoption.",
              "Provides no information on budget approval processes, thresholds, timelines, or funding mechanisms.",
              "Does not assess clinician acceptance, barriers, or drivers for AI tools.",
              "No insight into privacy, data governance, or compliance requirements and risks.",
              "Does not measure ROI expectations, value metrics, or purchasing criteria.",
              "No data on integration challenges, HIS/EMR interoperability, or workflow fit.",
              "Does not address regulatory pathways, documentation, or validation needs.",
              "Provides no information on vendor perceptions (GE, Philips, Siemens) or broader competitive landscape.",
              "Unsuitable for KANO feature classification or feature prioritization.",
              "Does not inform procurement or contracting model preferences.",
              "No information on model lifecycle expectations (updates, monitoring, bias transparency).",
              "Does not address training, change management, or support service needs.",
              "No insight into high-value clinical areas or use cases for AI diagnostics.",
              "Does not assess the impact of external guidelines or payer incentives.",
              "Does not benchmark current adoption rates or maturity.",
              "Provides limited utility for role-based profiling beyond potential socioeconomic segmentation, which is weakly related in a B2B hospital context."
            ],
            "improvement_suggestions": [
              "Replace or complement household income with hospital/department budget parameters: annual capital and operating budget ranges for diagnostics/IT, typical approval thresholds, and spending authority by role.",
              "Add decision-making and governance items: roles involved, RACI across stages (identification, evaluation, pilot, procurement), and committee participation (value analysis, IT governance, privacy).",
              "Include budget approval mechanics: steps, timelines, sign-off levels, threshold amounts, and funding sources (capital, operating, grants, payer programs).",
              "Measure clinician acceptance: perceived usefulness, trust, workflow fit, and barriers (liability, usability, alert fatigue), using Likert scales.",
              "Assess privacy/data governance: PHI handling, de-identification, data sharing policies, required safeguards, and acceptable data residency.",
              "Capture ROI criteria: required payback period, hurdle rates, clinical outcomes prioritized, and evidence types needed.",
              "Evaluate integration requirements: EHR/HIS vendors, interface standards (HL7, FHIR, DICOM), SSO, audit, and performance requirements.",
              "Map regulatory expectations: required certifications, validation evidence, and post-market surveillance expectations.",
              "Add vendor perception modules and competitive comparisons for GE, Philips, Siemens, and others; measure differentiation drivers.",
              "Include KANO-style feature battery with functional/dysfunctional phrasing to classify must-haves, satisfiers, and delighters.",
              "Design DCE attributes/levels for pricing and features; household income should be replaced by organizational budget constraints and WTP proxies.",
              "Profile respondents by role, department, hospital size (beds 100\u2013500), ownership type, region, EHR system, and adoption stage.",
              "Benchmark adoption maturity: current deployments, pilots, timelines, and scale.",
              "Probe procurement preferences: purchase vs subscription, risk-sharing, pilot-to-contract pathways, and contracting barriers.",
              "Assess lifecycle expectations: update cadence, performance monitoring, bias audits, and transparency reports.",
              "Include training/change management needs: onboarding time, preferred formats, support SLAs, and success metrics."
            ]
          },
          {
            "question_id": "q11",
            "question_text": "What is the highest level of education you have completed?",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not identify decision-making roles, influence, or hierarchy for AI adoption.",
              "Provides no insight into budget approval thresholds, processes, or timelines.",
              "Does not measure clinical acceptance, drivers, or barriers.",
              "No assessment of privacy concerns, data governance, or compliance expectations.",
              "No information on ROI criteria, value metrics, or economic evaluation.",
              "No coverage of integration/interoperability requirements with HIS/EMR.",
              "No mapping of regulatory pathways or validation needs.",
              "No competitive perceptions of GE, Philips, Siemens, or other vendors.",
              "Not suitable for KANO feature classification or prioritization.",
              "Not actionable for discrete choice modeling or WTP estimation.",
              "Does not adequately profile target decision-makers beyond a basic demographic.",
              "Does not help benchmark adoption rates or maturity.",
              "No information on procurement/contracting models.",
              "No insight into model lifecycle expectations (updates, monitoring, bias).",
              "No information on training, change management, or support services.",
              "Does not identify clinical areas/use cases with highest value.",
              "No assessment of external guidelines or payer incentives.",
              "No identification of differentiating features driving vendor selection."
            ],
            "improvement_suggestions": [
              "Add role and authority: What is your current role/title? Which of the following decisions are you directly involved in for AI diagnostics (influencer, recommender, approver, final signer)?",
              "Add organizational context: Which department do you primarily represent? How many beds does your hospital have? Is your organization part of an IDN?",
              "Add budget/review thresholds: What is the maximum purchase amount you can approve? What committees must review AI diagnostic purchases and typical review timelines?",
              "Add adoption/attitudes: Rate your agreement with statements on AI clinical value, workflow impact, and risks; list top drivers/barriers.",
              "Add privacy/governance: Who is responsible for data governance? What safeguards and compliance frameworks are required (HIPAA, SOC 2, ISO 27001, ONC HTI-1, state laws)?",
              "Add ROI/evaluation: Which metrics are required for approval (diagnostic accuracy, LOS reduction, readmission rates, cost per case, NPV payback)? Minimum evidence thresholds?",
              "Add integration: What EMR/HIS systems are in use? Required interoperability standards (HL7 v2, FHIR, DICOM, SSO/OIDC, audit logs)? Key integration pain points?",
              "Add regulatory: What regulatory clearances are required (FDA class, 510(k)/De Novo), documentation needs, and post-market surveillance expectations?",
              "Add competitive perceptions: Rate familiarity and preference for GE, Philips, Siemens, and others; key differentiators and concerns.",
              "Add KANO inputs: Classify potential features as must-have, performance, attractive, indifferent, or reverse.",
              "Add DCE inputs: Present choice tasks varying features, pricing, deployment model (SaaS vs on-prem), and support to estimate WTP.",
              "Add adoption baseline: Current deployment stage of AI diagnostics and number of live use cases.",
              "Add procurement models: Preferred contracting (subscription, usage-based, per-study, enterprise license), term length, and risk-sharing.",
              "Add lifecycle expectations: Requirements for model updates, monitoring, bias audits, version transparency, and performance reporting.",
              "Add enablement: Training modalities, change management support, SLAs, and success metrics.",
              "Add use cases: Rank clinical areas where AI delivers highest value (radiology triage, cardiology echo, pathology, ED, ICU, etc.).",
              "Add external levers: Impact of payer incentives, quality programs, and professional society guidelines on prioritization.",
              "Retain education but contextualize: Ask highest education AND field of study/clinical background to improve persona segmentation."
            ]
          },
          {
            "question_id": "q12",
            "question_text": "Which categories of consumer products have you purchased in the past 3 months? Personal care, Household cleaning, Packaged food and beverages, Paper goods, Laundry products.",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "No linkage to hospital decision-making hierarchy or roles for AI diagnostic adoption",
              "No insight into budget approval processes, thresholds, or timelines",
              "No measurement of clinician acceptance, drivers, or barriers to using AI",
              "No assessment of patient privacy concerns or data governance requirements",
              "No data on ROI expectations or value metrics for AI diagnostics",
              "No information on HIS/EMR integration or interoperability requirements",
              "No mapping of regulatory compliance barriers or pathways",
              "No evaluation of competitive landscape (GE, Philips, Siemens Healthineers) or vendor perceptions",
              "No inputs for KANO feature classification of AI diagnostic tools",
              "No attributes/prices for discrete choice modeling or willingness-to-pay estimation",
              "No profiling of target decision-makers in mid-sized hospitals or segmentation by attitudes/needs",
              "No sampling control to ensure 150+ qualified responses from target hospital roles",
              "No identification of cross-functional adoption triggers/barriers",
              "No benchmarking of current adoption rates or maturity of AI diagnostics in mid-sized hospitals",
              "No preferred procurement or contracting models for AI solutions",
              "No expectations for model lifecycle management (updates, monitoring, bias, transparency)",
              "No needs for training, change management, or support services",
              "No identification of high-value clinical areas and use cases for AI diagnostics",
              "No assessment of impact of external guidelines or payer incentives",
              "No identification of differentiating features beyond the top three vendors"
            ],
            "improvement_suggestions": [
              "Screen respondents to ensure they work in mid-sized hospitals (100\u2013500 beds) and hold relevant roles (C-suite, CIO, CMIO, CMO, department heads, IT, procurement, compliance).",
              "Add questions mapping decision-making hierarchy: influencers, decision-makers, committees involved, and stage-gates in the adoption process.",
              "Include budget and funding items: typical budget owners, approval thresholds, cycle timelines, capex vs opex preferences, and sources of funds.",
              "Measure clinician acceptance: Likert scales on willingness to use, perceived usefulness, trust, required evidence, and barriers (workflow impact, liability, false positives).",
              "Assess privacy and governance: data types processed, de-identification, PHI flows, consent, data residency, retention, auditability, and governance committees\u2019 requirements.",
              "Capture ROI criteria: required clinical endpoints, cost savings, throughput gains, payback period, NPV/IRR thresholds, and evidence standards.",
              "Probe integration: current HIS/EMR vendors, interoperability standards (HL7 v2/FHIR/DICOM), SSO, PACS/VNA, latency, uptime, and IT validation requirements.",
              "Address regulatory: expectations for FDA/CE status, post-market surveillance, model transparency, documentation, and validation evidence.",
              "Evaluate vendors: perception of GE, Philips, Siemens Healthineers and others; strengths/weaknesses; selection drivers and objection handlers.",
              "Include KANO items: classify key features into must-have, performance, delighters with functional/dysfunctional pair questions.",
              "Design a discrete choice experiment: vary price, integration level, performance metrics (sensitivity/specificity), deployment model, support SLAs, and regulatory status.",
              "Profile and segment: role, department, decision authority, risk tolerance, innovation orientation, budget control, and strategic priorities.",
              "Benchmark adoption: current usage, pilots, maturity stage, deployment scale, and outcomes achieved.",
              "Procurement model preferences: purchase vs subscription vs usage-based, enterprise vs departmental, trial/pilot terms, contracting constraints.",
              "Model lifecycle expectations: update cadence, monitoring dashboards, bias assessments, performance drift alerts, rollback, and human-in-the-loop.",
              "Training and change management: required training formats, time, super-user models, support SLAs, and go-live assistance.",
              "Prioritize use cases: departments (radiology, cardiology, ED, ICU, pathology), workflows, and perceived value/urgency.",
              "External factors: payer incentives, reimbursement codes, professional society guidelines, malpractice and liability considerations.",
              "Include quotas and verification items to reach 150+ qualified respondents and validate role/hospital size."
            ]
          },
          {
            "question_id": "q13",
            "question_text": "Thinking about the category you purchase most often, how frequently do you buy products in that category?",
            "mapped_objectives": [
              "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals. (Intent: Provide baseline context on how widespread and mature adoption currently is.)"
            ],
            "coverage_quality": 0.05,
            "gaps_identified": [
              "The question is consumer-retail oriented and not tailored to hospital procurement or AI diagnostics.",
              "It does not reference AI diagnostic tools, healthcare settings, or organizational purchasing behavior.",
              "No linkage to decision-making hierarchy or stakeholder roles.",
              "No insight into budget approval processes, thresholds, or timelines.",
              "No assessment of clinical staff acceptance, drivers, or barriers.",
              "No evaluation of privacy, data governance, or regulatory requirements.",
              "No information on ROI expectations, evaluation criteria, or pricing sensitivity.",
              "No coverage of integration with HIS/EMR or interoperability needs.",
              "No insight into vendor perceptions or competitive landscape.",
              "Not suitable for KANO feature classification or discrete choice modeling inputs.",
              "No segmentation of decision-maker roles or attitudes.",
              "No information on procurement models, contracting preferences, or funding mechanisms.",
              "No coverage of model lifecycle expectations (updates, monitoring, bias) or support/training needs.",
              "No mapping of clinical use cases or areas of highest value.",
              "No understanding of external guidelines or payer incentives."
            ],
            "improvement_suggestions": [
              "Reframe to the healthcare AI context and role-targeting. Example: Which best describes your organization\u2019s current stage of adoption for AI-powered diagnostic tools? (Not evaluating, evaluating/piloting, limited deployment, scaled deployment, no plans).",
              "Add decision-making hierarchy items. Example: Who initiates, influences, and makes final decisions for AI diagnostic tool adoption in your hospital? (Select roles and indicate level of influence).",
              "Capture budget and approval mechanics. Example: What is the typical budget threshold requiring board approval for diagnostic technology purchases? What is the average time from business case submission to final approval?",
              "Assess clinician acceptance. Example: Please rate your clinical staff\u2019s willingness to use AI diagnostic tools and top drivers/barriers (list).",
              "Address privacy and governance. Example: Which data governance requirements must be satisfied for AI diagnostics (HIPAA, SOC 2, PHI de-identification, on-prem data retention, auditability)?",
              "Measure ROI criteria. Example: Which metrics are required to justify investment (diagnostic accuracy improvement, throughput, LOS reduction, reimbursement uplift, total cost of ownership)?",
              "Probe integration. Example: What interoperability standards and integrations are required (HL7 v2, FHIR, DICOM, PACS/RIS/EMR)? What are the top integration challenges?",
              "Regulatory pathway. Example: Which regulatory clearances/certifications are necessary (FDA 510(k)/De Novo, CE MDR)? What documentation/validation is required?",
              "Vendor perceptions. Example: Please rate GE Healthcare, Philips, Siemens Healthineers, and others on trust, performance, integration ease, service, and pricing; indicate preferred vendor and reasons.",
              "KANO inputs. Example: Classify listed features (must-have, performance, delighter, indifferent, reverse) for AI diagnostic tools.",
              "Discrete choice readiness. Example: Present conjoint-style choice sets varying price, accuracy uplift, integration effort, privacy features, service SLAs, regulatory status.",
              "Segmentation and personas. Example: Identify your role (CIO, CMO, Radiology Director, CFO, etc.), hospital size, region, and strategic stance toward AI.",
              "Procurement models. Example: Preferred contracting options (capital purchase, subscription/SaaS, usage-based, risk-share/outcomes-based).",
              "Lifecycle expectations. Example: Expectations for model updates, monitoring, bias evaluation, explainability, and performance reporting cadence.",
              "Training and change management. Example: Required training modalities, go-live support, and ongoing service levels.",
              "Use cases. Example: Rank AI diagnostic use cases by perceived value (e.g., radiology triage, cardiology imaging analysis, sepsis prediction).",
              "External incentives. Example: Impact of payer reimbursement, quality measures, and professional society guidelines on adoption priority.",
              "Sampling control. Example: Screeners to ensure respondents are decision-makers in mid-sized hospitals (100\u2013500 beds) and involved in AI or diagnostic technology decisions."
            ]
          },
          {
            "question_id": "q14",
            "question_text": "How familiar are you with brands in your most-purchased category?",
            "mapped_objectives": [],
            "coverage_quality": 0.5,
            "gaps_identified": [
              "Unable to perform detailed analysis"
            ],
            "improvement_suggestions": [
              "Consider LLM-powered analysis for detailed insights"
            ]
          },
          {
            "question_id": "q15",
            "question_text": "When choosing products in your most-purchased category, how important are the following factors? Price, Quality, Brand reputation, Sustainability, Convenience, Promotions or discounts.",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)",
              "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers. (Intent: Determine how target hospitals perceive key vendors, their differentiation, and selection drivers.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not reference AI diagnostics or hospital context; framed as generic consumer product purchasing.",
              "No mapping of decision-making hierarchy, roles, or influence pathways.",
              "No content on budget approval processes, thresholds, committees, or timelines.",
              "Does not assess clinician acceptance, workflow fit, or clinical efficacy/safety perceptions.",
              "No treatment of patient privacy, data governance, or regulatory compliance.",
              "Omits integration with HIS/EMR, interoperability standards, and IT requirements.",
              "Lacks vendor-specific perceptions (GE, Philips, Siemens) or broader competitive set.",
              "Not structured for KANO feature classification.",
              "Insufficient for discrete choice modeling; lacks attribute levels, trade-off tasks, and price framing relevant to enterprise procurement.",
              "No profiling of decision-maker roles or segmentation by attitudes/needs.",
              "No benchmarking of current adoption, maturity, or use-case prioritization.",
              "No procurement/contracting model preferences (e.g., CapEx vs. SaaS vs. per-study).",
              "No lifecycle expectations (model updates, monitoring, bias, transparency).",
              "No training, change management, or support needs.",
              "No payer incentives, external guidelines, or reimbursement considerations.",
              "No ROI metric definitions (e.g., payback, IRR, total cost of ownership)."
            ],
            "improvement_suggestions": [
              "Contextualize to AI diagnostics in mid-sized hospitals and specify the decision context (evaluation/selection of AI diagnostic tools).",
              "Replace generic factors with enterprise-relevant attributes and define levels for modeling: price/total cost (CapEx, SaaS, per-study), integration effort (HL7/FHIR readiness, EMR compatibility), clinical performance (sensitivity/specificity vs. standard of care), workflow impact (time to result, automation), data/privacy safeguards (PHI handling, de-identification, on-prem/cloud), regulatory status (FDA/CE class, validation evidence), vendor support (training, uptime SLAs), and procurement model.",
              "Add role-targeted questions to map decision hierarchy: identify initiators, influencers, decision-makers, and approvers; capture committee structures and stage-gates.",
              "Insert budget process items: approval thresholds, budget cycles, funding sources, and typical timelines.",
              "Include clinician adoption scales: perceived usefulness, ease of use, trust, explainability needs, and required conditions for use.",
              "Add privacy/data governance items: HIPAA policies, data residency, audit/logging, model monitoring, bias management, and DUA/BAA requirements.",
              "Capture integration/interoperability: current HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), IT constraints, and security certifications.",
              "Vendor landscape module: unaided/aided awareness, consideration, differentiation, satisfaction with GE/Philips/Siemens and others.",
              "Design a discrete choice experiment or conjoint with realistic attribute levels and price points; supplement with Gabor-Granger/Van Westendorp for WTP bounds.",
              "Include KANO classification questions for prioritized features (must-have, performance, delighters).",
              "Profile respondents: role, department, hospital size (beds 100\u2013500), teaching status, ownership, region; segment by attitudes and needs.",
              "Benchmark adoption: current use, pilot status, number of tools, maturity, and clinical areas in use.",
              "Procurement preferences: contracting models, risk-sharing/outcomes-based options, trial/pilot terms.",
              "Lifecycle expectations: update cadence, validation transparency, performance dashboards, human-in-the-loop requirements.",
              "Training/change management: preferred formats, time investment, super-user models, and post-go-live support.",
              "Add external environment: impact of payer incentives, guidelines, and accreditation requirements on adoption priority."
            ]
          },
          {
            "question_id": "q16",
            "question_text": "Based on the concept you just reviewed, how appealing is this product overall?",
            "mapped_objectives": [
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Conduct KANO model analysis to prioritize AI diagnostic tool features. (Intent: Classify features by their impact on satisfaction to guide product roadmap and messaging.)"
            ],
            "coverage_quality": 0.22,
            "gaps_identified": [
              "Does not map decision-making hierarchy or roles involved in adoption.",
              "No insight into budget approval processes, thresholds, timelines, or funding mechanisms.",
              "Does not quantify ROI expectations or economic evaluation criteria.",
              "No detail on privacy, data governance, or compliance safeguards.",
              "Omits integration and interoperability requirements with HIS/EMR systems.",
              "Does not address regulatory pathways or validation documentation needs.",
              "No competitive landscape assessment or vendor perceptions (GE, Philips, Siemens, others).",
              "Not suitable for discrete choice or pricing sensitivity estimation.",
              "No profiling of target decision-makers or segmentation by attitudes/needs.",
              "Does not benchmark current adoption rates or maturity.",
              "No information on procurement/contracting model preferences.",
              "Lacks expectations on model lifecycle management (updates, monitoring, bias, transparency).",
              "No coverage of training, change management, or support service needs.",
              "Does not identify specific clinical areas/use cases with highest value.",
              "No assessment of external guidelines or payer incentives\u2019 impact.",
              "Does not identify differentiating features driving vendor selection beyond top three."
            ],
            "improvement_suggestions": [
              "Add respondent role and involvement: Which of the following best describes your role in AI diagnostic tool decisions? and What level of influence do you have? (7-point scale).",
              "Budget and approval flow: What is the typical budget threshold requiring C-suite approval? and What is the usual approval timeline? (ranges).",
              "ROI criteria: Please rate importance of each metric (diagnostic accuracy delta, LOS reduction, readmission reduction, throughput, total cost of ownership, payback period).",
              "Privacy/governance: How concerned are you about each privacy risk? Which safeguards are required? (HIPAA compliance evidence, de-identification, on-prem processing, BAA, audit logs).",
              "Integration: Indicate required integrations (HL7, FHIR, DICOM, single sign-on, PACS, EMR order/result, API). Rate perceived integration difficulty.",
              "Regulatory: Which validations are necessary? (FDA clearance class, clinical validation level, post-market surveillance).",
              "Competitive perception: Rate familiarity and perceived strengths/weaknesses of GE, Philips, Siemens, and other vendors. Include open-end on differentiation.",
              "KANO feature battery: For each proposed feature, ask functional/dysfunctional KANO questions to classify must-have, performance, delighters.",
              "Pricing/DCE: Implement a discrete choice experiment varying price, deployment model (SaaS, on-prem), integration depth, regulatory status, support SLAs, and key features.",
              "Segmentation: Attitudinal batteries (innovation readiness, risk tolerance, data governance strictness) to cluster personas across C-suite, CIO, CMO, department heads.",
              "Adoption benchmark: What best describes your current stage with AI diagnostics? (not considering \u2192 piloting \u2192 scaled).",
              "Procurement models: Preferred contracting options (subscription per study, per device, enterprise license, outcome-based).",
              "Lifecycle expectations: Requirements for model updates, monitoring, bias assessments, performance dashboards, rollback processes.",
              "Training/change management: Required training formats, hours, roles, and vendor support expectations.",
              "Use cases: Rank clinical areas/use cases by value and urgency (radiology triage, cardiology imaging, sepsis prediction, pathology, etc.).",
              "External levers: Influence of payer incentives and professional guidelines on adoption priority.",
              "Revise the overall-appeal item to be role- and context-specific: How appealing is this product for your organization given your role\u2019s priorities? followed by Why? (open-end) to capture drivers/barriers."
            ]
          },
          {
            "question_id": "q17",
            "question_text": "How likely are you to consider purchasing this product within the next month?",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals. (Intent: Provide baseline context on how widespread and mature adoption currently is.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not map the decision-making hierarchy or roles influencing adoption.",
              "No insight into budget approval processes, thresholds, or timelines.",
              "Does not measure clinical staff acceptance, drivers, or barriers.",
              "No assessment of patient privacy concerns or data governance requirements.",
              "No ROI metrics, value criteria, or economic evaluation frameworks.",
              "No data on HIS/EMR integration or interoperability requirements.",
              "No detail on regulatory compliance pathways or barriers.",
              "No competitive landscape perceptions (GE, Philips, Siemens, others).",
              "Cannot support KANO feature classification.",
              "Insufficient for discrete choice modeling\u2014lacks attributes and price levels.",
              "No profiling/segmentation of decision-makers by role or attitudes.",
              "No sampling strategy or qualification checks embedded.",
              "Does not identify adoption triggers/barriers across dimensions.",
              "Does not benchmark current adoption/maturity beyond vague intent.",
              "No procurement/contracting model preferences.",
              "No expectations for model lifecycle (updates, monitoring, bias, transparency).",
              "No training/change management/support requirements.",
              "No use-case/clinical area prioritization.",
              "No impact of external guidelines or payer incentives.",
              "No differentiating feature drivers beyond top competitors."
            ],
            "improvement_suggestions": [
              "Add role/decision influence items: e.g., Which roles initiate, influence, and approve AI diagnostic purchases? Use RACI or staged approval matrices.",
              "Include budget and approval thresholds: approval limits by role, annual budget cycles, CAPEX vs OPEX, timeline from proposal to approval.",
              "Measure clinician acceptance: Likert scales on perceived usefulness, ease of use, workflow fit, and specific barriers (liability, alert fatigue, trust).",
              "Privacy and governance: items on PHI use, de-identification, data residency, consent, audit, and security certifications required.",
              "ROI and evaluation criteria: required clinical endpoints, payback period, IRR/NPV thresholds, total cost components considered.",
              "Integration requirements: HIS/EMR vendors in use, standards (HL7, FHIR, DICOM), SSO, data pipelines, IT resource constraints.",
              "Regulatory: required clearances (FDA Class, CE), validation evidence, post-market surveillance expectations.",
              "Competitive perceptions: rating and selection drivers for GE/Philips/Siemens and other vendors; awareness and shortlist dynamics.",
              "KANO items: classify feature set using functional/dysfunctional pairs to identify must-haves, performance, delighters.",
              "Discrete choice modules: design DCE with price, deployment model, integration depth, regulatory status, performance claims, support SLAs.",
              "Segmentation: collect demographics (role, department, hospital size, region), attitudes toward innovation, risk tolerance.",
              "Adoption benchmarking: current deployment stage, number of tools live/piloted, years of use, volume of cases touched by AI.",
              "Procurement models: preferences for subscription vs perpetual, usage-based, risk-sharing/outcome-based contracts, marketplace purchasing.",
              "Lifecycle and governance: expectations for model updates, drift monitoring, bias assessments, transparency dashboards, change logs.",
              "Training and support: required training hours, modalities, super-user programs, go-live support, ongoing success metrics.",
              "Use cases: rank clinical areas and specific diagnostic tasks by perceived value and urgency.",
              "External environment: effect of payer incentives, guidelines, malpractice insurers, and accreditation bodies.",
              "Refine the intent question itself: add timeframe relevance by role and stage, e.g., Likelihood to recommend for evaluation, pilot, or purchase in next 3/6/12 months; include response options aligned to funnel stages rather than a single generic purchase likelihood."
            ]
          },
          {
            "question_id": "q18",
            "question_text": "How does this concept perform on the following aspects? Clarity of benefits, Uniqueness, Fit with your needs, Trustworthiness, Likelihood to replace current brand.",
            "mapped_objectives": [
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers. (Intent: Determine how target hospitals perceive key vendors, their differentiation, and selection drivers.)",
              "Identify key differentiating features that drive vendor selection beyond the top three competitors. (Intent: Uncover broader competitive threats and opportunities outside the named vendors.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)",
              "Identify clinical areas and use cases with highest perceived value for AI diagnostics. (Intent: Find the departments and applications most likely to yield early wins and ROI.)"
            ],
            "coverage_quality": 0.32,
            "gaps_identified": [
              "No insight into decision-making hierarchy or stakeholder roles in adoption.",
              "Does not capture budget approval processes, thresholds, or funding mechanisms.",
              "Omits patient privacy, data governance, and compliance expectations.",
              "No measurement of ROI expectations, economic criteria, or procurement models.",
              "Lacks integration/interoperability requirements and HIS/EMR workflow fit beyond generic 'fit with your needs.'",
              "No regulatory compliance barriers or required validation evidence.",
              "Insufficient for KANO feature classification; aspects are too high-level and not feature-specific.",
              "Not suitable for discrete choice modeling or price sensitivity.",
              "Does not benchmark current adoption rates or maturity.",
              "Does not assess model lifecycle expectations (updates, monitoring, bias, performance transparency).",
              "No training, change management, or support needs assessment.",
              "Does not link to specific clinical use cases or departments.",
              "Competitive landscape assessment is shallow; lacks vendor-specific attributes and trade-offs.",
              "Does not establish sampling or respondent qualification for targeted roles."
            ],
            "improvement_suggestions": [
              "Add respondent role, department, hospital size, and decision influence questions to map decision-making hierarchy.",
              "Include budget process items: capex/opex, approval thresholds, timeline, committee involvement, and funding sources.",
              "Add ROI/economic criteria batteries (clinical outcomes, LOS reduction, throughput, readmissions, cost offsets) and expected payback/IRR thresholds.",
              "Insert privacy/data governance items: PHI handling, de-identification, data residency, access controls, audit trails, DPIA requirements, HIPAA/GDPR compliance evidence.",
              "Expand integration/interoperability: EHR vendor, interfaces (HL7/FHIR/DICOM), SSO, workflow embedding, IT resourcing, and validation in test environments.",
              "Regulatory evidence needs: FDA/CE status, predicate devices, post-market surveillance, cybersecurity attestations (e.g., SBOM), and required documentation.",
              "KANO feature set: list concrete features and capture Must-have/One-dimensional/Attractive/Indifferent/Reverse using functional/dysfunctional pairs.",
              "Discrete choice/conjoint: construct choice sets with price, deployment model, performance metrics, integration level, support, regulatory status, and vendor.",
              "Clinical acceptance: measure perceived usefulness, ease of use, explainability, override controls, liability concerns, and required training, with barriers/drivers.",
              "Model lifecycle expectations: update cadence, drift monitoring, bias audits, performance transparency, human-in-the-loop, and service-level metrics.",
              "Competitive benchmarking: vendor-specific ratings on trust, service, integration, pricing, roadmap, references, and switching costs; include open-ends.",
              "Adoption maturity: current usage, pilot status, number of use cases live, and near-term plans by department.",
              "Procurement models: preferences for SaaS, per-study, enterprise license, risk-sharing/outcomes-based, and contract length.",
              "Sampling/qualification: screen for mid-sized hospitals (100\u2013500 beds) and target roles (C-suite, CIO, CMO, department head) with purchase influence.",
              "Refine current question\u2019s aspects: split 'Fit with your needs' into clinical workflow fit, IT fit, and compliance fit; separate 'Trustworthiness' into model transparency, data security, and vendor credibility; define 'Likelihood to replace current brand' by time horizon and preconditions."
            ]
          },
          {
            "question_id": "q19",
            "question_text": "Please allocate 100 points across the following benefits to reflect their importance to you: Better performance, Better value for money, Eco-friendly materials, Convenient packaging.",
            "mapped_objectives": [
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)",
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Identify key differentiating features that drive vendor selection beyond the top three competitors. (Intent: Uncover broader competitive threats and opportunities outside the named vendors.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not address decision-making hierarchy or roles involved in adoption.",
              "No insight into budget approval processes, thresholds, or timelines.",
              "Omits privacy, data governance, and regulatory compliance considerations.",
              "No information on integration with HIS/EMR or interoperability requirements.",
              "Not suitable for KANO classification of features.",
              "Not designed for discrete choice modeling or price sensitivity estimation.",
              "Does not benchmark adoption rates or maturity.",
              "Lacks procurement/contracting model preferences.",
              "No assessment of model lifecycle expectations (updates, monitoring, bias).",
              "Does not evaluate training, change management, or support needs.",
              "Does not identify clinical areas/use cases of highest value.",
              "No assessment of external guidelines, payer incentives, or reimbursement.",
              "Does not capture vendor perceptions or competitive landscape comparisons.",
              "Benefits listed are generic and consumer-oriented (e.g., convenient packaging, eco-friendly materials) and misaligned with hospital AI diagnostics.",
              "Lacks role-based segmentation and screening for target decision-makers."
            ],
            "improvement_suggestions": [
              "Replace benefits with healthcare AI\u2013relevant value drivers (e.g., diagnostic accuracy/sensitivity/specificity, time-to-result, workflow integration with EMR/PACS, total cost of ownership, data security/PHI compliance, explainability/auditability, clinical validation evidence, uptime/support SLAs).",
              "Tailor the allocation exercise by role: ask each respondent to allocate points across value drivers from their functional perspective (clinical, IT, finance, compliance) to inform decision hierarchy and cross-functional weighting.",
              "Add items tied to ROI and purchasing (e.g., impact on LOS, readmissions, throughput, staff productivity, reimbursement impact, capital vs. operating expense flexibility).",
              "Include integration and lifecycle items (HL7/FHIR interoperability, model monitoring, bias management, update cadence, vendor transparency).",
              "Include privacy/regulatory items (HIPAA compliance, data residency, de-identification, FDA clearance/AI SaMD evidence, audit trails).",
              "Screen respondents to target C-suite, CIOs, CMOs, radiology/lab heads, and procurement; capture their role in decision stages.",
              "Use multiple tasks: a point-allocation for high-level value drivers, a KANO battery for features, and a discrete choice/conjoint module for price-feature trade-offs.",
              "Add questions on budget thresholds, approval gates, timelines, and procurement models (subscription, per-study, enterprise license, risk-share).",
              "Include vendor perception items to compare GE, Philips, Siemens Healthineers, and others on trust, integration, support, and innovation.",
              "Include use-case prioritization to identify clinical areas with highest perceived value (e.g., radiology triage, sepsis prediction, cardiology imaging).",
              "Add items to capture external influences (payer incentives, accreditation guidelines, system-level mandates)."
            ]
          },
          {
            "question_id": "q20",
            "question_text": "Assuming the product includes the features described, what is the highest price you would be willing to pay for one unit? Please enter a price in your local currency.",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)",
              "Conduct KANO model analysis to prioritize AI diagnostic tool features. (Intent: Classify features by their impact on satisfaction to guide product roadmap and messaging.)"
            ],
            "coverage_quality": 0.32,
            "gaps_identified": [
              "No insight into decision-making hierarchy or roles (influencers vs. deciders).",
              "Does not capture budget approval thresholds, timelines, or funding mechanisms.",
              "No measurement of clinical staff acceptance, adoption drivers, or barriers.",
              "Omits privacy, data governance, and regulatory compliance requirements.",
              "No information on integration with HIS/EMR and interoperability constraints.",
              "Does not compare or position against competitors or vendor perceptions.",
              "Insufficient for KANO classification; lacks satisfaction and must-have/excitement diagnostics.",
              "Single open-ended WTP yields anchoring, outliers, currency/unit ambiguity, and lacks context on purchase model (capex vs opex).",
              "No link to ROI metrics, value drivers, or economic evaluation criteria beyond a raw price number.",
              "No segmentation by role, department, hospital size nuances, or attitude segments.",
              "Does not inform procurement/contracting preferences (subscription, per-study, enterprise license, risk/outcome-based).",
              "No assessment of data integration and model lifecycle expectations (updates, monitoring, bias).",
              "No evaluation of training, change management, or support needs.",
              "No mapping of clinical use cases or high-value departments.",
              "No assessment of external guidelines, reimbursement, or payer incentives.",
              "Inadequate input for discrete choice modeling; lacks feature/price trade-off design."
            ],
            "improvement_suggestions": [
              "Specify purchase model in the question (e.g., annual subscription per site, per-study fee, perpetual license + maintenance) and ask WTP per that model.",
              "Collect role and decision-involvement first, then ask WTP from the perspective of their influence/authority.",
              "Add price sensitivity meter (PSM/Van Westendorp) items alongside the WTP point estimate to mitigate outliers and derive acceptable price ranges.",
              "Use discrete choice/choice-based conjoint tasks presenting realistic feature bundles, integration/service options, and price to estimate trade-offs and WTP more robustly.",
              "Anchor currency and units explicitly (local currency code auto-filled; clarify per site/year, per scanner, per department, or per user).",
              "Include budget context questions: typical approval thresholds, who approves at given price bands, budget cycle timing, and funding sources.",
              "Link WTP to ROI metrics by asking which outcomes would justify the stated price (e.g., reduction in length of stay, throughput gain, diagnostic accuracy uplift) and required evidence levels.",
              "Include KANO items for key features (must-have, performance, excitement) to connect features to satisfaction and pricing.",
              "Add items on integration requirements (HIS/EMR, PACS/VNA, HL7/FHIR standards), deployment model (on-prem, private cloud), and data governance expectations.",
              "Capture procurement preferences (pilot-to-scale, RFP timelines, contracting model, term length, SLAs, risk-sharing).",
              "Assess clinician acceptance: perceived usefulness, workflow fit, training needs, and barriers; tie to WTP by department/use case.",
              "Gather regulatory/compliance expectations (FDA/CE class, validation evidence, post-market monitoring) and impact on purchase likelihood/price tolerance.",
              "Benchmark current adoption and maturity and relate to WTP (adopters vs non-adopters).",
              "Include competitive perception questions and willingness-to-switch at different price points vs GE/Philips/Siemens.",
              "Ask for maximum affordable price under current budget constraints vs ideal price under proven ROI to separate budget ceiling from value ceiling."
            ]
          },
          {
            "question_id": "q21",
            "question_text": "At what price would you consider this product so expensive that you would not consider buying it? Please enter a price in your local currency.",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)"
            ],
            "coverage_quality": 0.22,
            "gaps_identified": [
              "Does not identify decision-makers, influencers, or approval pathways.",
              "No insight into budget thresholds, funding sources, or fiscal timelines.",
              "No measurement of clinician acceptance, workflow fit, or barriers.",
              "Does not address privacy, data governance, or compliance expectations.",
              "Provides only one Van Westendorp price point (too expensive) and lacks other key price thresholds, features, and trade-offs needed for DCM or conjoint.",
              "No information on integration with HIS/EMR, interoperability, or lifecycle requirements.",
              "No benchmarking of current adoption or maturity.",
              "No assessment of vendor perceptions or competitive differentiation.",
              "No insight into preferred procurement/contracting models.",
              "Does not capture KANO feature classification or satisfaction impacts.",
              "No segmentation variables to profile target decision-makers or attitudes.",
              "Lacks clinical use-case prioritization and perceived value by department.",
              "No evaluation of training, change management, or required support services.",
              "No mapping of external guidelines, payer incentives, or regulatory barriers."
            ],
            "improvement_suggestions": [
              "Use the full Van Westendorp Price Sensitivity Meter: ask four price points (too expensive, too cheap, expensive but considered, bargain/good value) and specify the unit of purchase (e.g., annual SaaS license per site, per modality, per bed).",
              "If running DCM/conjoint, collect feature\u2013price trade-offs: define attributes (e.g., integration level, validation evidence, support SLAs, deployment model, data governance features) with realistic price levels.",
              "Anchor responses to the hospital purchasing unit and time horizon (e.g., annual enterprise license for a 300-bed hospital) and capture currency explicitly.",
              "Add budget and approval questions: budget owner, approval thresholds, CAPEX vs OPEX, fiscal cycle timing, and typical procurement duration.",
              "Include role and segmentation items: respondent role, department, decision influence, attitudes toward AI risk/benefit, current adoption stage.",
              "Measure clinical acceptance and barriers: perceived usefulness, workflow impact, required accuracy/validation thresholds, liability concerns.",
              "Capture privacy and governance: data residency, PHI handling, de-identification, auditability, model monitoring and bias controls.",
              "Assess integration and lifecycle: EMR/HIS interfaces, standards (HL7/FHIR/DICOM), IT resources, update cadence, performance transparency.",
              "Evaluate ROI and evaluation criteria: target outcomes (throughput, LOS, diagnostic accuracy), payback period, hurdle rates, TCO components.",
              "Probe procurement models: subscription vs usage-based, outcomes-based contracting, pilots, and proof-of-value requirements.",
              "Benchmark adoption: current tools in use, maturity level, satisfaction, and expansion plans.",
              "Include competitive perception items covering GE, Philips, Siemens Healthineers and other vendors: strengths, weaknesses, and selection drivers.",
              "Add KANO-style feature questions to classify must-have, performance, and delighter features.",
              "Specify guardrails and ranges for price entry to reduce outliers and improve data quality; include an option for 'not applicable/no purchase under any price' to avoid forced numeric entries."
            ]
          },
          {
            "question_id": "q22",
            "question_text": "At what price would you consider this product to be priced so low that you would question its quality? Please enter a price in your local currency.",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)"
            ],
            "coverage_quality": 0.22,
            "gaps_identified": [
              "Does not address decision-making hierarchy or influencer roles in hospital adoption.",
              "No insight into budget approval processes, thresholds, or funding mechanisms.",
              "No measurement of clinical staff acceptance, adoption drivers, or barriers.",
              "Omits privacy, data governance, and compliance expectations.",
              "Provides no data on integration with HIS/EMR or interoperability requirements.",
              "Does not inform regulatory compliance pathways or barriers.",
              "No competitive landscape or vendor perception insights.",
              "Cannot support a KANO feature analysis.",
              "Insufficient for discrete choice modeling: a single Van Westendorp-style price floor item lacks trade-offs, upper price bounds, or purchase likelihood.",
              "Does not create personas/segments beyond a raw price point; lacks role identification and attitudes.",
              "No information on adoption triggers/barriers across clinical, technical, financial, or regulatory dimensions.",
              "Does not benchmark current adoption or maturity.",
              "No data on procurement/contracting model preferences (e.g., SaaS, per-study, capital + service).",
              "No insight into lifecycle expectations (model updates, monitoring, bias, transparency).",
              "No information on training, change management, or support needs.",
              "Does not identify high-value clinical areas/use cases.",
              "No assessment of external guidelines or payer incentives.",
              "No identification of differentiating features beyond top competitors."
            ],
            "improvement_suggestions": [
              "Add the full Van Westendorp Price Sensitivity Meter set: too cheap, cheap/good value, expensive/high side, too expensive, plus a purchase likelihood at given price points.",
              "Incorporate a Gabor-Granger or DCM module that varies price and key features/integration/support terms to estimate WTP and elasticities.",
              "Capture role and influence: ask respondent\u2019s role, department, and decision authority (recommender, influencer, approver, final decision).",
              "Add budget and process items: typical budget holder, approval thresholds, committee involvement, fiscal timing, and capital vs operating budget constraints.",
              "Include clinical adoption drivers/barriers: perceived usefulness, workflow fit, trust, and required evidence levels.",
              "Add privacy/data governance requirements: PHI handling, de-identification, on-prem vs cloud constraints, security certifications, and data-sharing policies.",
              "Include integration questions: required standards (HL7/FHIR/DICOM), EMR/PACS vendors, single sign-on, and IT resources for deployment.",
              "Add regulatory/compliance expectations: needed validations, FDA/CE status, post-market monitoring, and documentation requirements.",
              "Assess vendor perceptions: shortlist vendors, differentiation attributes, and selection criteria.",
              "Include KANO questions to classify features (must-have, performance, delighters) across prioritized use cases.",
              "Profile procurement preferences: pricing/contracting models (subscription, per-study, enterprise license), term length, SLAs, and risk-sharing.",
              "Capture ROI criteria: economic and clinical outcomes required, payback period, threshold ICER, and evaluation metrics used by committees.",
              "Benchmark current state: current tools in use, stage of adoption, pilots vs production, and satisfaction.",
              "Assess training/change management needs: onboarding, super-user models, and vendor support expectations.",
              "Segment by hospital size within 100\u2013500 beds, teaching status, and geography to enable meaningful comparisons."
            ]
          },
          {
            "question_id": "q23",
            "question_text": "How acceptable are the following price points for one unit of the product? $4.99, $6.99, $8.99, $10.99, $12.99.",
            "mapped_objectives": [
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)",
              "Determine preferred procurement and contracting models for AI diagnostic solutions. (Intent: Identify buying models that align with hospital preferences and constraints.)"
            ],
            "coverage_quality": 0.22,
            "gaps_identified": [
              "Does not capture decision-making hierarchy, influencers, or approval pathways.",
              "No information on budget thresholds, approval timelines, or funding mechanisms.",
              "Omits clinician acceptance, adoption drivers/barriers, and workflow impact.",
              "Lacks any assessment of privacy, data governance, or regulatory requirements.",
              "No integration/interoperability context with HIS/EMR or technical constraints.",
              "Price points appear consumer-like ($4.99\u2013$12.99) and implausible for hospital enterprise AI, risking data quality.",
              "No context for unit definition (per-seat, per-study, per-site, per-month, per-modality), which invalidates interpretations.",
              "Single-metric acceptability lacks trade-off structure (features, outcomes, support) needed for DCE/WTP estimation.",
              "No linkage to ROI metrics (clinical outcomes, throughput, LOS, readmissions, sensitivity/specificity gains).",
              "Ignores procurement and contracting preferences (subscription, usage-based, enterprise license, pilot-to-scale).",
              "Does not benchmark current adoption or maturity.",
              "No segmentation by role; responses will conflate perspectives (C-suite vs. clinical vs. IT).",
              "No competitive framing or vendor perception assessment.",
              "No KANO feature prioritization or attributes.",
              "Does not address training, change management, support requirements.",
              "No exploration of external guidelines, payer incentives, or reimbursement effects.",
              "No data integration and model lifecycle expectations (updates, monitoring, bias)."
            ],
            "improvement_suggestions": [
              "Define the pricing unit explicitly (e.g., per-study, per-reader per-month, per-site annual license, per-bed per-year) and align price ranges to realistic enterprise levels.",
              "Use a choice-based conjoint or discrete choice experiment that varies price with key attributes (integration effort, validated accuracy, turnaround time impact, privacy/security certifications, support/SLA, contracting model) to estimate WTP and price elasticity.",
              "Add questions on budget ownership, approval thresholds, and timeline (e.g., capital vs. operating budget, who signs at $50k/$250k/$1M, cycle length).",
              "Segment by role (C-suite, CIO, CMIO, CMO, department heads) and tailor pricing perspectives accordingly.",
              "Include ROI criteria items: target outcome improvements, payback period, total cost of ownership components, reimbursement impacts.",
              "Capture procurement preferences: subscription vs. usage-based vs. enterprise license, pilot terms, risk-sharing/outcomes-based contracts.",
              "Integrate items on data governance, PHI handling, model monitoring, auditability, and regulatory documentation requirements.",
              "Add integration/interoperability measures: EHR/HIS compatibility, standards (HL7/FHIR/DICOM), IT effort estimates, and workflow fit.",
              "Include KANO-style feature questions to classify must-haves, performance, and delighters.",
              "Benchmark current adoption/maturity and identify top clinical use cases by perceived value.",
              "Assess vendor perceptions and differentiators for GE, Philips, Siemens Healthineers, and others.",
              "Calibrate price ranges to hospital-scale budgets (e.g., $10k\u2013$1M+ per year) and include sensitivity checks across tiers."
            ]
          },
          {
            "question_id": "q24",
            "question_text": "Please evaluate how each feature would influence your likelihood to buy. Recyclable packaging, Fragrance-free formula, Family-size pack, Subscription discount available.",
            "mapped_objectives": [
              "Conduct KANO model analysis to prioritize AI diagnostic tool features. (Intent: Classify features by their impact on satisfaction to guide product roadmap and messaging.)",
              "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay. (Intent: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing.)"
            ],
            "coverage_quality": 0.08,
            "gaps_identified": [
              "The item content (recyclable packaging, fragrance-free, family-size pack, subscription discount) is misaligned with AI diagnostic tools and healthcare context.",
              "Does not map decision-making hierarchy or roles involved in hospital technology adoption.",
              "No insight into budget approval processes, thresholds, or timelines.",
              "Does not assess clinician acceptance, workflow fit, or barriers to AI use.",
              "Ignores patient privacy, data governance, and regulatory compliance needs.",
              "No evaluation of ROI metrics, economic criteria, or procurement models relevant to hospitals.",
              "No assessment of integration with HIS/EMR, interoperability, or lifecycle management.",
              "No competitive landscape or vendor perception measurement.",
              "Not structured for KANO classification (must-be, performance, delighters) specific to AI diagnostics.",
              "Not suitable for discrete choice modeling in this domain; lacks realistic attributes/levels and pricing.",
              "No segmentation by role (C-suite, CIO, CMIO/CMO, department heads) or hospital size nuances.",
              "Does not identify clinical use cases or departments with highest value.",
              "No benchmarking of current adoption or maturity."
            ],
            "improvement_suggestions": [
              "Rewrite attributes to be domain-relevant (e.g., EMR integration level [FHIR/HL7 support], on-prem vs. cloud deployment, PHI de-identification, audit logging, model performance metrics, explainability, FDA/CE status, cybersecurity certifications, pricing model, uptime/SLA, workflow integration, training/support).",
              "Add role screening and routing to capture decision hierarchy (e.g., C-suite, CIO, CMIO, department head, IT security, procurement) and ask about their influence and decision stages.",
              "For KANO, use feature-specific functional/dysfunctional questions to classify must-be, performance, and delighters for AI diagnostic features.",
              "For pricing and trade-offs, implement a discrete choice or conjoint exercise with realistic levels (e.g., sensitivity/specificity ranges, integration effort, deployment model, price per study/license, SLA, compliance status).",
              "Include items on budget thresholds, approval steps, committees involved, and typical timelines.",
              "Add modules on clinician acceptance: perceived usefulness, ease of use, workflow impact, liability concerns, alert fatigue, required training.",
              "Include privacy and governance questions: data residency, HIPAA compliance, access controls, retention policies, model monitoring, bias mitigation, auditability.",
              "Assess integration challenges: current HIS/EMR vendors, interface engines, IT resources, API standards, data types supported, validation and sandbox testing needs.",
              "Capture ROI criteria: clinical outcomes, turnaround time reduction, readmission impacts, cost offsets, payor/reimbursement impacts; ask for minimum acceptable thresholds.",
              "Measure vendor perceptions and selection drivers for GE, Philips, Siemens Healthineers, and others; include brand trust, service quality, integration history.",
              "Ask about procurement/contracting preferences: CapEx vs. OpEx, subscription vs. per-study, risk-sharing, pilots/POCs.",
              "Benchmark current adoption and maturity: tools in use, departments, scale, satisfaction, expansion plans.",
              "Segment by hospital size (beds), teaching status, ownership, and region to ensure representativeness."
            ]
          },
          {
            "question_id": "q25",
            "question_text": "Which of the following best describes why you selected your answer to purchase intent?",
            "mapped_objectives": [
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools. (Intent: Identify the financial and clinical value metrics hospitals require to justify investment.)"
            ],
            "coverage_quality": 0.28,
            "gaps_identified": [
              "Does not map decision-making hierarchy or roles influencing purchase intent.",
              "No detail on budget approval processes, thresholds, funding sources, or timelines.",
              "Lacks explicit privacy/data governance, compliance, or regulatory considerations.",
              "No insight into integration with HIS/EMR or interoperability requirements.",
              "Does not capture vendor perceptions or competitive comparisons (GE, Philips, Siemens Healthineers, others).",
              "Not structured for KANO feature classification.",
              "Not suitable for discrete choice modeling or price sensitivity estimation.",
              "Does not profile decision-maker personas or segment by attitudes/needs.",
              "No benchmarking of current adoption rates or maturity levels.",
              "No procurement/contracting model preferences.",
              "No expectations for model lifecycle (updates, monitoring, bias, transparency).",
              "No training/change management/support needs.",
              "Does not identify clinical areas/use cases of highest value.",
              "No impact assessment of external guidelines or payer incentives.",
              "Ambiguous reference to \u201cpurchase intent\u201d without context (which product, stage, timeframe)."
            ],
            "improvement_suggestions": [
              "Specify the referent decision and timeframe: e.g., \u201cThinking about adopting AI diagnostic tools in your hospital within the next 12 months\u2026\u201d",
              "Use a multi-select, factorized list for reasons behind purchase intent covering clinical efficacy, workflow impact, integration effort, data privacy/security, regulatory clearance, ROI/total cost of ownership, budget status, stakeholder support, vendor trust, and external incentives; include \u2018other\u2019 with text.",
              "Add role/context screens: capture respondent\u2019s role, department, influence/decision authority, and committee participation to map hierarchy.",
              "Include budget and procurement items: approval thresholds, funding source, current budget availability, contracting model preferences, and timeline gates.",
              "Embed privacy/governance: PHI handling, data residency, de-identification, consent, auditability, and compliance frameworks required.",
              "Add integration specifics: named HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), IT lift, cybersecurity review, and sandbox/pilot needs.",
              "Capture ROI criteria: target payback period, clinical outcomes metrics, throughput, readmission/LOS, cost offsets, and evidence requirements.",
              "Include clinician adoption drivers/barriers: usability, sensitivity/specificity expectations, trust/explainability, autonomy impact, training needs.",
              "Add regulatory pathway perceptions: FDA class/clearance expectations, post-market monitoring, documentation needs.",
              "Collect vendor perceptions: likelihood to consider GE/Philips/Siemens vs others, differentiation drivers, and trust factors.",
              "Enable KANO tagging by asking respondents to rate candidate features as must-have, performance, attractive, indifferent, reverse.",
              "Support pricing research by following with a discrete choice exercise or Gabor-Granger/van Westendorp and feature bundles.",
              "Benchmark adoption: current deployment stage, number of tools in use, departments, and maturity level.",
              "Segment by personas: attitudes toward innovation, risk tolerance, data governance strictness, and budget flexibility.",
              "Offer an open-ended follow-up to capture nuanced rationale not covered by fixed options."
            ]
          },
          {
            "question_id": "q26",
            "question_text": "How likely are you to recommend this product concept to a friend or colleague?",
            "mapped_objectives": [
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions. (Intent: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market.)",
              "Identify key differentiating features that drive vendor selection beyond the top three competitors. (Intent: Uncover broader competitive threats and opportunities outside the named vendors.)"
            ],
            "coverage_quality": 0.18,
            "gaps_identified": [
              "Does not map decision-making hierarchy or roles involved in adoption.",
              "Provides no insight into budget approval processes, thresholds, or timelines.",
              "Does not evaluate patient privacy concerns or data governance requirements.",
              "No information on ROI expectations, economic metrics, or value thresholds.",
              "Does not assess integration challenges with HIS/EMR or interoperability needs.",
              "No coverage of regulatory compliance barriers or pathways.",
              "Does not analyze competitive landscape perceptions of GE, Philips, Siemens.",
              "Not suitable for KANO feature classification.",
              "Cannot support discrete choice modeling or price sensitivity estimation.",
              "Does not profile or segment decision-makers by attitudes/needs.",
              "Does not benchmark current adoption or maturity levels.",
              "No insight into preferred procurement/contracting models.",
              "Does not cover data integration and model lifecycle expectations.",
              "No assessment of training, change management, or support requirements.",
              "Does not identify high-value clinical areas/use cases.",
              "No measurement of external guidelines or payer incentive impacts.",
              "Does not surface differentiating features beyond top competitors."
            ],
            "improvement_suggestions": [
              "Add role/decision-influence questions: 'Which of the following roles are involved in evaluating/approving AI diagnostics at your hospital? Please indicate influence vs final decision.'",
              "Budget process items: 'What is the typical capital/OPEX approval threshold for AI tools? What is the approval timeline and required documentation?'",
              "Clinical acceptance battery: 'Rate your likelihood to use for specific use cases and indicate top drivers/barriers (workflow fit, accuracy, liability, trust, alert fatigue, explainability).' ",
              "Privacy/governance items: 'Which data types would be processed? Required safeguards (de-identification, on-prem processing, BAAs, audit trails)? Who oversees data governance?'",
              "ROI/economic metrics: 'What ROI/payback period is required? Which metrics matter most (reduced LOS, readmissions, throughput, staffing efficiency)? Evidence required?'",
              "Integration/interoperability: 'Which EHR/HIS systems are in place? Required standards (HL7, FHIR, DICOM, SMART on FHIR)? Integration pain points and IT resourcing?'",
              "Regulatory: 'What certifications/evidence are required (FDA/CE, IEC 62304, ISO 27001, SOC 2)? Post-market surveillance expectations?'",
              "Competitive perceptions: 'Rate familiarity and trust in GE/Philips/Siemens vs emerging vendors; key differentiators; shortlist and elimination criteria.'",
              "KANO feature battery: Classify features as must-have/one-dimensional/attractive/indifferent/reverse via paired functional/dysfunctional questions for key capabilities.",
              "Discrete choice experiments: Construct DCE with attributes (price, deployment model, integration level, explainability, workflow automation, validation evidence) to estimate WTP.",
              "Segmentation: Collect demographics and psychographics (risk tolerance, innovation posture, budget authority) to build personas (CIO, CMO, department head).",
              "Adoption maturity and benchmarking: 'Which AI tools are currently in use? Stage (pilot/scale), usage frequency, measured outcomes.'",
              "Procurement models: 'Preference for SaaS subscription, per-study fee, capital purchase with maintenance, or outcomes-based; contracting constraints.'",
              "Lifecycle expectations: 'Model update cadence, monitoring KPIs, bias detection/reporting, human-in-the-loop, rollback procedures, transparency needs.'",
              "Training/change management: 'Required training hours/modalities, super-user programs, vendor support SLAs, go-live support expectations.'",
              "Use-case prioritization: 'Rank clinical areas by expected value (radiology triage, sepsis prediction, cardiology imaging, pathology) and rationale.'",
              "External drivers: 'Impact of payer incentives, guidelines (AHA, CMS, FDA) on prioritization and timelines.'",
              "Refine the recommendation question: specify respondent role and context (e.g., 'Based on your hospital\u2019s needs and constraints, how likely are you to recommend this AI diagnostic concept for adoption in your department?') and follow with 'Why?' open-end to capture drivers/barriers."
            ]
          },
          {
            "question_id": "q27",
            "question_text": "How confident are you that you understood the product concept correctly?",
            "mapped_objectives": [
              "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools. (Intent: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption.)",
              "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals. (Intent: Ensure statistically useful, role-representative data for robust analysis.)"
            ],
            "coverage_quality": 0.12,
            "gaps_identified": [
              "Does not map decision-making hierarchy or identify influencers/deciders.",
              "Provides no information on budgeting, approval thresholds, or timelines.",
              "Does not measure adoption drivers/barriers, only respondent\u2019s confidence in their own understanding.",
              "No coverage of privacy, data governance, or compliance requirements.",
              "No insight into ROI expectations or economic evaluation criteria.",
              "No information on HIS/EMR integration or interoperability requirements.",
              "Does not address regulatory pathways or validation documentation.",
              "No competitive landscape or vendor perception data.",
              "Not suitable for KANO feature classification.",
              "Not structured for discrete choice modeling or price sensitivity.",
              "Does not profile decision-maker roles, needs, or attitudes.",
              "Does not benchmark adoption rates or maturity.",
              "No information on procurement/contracting models.",
              "No data on model lifecycle expectations (updates, monitoring, bias).",
              "No assessment of training, change management, or support needs.",
              "Does not identify high-value clinical areas/use cases.",
              "No mapping of external guidelines/payer incentives.",
              "No identification of differentiating features beyond top competitors."
            ],
            "improvement_suggestions": [
              "Reframe to comprehension check plus content probes: pair the confidence item with objective measures (e.g., a few true/false statements about the concept and a short summary recall) to validate understanding before substantive questions.",
              "Add role and organization screener items to ensure target sample (hospital size, respondent role, department, decision influence).",
              "Insert modules aligned to each objective: decision-making map (who initiates, evaluates, approves; RACI-style questions), budget thresholds/timelines, clinical acceptance (Likert drivers/barriers), privacy/data governance requirements, ROI metrics and target payback, integration and interoperability specifics, regulatory evidence needs, vendor perceptions and shortlists, KANO feature ratings, DCE choice sets with price/feature trade-offs, procurement models, lifecycle governance, training/support requirements, use-case prioritization, influence of guidelines/reimbursement, and differentiators beyond top vendors.",
              "If retaining a confidence item, anchor it to specific facets (e.g., confidence in data sources, workflow impact, integration model, pricing, regulatory status) to be diagnostically useful.",
              "Use validated scales where possible (e.g., technology acceptance constructs, privacy concern indices) and structured matrices for decision stages and stakeholders.",
              "Include benchmarking items on current adoption stage, pilots, and planned timelines.",
              "Add quality controls: comprehension gate, attention checks, and consistency checks across modules."
            ]
          },
          {
            "question_id": "q28",
            "question_text": "Please indicate how closely the following statements describe your typical shopping behavior. I look for the lowest price, I prefer sustainable options, I am loyal to specific brands, I try new products frequently.",
            "mapped_objectives": [
              "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs. (Intent: Create actionable personas and segments to tailor product, pricing, and sales approaches.)"
            ],
            "coverage_quality": 0.12,
            "gaps_identified": [
              "The item uses consumer retail shopping heuristics (lowest price, sustainability, brand loyalty, novelty seeking) that are poorly aligned with B2B hospital technology procurement.",
              "No linkage to AI diagnostic tool context (clinical value, workflow fit, regulatory risk, data governance, interoperability, reimbursement).",
              "Does not identify decision-making hierarchy, influencers, or stages in the hospital purchase process.",
              "No information on budget approval thresholds, timelines, or funding mechanisms.",
              "Does not capture clinician acceptance drivers/barriers or change management needs.",
              "No assessment of privacy, data governance, or regulatory compliance requirements.",
              "No measurement of ROI criteria, economic evaluation, or pricing sensitivity.",
              "No insights into integration with HIS/EMR or interoperability requirements.",
              "Does not address vendor perceptions (GE, Philips, Siemens Healthineers) or differentiation factors.",
              "Not suitable for KANO or discrete choice modeling inputs.",
              "Lacks segmentation by role, department, or hospital characteristics.",
              "No coverage of adoption maturity, procurement models, or external guidelines/payer incentives.",
              "No assessment of data lifecycle expectations (monitoring, updates, bias).",
              "No identification of high-value clinical use cases."
            ],
            "improvement_suggestions": [
              "Anchor the question in the AI diagnostics enterprise purchase context; replace consumer heuristics with hospital-relevant decision criteria (e.g., clinical efficacy, workflow impact, integration effort, regulatory risk, data security, total cost of ownership).",
              "Use role-specific batteries: separate versions for executive leadership, IT, clinical leadership, and procurement to map decision influence and priorities.",
              "Add items to map decision-making hierarchy and stages (awareness, evaluation, pilot, committee review, CFO approval, contracting). Include who initiates, who evaluates, who approves, and veto points.",
              "Include budget process questions: approval thresholds, capital vs. OpEx, cycle timelines, sources of funding, committee cadence.",
              "Add clinician acceptance items: perceived usefulness, trust in AI, explainability needs, impact on workload, training needs, liability concerns.",
              "Insert privacy/data governance items: PHI handling, de-identification, data residency, audit trails, SOC2/HITRUST, HIPAA, GDPR where applicable.",
              "Add integration and interoperability items: required standards (HL7/FHIR/DICOM), SSO, data pipelines, IT resources, sandbox/pilot capabilities.",
              "Include ROI/economic evaluation items: payback period, NPV/IRR thresholds, clinical and operational KPIs, reimbursement impacts.",
              "Add vendor perception and selection criteria items covering GE, Philips, Siemens Healthineers and others; measure trust, support quality, roadmap alignment, pricing models.",
              "Design Kano-style feature questions: classify must-haves, performance features, and delighters across explainability, bias monitoring, calibration, auto-documentation, and integration utilities.",
              "Prepare attributes/levels for discrete choice or conjoint tasks: price/licensing model, integration effort, accuracy lift, explainability features, support SLAs, compliance certifications.",
              "Measure adoption maturity: current use, pilots, number of departments, outcomes achieved, barriers faced.",
              "Assess preferred procurement and contracting models: subscription vs. perpetual, risk-sharing, outcome-based, enterprise vs. departmental licensing.",
              "Capture data lifecycle expectations: model updates cadence, monitoring dashboards, drift/bias alerts, validation transparency, rollback procedures.",
              "Add items on external guidelines and payer incentives: awareness, perceived impact on prioritization, specific programs influencing adoption.",
              "Refine the attitudinal battery to healthcare-relevant frames (e.g., I prioritize evidence strength; I avoid tools without clear accountability; I prefer vendors with proven integrations in our EMR; I value outcome-based pricing).",
              "Include demographic/screener variables: role, department, hospital bed size (confirm 100\u2013500), EMR vendor, existing AI deployments, regional regulations."
            ]
          },
          {
            "question_id": "q29",
            "question_text": "Programmer note: Randomize the order of features in Q19 and Q24 and anchor the first and last options in all Likert scales.",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "No substantive question content is provided\u2014only a programmer note about randomization and anchoring.",
              "Without the text of Q19 and Q24 or any Likert scale items, none of the research objectives can be addressed or mapped.",
              "Cannot evaluate suitability for KANO analysis, DCM, decision hierarchy, budget process, clinical adoption, privacy, ROI, integration, regulatory, competitive landscape, procurement, lifecycle, training, use cases, payer incentives, or differentiators."
            ],
            "improvement_suggestions": [
              "Provide the actual survey questions/items for Q19, Q24, and any Likert scales so they can be mapped to objectives.",
              "For each objective, include at least one targeted question block, e.g.:",
              "- Decision-making hierarchy: role-specific influence/decision matrices and process flow items.",
              "- Budget approval: thresholds, approvers, timelines, funding sources, fiscal year cadence.",
              "- Clinical acceptance: Likert items on perceived usefulness, trust, workflow fit, safety, change readiness.",
              "- Privacy/data governance: items on HIPAA, data residency, consent, de-identification, audit trails, DUA/BAA requirements.",
              "- ROI/economic criteria: total cost components, payback period, NPV/IRR use, clinical outcomes thresholds.",
              "- Integration/interoperability: specific standards (HL7 v2, FHIR, DICOM), SSO, order/result flows, IT effort.",
              "- Regulatory: FDA/CE status importance, validation documentation, post-market surveillance needs.",
              "- Competitive landscape: awareness, consideration, preference, perceived strengths/weaknesses for GE, Philips, Siemens and others.",
              "- KANO: functional/dysfunctional paired items for prioritized features.",
              "- Discrete choice: conjoint tasks with price and feature levels tailored to AI diagnostics.",
              "- Profiling/segmentation: role, department, bed size, EMR, adoption stage, attitudes.",
              "- Procurement models: CapEx vs OpEx, subscription, per-study, outcomes-based, pilots.",
              "- Lifecycle expectations: update cadence, monitoring, bias mitigation, transparency, explainability.",
              "- Training/support: onboarding, CME/CE, super-user programs, vendor SLAs.",
              "- Use cases: ranked clinical areas (radiology, cardiology, pathology, ED triage, sepsis, stroke, etc.).",
              "- External guidelines/payer incentives: awareness and impact of CMS reimbursement, professional society guidance.",
              "- Differentiators beyond top vendors: openness, extensibility, TCO, service quality, local support.",
              "Maintain the programmer note as a survey programming instruction attached to relevant questions, but do not treat it as a standalone question.",
              "Ensure randomization and anchoring are applied where appropriate: randomize feature lists for KANO and DCM tasks; anchor endpoints in Likert scales to reduce response bias."
            ]
          },
          {
            "question_id": "q30",
            "question_text": "Programmer note: Apply soft quotas to balance age and gender to census distributions within country where feasible.",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "No substantive content to elicit data on decision-making hierarchy or any other objective",
              "Does not capture budget processes, clinical acceptance, privacy/data governance, ROI expectations, integration/interoperability, or regulatory needs",
              "Provides no input for competitive landscape, KANO features, DCE pricing, or vendor perceptions",
              "Does not profile decision-makers or segment by attitudes/needs",
              "Does not benchmark adoption/maturity, procurement models, or lifecycle expectations",
              "No coverage of training/change management, high-value use cases, external guidelines/payer incentives, or differentiating features",
              "Does not contribute to sampling beyond a basic age/gender balancing instruction"
            ],
            "improvement_suggestions": [
              "Replace or supplement the programmer note with actual survey questions aligned to each objective (e.g., decision authority matrix, RACI items, and process flow for AI tool adoption)",
              "Add screening and profiling items to ensure respondents are target roles (C-suite, CIO, CMO, department heads) at mid-sized hospitals (100\u2013500 beds)",
              "Include modules for: budget thresholds/approval timelines; clinical acceptance (drivers/barriers, use scenarios); privacy/data governance policies; ROI/economic criteria; integration/interoperability with HIS/EMR; regulatory documentation and validation needs",
              "Add competitive perception batteries for GE Healthcare, Philips, Siemens Healthineers, and other vendors; capture differentiators and selection drivers",
              "Design KANO questions (functional/dysfunctional paired items) for prioritized AI features",
              "Embed a discrete choice experiment (conjoint) with price and feature attributes to estimate WTP and sensitivity",
              "Include items on procurement/contracting models (CAPEX vs OPEX, subscription, outcomes-based), support/training/change management requirements, and lifecycle expectations (updates, monitoring, bias, transparency)",
              "Add benchmarking questions on current adoption, deployment scale, and maturity",
              "Refine sampling plan and quotas to target hospital size and roles; consider additional soft quotas by role and region rather than only age/gender",
              "Retain the programmer note as a sampling instruction but move it to the sample plan/specifications section, not as a survey question"
            ]
          },
          {
            "question_id": "q31",
            "question_text": "Programmer note: Implement validation for constant sum to equal 100 in Q19 and require numeric entries greater than zero for pricing questions.",
            "mapped_objectives": [],
            "coverage_quality": 0.0,
            "gaps_identified": [
              "No substantive survey content is present\u2014only programmer instructions about validation.",
              "Does not capture any information on decision-making hierarchy or stakeholder roles.",
              "No items on budget approval processes, thresholds, or timing.",
              "No measures of clinician acceptance, drivers, or barriers.",
              "No assessment of privacy, data governance, or compliance requirements.",
              "No items on ROI expectations, value metrics, or economic evaluation criteria.",
              "No questions on integration with HIS/EMR or interoperability.",
              "No regulatory pathway, documentation, or validation content.",
              "No competitive landscape perception (GE, Philips, Siemens) or vendor selection criteria.",
              "No KANO features classification content.",
              "No discrete choice or pricing trade-off content; only a validation note about numeric entries.",
              "No profiling/segmentation of decision-makers.",
              "No adoption triggers/barriers across dimensions.",
              "No benchmarking of current adoption or maturity.",
              "No procurement/contracting model preferences.",
              "No data integration and model lifecycle expectations.",
              "No training, change management, or support services.",
              "No prioritization of clinical areas/use cases.",
              "No external guidelines/payer incentives assessment.",
              "No differentiating features beyond top competitors."
            ],
            "improvement_suggestions": [
              "Replace the programmer note with actual survey items tied to objectives; keep validation instructions separate in a survey spec or as field notes.",
              "For decision-making hierarchy: add role-selection grids and influence/decision authority matrices (e.g., RACI-style) and process flow questions.",
              "For budgets: include questions on budget owners, approval thresholds, timing windows, and funding sources (Opex/Capex, grants).",
              "For clinician acceptance: add Likert scales on perceived usefulness, ease of use, trust, and barriers; include open-ends for concerns.",
              "For privacy/governance: include items on HIPAA, data retention, de-identification, PHI handling, data residency, and required safeguards.",
              "For ROI: ask required payback period, acceptable total cost of ownership, and clinical/economic outcomes used in business cases.",
              "For integration: measure current HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), SSO/IDM needs, and workflow integration points.",
              "For regulatory: ask required evidence (FDA clearance class, performance validation), documentation, and internal review bodies.",
              "For competitive landscape: add brand familiarity, consideration, perceived strengths/weaknesses of GE, Philips, Siemens, and others.",
              "For KANO: include functional/dysfunctional pair items for target features to classify must-be, performance, and delighters.",
              "For pricing/WTP: implement discrete choice/conjoint tasks with price, features, and service levels; keep numeric validation rules as programming notes.",
              "For profiling/segmentation: capture role, department, tenure, hospital size (beds 100\u2013500), and attitudes toward innovation/risk.",
              "For adoption triggers/barriers: include max-diff or rating of triggers (e.g., reimbursement, clinical champions) and barriers (IT constraints, privacy).",
              "For benchmarking: ask current deployment status, number of use cases live, and maturity level.",
              "For procurement models: include preferences for subscription vs. perpetual, per-study vs. enterprise, and contracting constraints.",
              "For lifecycle expectations: items on update cadence, monitoring, bias audits, model explainability, and transparency dashboards.",
              "For training/support: measure desired training formats, change management support, SLAs, and post-go-live support needs.",
              "For clinical use cases: rate value by department (radiology, pathology, cardiology, ED triage) and anticipated ROI/time-to-value.",
              "For external incentives: assess impact of payer reimbursement codes, guidelines, and accreditation requirements.",
              "For differentiation: ask which features/services beyond top vendors would drive switching or selection."
            ]
          }
        ],
        "gap_analysis": {
          "missing_objectives": [
            {
              "text": "Map the decision-making hierarchy for adopting AI-powered diagnostic tools in mid-sized hospitals (100\u2013500 beds).",
              "category": "primary",
              "priority": 0.98,
              "keywords": [
                "decision-making hierarchy",
                "stakeholder roles",
                "governance",
                "procurement workflow",
                "approval gates",
                "C-suite",
                "CIO",
                "CMO",
                "department heads"
              ],
              "semantic_intent": "Identify who influences and decides on AI diagnostic tool adoption and how decisions progress through the organization."
            },
            {
              "text": "Detail budget approval processes and funding mechanisms for AI diagnostic tool purchases.",
              "category": "primary",
              "priority": 0.95,
              "keywords": [
                "budget approval",
                "CAPEX vs OPEX",
                "budget cycles",
                "thresholds",
                "financial sign-off",
                "procurement policies"
              ],
              "semantic_intent": "Understand how budgets are allocated and approved, including thresholds and timelines that affect purchasing."
            },
            {
              "text": "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools.",
              "category": "primary",
              "priority": 0.93,
              "keywords": [
                "clinician acceptance",
                "change management",
                "workflow impact",
                "trust in AI",
                "usability",
                "training needs",
                "perceived usefulness"
              ],
              "semantic_intent": "Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption."
            },
            {
              "text": "Evaluate patient privacy concerns and data governance requirements associated with AI diagnostics.",
              "category": "primary",
              "priority": 0.9,
              "keywords": [
                "patient privacy",
                "data governance",
                "HIPAA",
                "PHI handling",
                "data residency",
                "consent",
                "security controls"
              ],
              "semantic_intent": "Determine privacy risks, compliance expectations, and safeguards needed to adopt AI tools."
            },
            {
              "text": "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools.",
              "category": "primary",
              "priority": 0.94,
              "keywords": [
                "ROI",
                "payback period",
                "total cost of ownership",
                "clinical outcomes",
                "operational efficiency",
                "financial KPIs"
              ],
              "semantic_intent": "Identify the financial and clinical value metrics hospitals require to justify investment."
            },
            {
              "text": "Identify integration challenges with existing HIS/EMR systems and interoperability requirements.",
              "category": "primary",
              "priority": 0.96,
              "keywords": [
                "integration",
                "HIS",
                "EMR",
                "HL7",
                "FHIR",
                "PACS",
                "workflow interoperability",
                "IT burden",
                "vendor APIs"
              ],
              "semantic_intent": "Understand technical barriers and requirements to seamlessly integrate AI tools into current systems and workflows."
            },
            {
              "text": "Map regulatory compliance barriers for deploying AI diagnostics in mid-sized hospitals.",
              "category": "primary",
              "priority": 0.91,
              "keywords": [
                "regulatory compliance",
                "FDA/CE",
                "SaMD",
                "clinical validation",
                "audit trails",
                "model updates",
                "risk management"
              ],
              "semantic_intent": "Clarify regulatory pathways, documentation, and validation needs that influence adoption."
            },
            {
              "text": "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers.",
              "category": "primary",
              "priority": 0.92,
              "keywords": [
                "competitive landscape",
                "vendor selection criteria",
                "brand perception",
                "feature comparison",
                "pricing models",
                "support/services"
              ],
              "semantic_intent": "Determine how target hospitals perceive key vendors, their differentiation, and selection drivers."
            },
            {
              "text": "Conduct KANO model analysis to prioritize AI diagnostic tool features.",
              "category": "primary",
              "priority": 0.9,
              "keywords": [
                "KANO",
                "must-have",
                "performance features",
                "delighters",
                "indifferent",
                "feature prioritization"
              ],
              "semantic_intent": "Classify features by their impact on satisfaction to guide product roadmap and messaging."
            },
            {
              "text": "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay.",
              "category": "primary",
              "priority": 0.93,
              "keywords": [
                "discrete choice modeling",
                "conjoint",
                "price elasticity",
                "WTP",
                "attribute trade-offs",
                "bundling"
              ],
              "semantic_intent": "Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing."
            },
            {
              "text": "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs.",
              "category": "secondary",
              "priority": 0.82,
              "keywords": [
                "stakeholder profiling",
                "segmentation",
                "personas",
                "attitudes",
                "needs",
                "influence mapping"
              ],
              "semantic_intent": "Create actionable personas and segments to tailor product, pricing, and sales approaches."
            },
            {
              "text": "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals.",
              "category": "secondary",
              "priority": 0.8,
              "keywords": [
                "sample frame",
                "qualification criteria",
                "hospital size 100\u2013500 beds",
                "response quotas",
                "data quality"
              ],
              "semantic_intent": "Ensure statistically useful, role-representative data for robust analysis."
            },
            {
              "text": "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions.",
              "category": "secondary",
              "priority": 0.86,
              "keywords": [
                "adoption drivers",
                "barriers",
                "risk mitigation",
                "value propositions",
                "change readiness"
              ],
              "semantic_intent": "Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market."
            },
            {
              "text": "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals.",
              "category": "secondary",
              "priority": 0.78,
              "keywords": [
                "current adoption",
                "penetration",
                "maturity curve",
                "pilots vs scale",
                "time to deployment"
              ],
              "semantic_intent": "Provide baseline context on how widespread and mature adoption currently is."
            },
            {
              "text": "Determine preferred procurement and contracting models for AI diagnostic solutions.",
              "category": "secondary",
              "priority": 0.77,
              "keywords": [
                "procurement model",
                "SaaS vs perpetual",
                "subscription",
                "usage-based",
                "enterprise agreements",
                "GPOs"
              ],
              "semantic_intent": "Identify buying models that align with hospital preferences and constraints."
            },
            {
              "text": "Assess data integration and model lifecycle expectations (updates, monitoring, bias, and performance transparency).",
              "category": "secondary",
              "priority": 0.81,
              "keywords": [
                "model updates",
                "MLOps",
                "performance monitoring",
                "bias mitigation",
                "explainability",
                "auditability"
              ],
              "semantic_intent": "Understand post-deployment expectations that influence trust and compliance."
            },
            {
              "text": "Evaluate training, change management, and support services required for successful implementation.",
              "category": "secondary",
              "priority": 0.76,
              "keywords": [
                "training",
                "enablement",
                "super-user programs",
                "onboarding",
                "vendor support",
                "SLA"
              ],
              "semantic_intent": "Clarify service requirements that reduce friction and drive sustained usage."
            },
            {
              "text": "Identify clinical areas and use cases with highest perceived value for AI diagnostics.",
              "category": "exploratory",
              "priority": 0.65,
              "keywords": [
                "use cases",
                "radiology",
                "cardiology",
                "pathology",
                "triage",
                "workflow automation",
                "prioritization"
              ],
              "semantic_intent": "Find the departments and applications most likely to yield early wins and ROI."
            },
            {
              "text": "Map perception and impact of external guidelines and payer incentives on AI adoption.",
              "category": "exploratory",
              "priority": 0.58,
              "keywords": [
                "payer incentives",
                "reimbursement",
                "quality metrics",
                "accreditation",
                "professional society guidelines"
              ],
              "semantic_intent": "Explore how reimbursement and external standards shape adoption priorities."
            },
            {
              "text": "Identify key differentiating features that drive vendor selection beyond the top three competitors.",
              "category": "exploratory",
              "priority": 0.6,
              "keywords": [
                "long tail vendors",
                "differentiators",
                "ecosystem partnerships",
                "total solution fit"
              ],
              "semantic_intent": "Uncover broader competitive threats and opportunities outside the named vendors."
            }
          ],
          "partially_covered": [],
          "over_covered": [],
          "critical_gaps": [
            "Missing primary objective: Map the decision-making hierarchy for adopting AI-powered diagnostic tools in mid-sized hospitals (100\u2013500 beds).",
            "Missing primary objective: Detail budget approval processes and funding mechanisms for AI diagnostic tool purchases.",
            "Missing primary objective: Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools.",
            "Missing primary objective: Evaluate patient privacy concerns and data governance requirements associated with AI diagnostics.",
            "Missing primary objective: Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools.",
            "Missing primary objective: Identify integration challenges with existing HIS/EMR systems and interoperability requirements.",
            "Missing primary objective: Map regulatory compliance barriers for deploying AI diagnostics in mid-sized hospitals.",
            "Missing primary objective: Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers.",
            "Missing primary objective: Conduct KANO model analysis to prioritize AI diagnostic tool features.",
            "Missing primary objective: Run discrete choice modeling to estimate pricing sensitivity and willingness to pay."
          ],
          "impact_assessment": {
            "missing_primary": 10
          }
        },
        "multi_perspective": {
          "researcher_view": {
            "objectives_coverage": 0.7,
            "methodological_soundness": 0.75,
            "concerns": [
              "Some primary objectives not fully addressed"
            ]
          },
          "respondent_view": {
            "clarity_score": 0.8,
            "relevance_score": 0.75,
            "concerns": [
              "Some questions may seem disconnected from stated purpose"
            ]
          },
          "analyst_view": {
            "data_quality_potential": 0.8,
            "actionability_score": 0.7,
            "concerns": [
              "Missing questions for key decision factors"
            ]
          },
          "consensus_score": 0.75
        },
        "specific_recommendations": [
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Map the decision-making hierarchy for adopting AI-powered diagnostic tools in mid-sized hospitals (100\u2013500 beds).",
            "suggested_questions": [
              "Question addressing: Identify who influences and decides on AI diagnostic tool adoption and how decisions progress through the organization."
            ],
            "implementation_notes": "Focus on keywords: decision-making hierarchy, stakeholder roles, governance, procurement workflow, approval gates, C-suite, CIO, CMO, department heads",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Detail budget approval processes and funding mechanisms for AI diagnostic tool purchases.",
            "suggested_questions": [
              "Question addressing: Understand how budgets are allocated and approved, including thresholds and timelines that affect purchasing."
            ],
            "implementation_notes": "Focus on keywords: budget approval, CAPEX vs OPEX, budget cycles, thresholds, financial sign-off, procurement policies",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Assess clinical staff acceptance and adoption drivers/barriers for AI diagnostic tools.",
            "suggested_questions": [
              "Question addressing: Gauge clinicians\u2019 willingness to use AI tools and the conditions that increase or decrease adoption."
            ],
            "implementation_notes": "Focus on keywords: clinician acceptance, change management, workflow impact, trust in AI, usability, training needs, perceived usefulness",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Evaluate patient privacy concerns and data governance requirements associated with AI diagnostics.",
            "suggested_questions": [
              "Question addressing: Determine privacy risks, compliance expectations, and safeguards needed to adopt AI tools."
            ],
            "implementation_notes": "Focus on keywords: patient privacy, data governance, HIPAA, PHI handling, data residency, consent, security controls",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Quantify ROI expectations and economic evaluation criteria for AI diagnostic tools.",
            "suggested_questions": [
              "Question addressing: Identify the financial and clinical value metrics hospitals require to justify investment."
            ],
            "implementation_notes": "Focus on keywords: ROI, payback period, total cost of ownership, clinical outcomes, operational efficiency, financial KPIs",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Identify integration challenges with existing HIS/EMR systems and interoperability requirements.",
            "suggested_questions": [
              "Question addressing: Understand technical barriers and requirements to seamlessly integrate AI tools into current systems and workflows."
            ],
            "implementation_notes": "Focus on keywords: integration, HIS, EMR, HL7, FHIR, PACS, workflow interoperability, IT burden, vendor APIs",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Map regulatory compliance barriers for deploying AI diagnostics in mid-sized hospitals.",
            "suggested_questions": [
              "Question addressing: Clarify regulatory pathways, documentation, and validation needs that influence adoption."
            ],
            "implementation_notes": "Focus on keywords: regulatory compliance, FDA/CE, SaMD, clinical validation, audit trails, model updates, risk management",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Analyze the competitive landscape for AI diagnostic vendors, focusing on GE Healthcare, Philips, and Siemens Healthineers.",
            "suggested_questions": [
              "Question addressing: Determine how target hospitals perceive key vendors, their differentiation, and selection drivers."
            ],
            "implementation_notes": "Focus on keywords: competitive landscape, vendor selection criteria, brand perception, feature comparison, pricing models, support/services",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Conduct KANO model analysis to prioritize AI diagnostic tool features.",
            "suggested_questions": [
              "Question addressing: Classify features by their impact on satisfaction to guide product roadmap and messaging."
            ],
            "implementation_notes": "Focus on keywords: KANO, must-have, performance features, delighters, indifferent, feature prioritization",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "critical",
            "issue": "Missing coverage for primary objective",
            "objective": "Run discrete choice modeling to estimate pricing sensitivity and willingness to pay.",
            "suggested_questions": [
              "Question addressing: Quantify how price and feature trade-offs affect purchase likelihood and optimal pricing."
            ],
            "implementation_notes": "Focus on keywords: discrete choice modeling, conjoint, price elasticity, WTP, attribute trade-offs, bundling",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Profile the target decision-makers (C-suite, CIOs, CMOs, department heads) and segment by attitudes and needs.",
            "suggested_questions": [
              "Question addressing: Create actionable personas and segments to tailor product, pricing, and sales approaches."
            ],
            "implementation_notes": "Focus on keywords: stakeholder profiling, segmentation, personas, attitudes, needs, influence mapping",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Establish sampling strategy and achieve 150+ qualified responses from target roles in mid-sized hospitals.",
            "suggested_questions": [
              "Question addressing: Ensure statistically useful, role-representative data for robust analysis."
            ],
            "implementation_notes": "Focus on keywords: sample frame, qualification criteria, hospital size 100\u2013500 beds, response quotas, data quality",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Identify key adoption triggers and barriers across clinical, technical, financial, and regulatory dimensions.",
            "suggested_questions": [
              "Question addressing: Synthesize cross-functional factors that accelerate or impede adoption to inform go-to-market."
            ],
            "implementation_notes": "Focus on keywords: adoption drivers, barriers, risk mitigation, value propositions, change readiness",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Benchmark current adoption rates and maturity of AI diagnostic tools in mid-sized hospitals.",
            "suggested_questions": [
              "Question addressing: Provide baseline context on how widespread and mature adoption currently is."
            ],
            "implementation_notes": "Focus on keywords: current adoption, penetration, maturity curve, pilots vs scale, time to deployment",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Determine preferred procurement and contracting models for AI diagnostic solutions.",
            "suggested_questions": [
              "Question addressing: Identify buying models that align with hospital preferences and constraints."
            ],
            "implementation_notes": "Focus on keywords: procurement model, SaaS vs perpetual, subscription, usage-based, enterprise agreements, GPOs",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Assess data integration and model lifecycle expectations (updates, monitoring, bias, and performance transparency).",
            "suggested_questions": [
              "Question addressing: Understand post-deployment expectations that influence trust and compliance."
            ],
            "implementation_notes": "Focus on keywords: model updates, MLOps, performance monitoring, bias mitigation, explainability, auditability",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for secondary objective",
            "objective": "Evaluate training, change management, and support services required for successful implementation.",
            "suggested_questions": [
              "Question addressing: Clarify service requirements that reduce friction and drive sustained usage."
            ],
            "implementation_notes": "Focus on keywords: training, enablement, super-user programs, onboarding, vendor support, SLA",
            "expected_impact": "high"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for exploratory objective",
            "objective": "Identify clinical areas and use cases with highest perceived value for AI diagnostics.",
            "suggested_questions": [
              "Question addressing: Find the departments and applications most likely to yield early wins and ROI."
            ],
            "implementation_notes": "Focus on keywords: use cases, radiology, cardiology, pathology, triage, workflow automation, prioritization",
            "expected_impact": "medium"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for exploratory objective",
            "objective": "Map perception and impact of external guidelines and payer incentives on AI adoption.",
            "suggested_questions": [
              "Question addressing: Explore how reimbursement and external standards shape adoption priorities."
            ],
            "implementation_notes": "Focus on keywords: payer incentives, reimbursement, quality metrics, accreditation, professional society guidelines",
            "expected_impact": "medium"
          },
          {
            "type": "add_question",
            "priority": "high",
            "issue": "Missing coverage for exploratory objective",
            "objective": "Identify key differentiating features that drive vendor selection beyond the top three competitors.",
            "suggested_questions": [
              "Question addressing: Uncover broader competitive threats and opportunities outside the named vendors."
            ],
            "implementation_notes": "Focus on keywords: long tail vendors, differentiators, ecosystem partnerships, total solution fit",
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Which of the following best describes your role in...' has poor objective coverage",
            "current_question": "Which of the following best describes your role in household shopping for everyday consumer products such as personal care, cleaning, and packaged goods?",
            "improvements": [
              "Replace with a role/authority screener specific to hospital context, e.g., 'Which best describes your role in decisions about AI-enabled diagnostic tools at your hospital?' with options: Final decision maker, Budget approver, Recommender/influencer, Evaluator, End user/clinician, IT/Integration lead, Data governance/privacy lead, No role.",
              "Add healthcare-specific role taxonomy: C-suite (CEO, CFO, CIO, CMO), Service line leaders (Radiology Chair, Pathology Director, ED Director), IT (CTO, Enterprise Architect, Integration Manager), Clinical Engineering/Biomed, Compliance/Privacy Officer, Procurement/Supply Chain.",
              "Include hospital profile screeners: bed size (100\u2013500), hospital type (community/academic), location, ownership, and current EMR/HIS vendor.",
              "Capture budget authority and thresholds: 'What is the maximum capital/opex you can approve without additional sign-off?' and 'Who must approve purchases above $X?'",
              "Map decision process: stages, involved stakeholders, and typical timelines from evaluation to deployment.",
              "Assess clinician acceptance: Likert items on perceived usefulness, workflow impact, trust in AI, required evidence, and training needs.",
              "Measure privacy/data governance requirements: data residency, de-identification, PHI handling, model auditability, monitoring, bias management.",
              "Evaluate integration: required standards (HL7, FHIR, DICOM), SSO/IdP, data pipelines, inference latency, IT resources needed.",
              "Quantify ROI expectations: target payback period, TCO considerations, clinical and operational KPIs, evidence thresholds (RCTs, peer-reviewed studies).",
              "Add competitive/vendor perception items: aided/unaided awareness, consideration, differentiation, and selection criteria for GE, Philips, Siemens Healthineers, and others.",
              "Include KANO feature battery and DCE design blocks for price-feature trade-offs.",
              "Ask procurement model preferences: capital purchase vs. subscription/SaaS, per-study pricing, risk-sharing/outcomes-based contracts.",
              "Screen for current adoption/maturity and planned timelines (pilot, scale, budgeted next 12\u201324 months)."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How often do you purchase consumer products like p...' has poor objective coverage",
            "current_question": "How often do you purchase consumer products like personal care, cleaning, or packaged goods?",
            "improvements": [
              "Screen for target audience: 'Which best describes your role? (C-suite, CIO, CMO, department head, IT, Radiology lead, etc.)' and confirm hospital size (100\u2013500 beds).",
              "Decision-making hierarchy: 'Who initiates, influences, and makes the final decision for AI diagnostic tools? Please select all that apply and indicate level of influence.'",
              "Process and budget: 'What are approval thresholds, committees involved, and typical timelines from evaluation to purchase?' with scaled options.",
              "Clinician adoption: 'How willing are clinicians to use AI diagnostics in your department?' and 'Top barriers/drivers' with Likert and multi-select.",
              "Privacy and governance: 'Which data governance requirements must AI vendors meet?' and 'Level of concern about PHI privacy risks.'",
              "ROI and value metrics: 'Which metrics are required for approval? (diagnostic accuracy uplift, throughput, LOS reduction, readmission, cost per study, payback period)' and thresholds.",
              "Integration: 'Which HIS/EMR/PACS/RIS systems do you use and what interoperability standards are required (HL7, FHIR, DICOM, APIs)?' plus perceived integration difficulty.",
              "Regulatory: 'Which certifications/validations are required (FDA 510(k)/De Novo, CE, IEC 62304, ISO 13485, SOC 2, HIPAA BAA)?'",
              "Competitive perception: 'How do you rate GE, Philips, Siemens Healthineers, and others on reliability, integration, support, pricing, and innovation?'",
              "KANO feature testing: Present key features (auto-triage, explainability, bias reporting, on-prem vs cloud, continuous monitoring) with functional/dysfunctional KANO questions.",
              "Discrete choice/conjoint: Include randomized choice tasks varying price, deployment model, integration level, performance claims, support SLAs, and regulatory status.",
              "Procurement model preferences: 'Preferred contracting: perpetual license, subscription, usage-based, risk-share/outcomes-based, enterprise vs departmental buy.'",
              "Lifecycle expectations: 'Expectations for model updates, drift monitoring, bias audits, transparency reporting cadence.'",
              "Training and change management: 'Required training formats, go-live support, super-user programs, and acceptable vendor responsibilities.'",
              "Use cases: 'Which clinical areas are highest priority for AI diagnostics in your hospital?' with ranking (e.g., radiology triage, cardiology imaging, pathology, ED).",
              "External levers: 'Impact of payer incentives, guidelines (e.g., ACR, CMS), and health system policies on adoption priority.'",
              "Benchmarking: 'Current adoption stage' and 'Number of AI diagnostic tools deployed/piloted; outcomes achieved.'",
              "Sampling validation: Enforce quotas by role and hospital size, and include screener items to confirm involvement in AI tool decisions."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'In which country do you currently reside?...' has poor objective coverage",
            "current_question": "In which country do you currently reside?",
            "improvements": [
              "Retain the country item but add routing logic so subsequent modules tailor to jurisdiction-specific regulations, reimbursement, and data laws.",
              "Add role and organization screening: hospital size (beds 100\u2013500), role (CIO, CMO, etc.), department, decision authority, and involvement stage.",
              "Include budget and procurement items: annual capital/operational budgets, approval thresholds, timelines, sourcing models (purchase, subscription, managed service).",
              "Add clinician acceptance measures: Likert items on usefulness, trust, workflow fit, liability, and change readiness; include barriers/drivers.",
              "Include privacy/data governance: data types used, de-identification, PHI handling, cross-border transfer, consent practices, DPO involvement.",
              "Add ROI/economic criteria: required payback, NPV/IRR use, clinical KPIs, evidence types needed (RCT, real-world, health economic models).",
              "Include integration/interoperability: current HIS/EMR vendors, standards (HL7/FHIR/DICOM), integration timelines, IT constraints, security requirements.",
              "Regulatory pathway items tailored by country: approvals required (FDA, CE, MHRA), documentation, post-market surveillance, and validation expectations.",
              "Vendor landscape items: awareness, consideration, perceived strengths/weaknesses of GE/Philips/Siemens and others; selection criteria.",
              "KANO feature battery: classify features as must-be, one-dimensional, attractive, indifferent, reverse for prioritized capabilities.",
              "Discrete choice tasks: experimentally designed choice sets across price, deployment model, evidence, integration level, and feature bundles.",
              "Adoption benchmarking: current usage status, number of tools, deployment stage, departments using AI, and maturity scale.",
              "Lifecycle and governance: model updates, monitoring, bias audits, performance transparency, human oversight.",
              "Training and support: required training hours, modalities, champions, go-live support, SLAs.",
              "Use-case prioritization: rank clinical areas (radiology, cardiology, ED triage, pathology, etc.) by value and feasibility.",
              "External incentives: impact of payer reimbursement, accreditation, and guidelines on prioritization.",
              "Sampling plan controls: quotas by country, role, and hospital type; validate eligibility with screening logic and IP/geolocation checks."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'What is your age?...' has poor objective coverage",
            "current_question": "What is your age?",
            "improvements": [
              "Add role and function: Which best describes your primary role? (CIO, CMO, CFO, COO, Department Head, IT Director, Clinical Lead, Procurement, Compliance, Other).",
              "Add decision authority: What is your level of influence in AI diagnostic tool adoption? (final decision, strong influence, consult, no role).",
              "Add budget process items: What is the capital/opex threshold requiring board approval? Typical approval timeline? Funding sources used?",
              "Add clinical adoption: Rate your willingness to use/endorse AI diagnostics and top drivers/barriers.",
              "Add privacy/compliance: Rank privacy concerns, required safeguards, and governance bodies involved.",
              "Add ROI/evaluation: What financial and clinical KPIs are required? Minimum ROI/payback period?",
              "Add integration: Current HIS/EMR vendors, integration standards used (HL7, FHIR, DICOM), and key interoperability hurdles.",
              "Add regulatory: Required evidentiary standards (clinical validation, FDA/CE status), documentation expectations.",
              "Add competitive perception: Familiarity and preference for GE, Philips, Siemens; key differentiators and concerns; openness to challengers.",
              "Add KANO items: Classify candidate features as must-have, performance, delighter, indifferent, reverse.",
              "Add discrete choice tasks: Include conjoint/DCE with price, deployment model, integration level, performance, support, compliance attributes.",
              "Add procurement model preferences: Capex, subscription/SaaS, per-study, risk-share/outcomes-based, marketplace/GPO.",
              "Add adoption maturity: Current usage stage, number of deployed AI tools, departments using them.",
              "Add data lifecycle expectations: Update cadence, performance monitoring, bias auditing, transparency requirements.",
              "Add training/change management: Required training formats, change management support, go-live resources.",
              "Add sampling screens: Confirm hospital size (100\u2013500 beds) and qualifying roles before survey start.",
              "Retain age only as a demographic control variable for segmentation, and ensure optional with ranges (e.g., 18\u201324, 25\u201334, ..., 65+)."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Which of the following industries do you or a clos...' has poor objective coverage",
            "current_question": "Which of the following industries do you or a close family member work in?",
            "improvements": [
              "Add a hospital screening block: hospital type, bed count (ensure 100\u2013500), geography, teaching status.",
              "Replace or augment with role-focused screening: job title/role, department, decision-making authority level, involvement in AI diagnostics purchase/use.",
              "Clarify respondent eligibility: remove 'close family member' and focus on self only; include a termination path for non-hospital respondents.",
              "Add hierarchy mapping items: who initiates, evaluates, influences, and approves AI diagnostics; stage-gate process and committees involved.",
              "Include budget items: capex/opex mix, approval thresholds, budget cycle timing, sources of funding, and required business case elements.",
              "Measure clinical adoption: perceived usefulness, trust, barriers (workflow, accuracy, liability), required evidence, training needs.",
              "Privacy/compliance section: HIPAA/GDPR applicability, data-sharing policies, de-identification, PHI handling, model governance and audit trails.",
              "Integration questions: current EHR/HIS vendor, interface standards (HL7 v2/FHIR/DICOM), integration resources, security reviews, IT constraints.",
              "ROI and pricing module: KPIs, payback thresholds, TCO components, willingness-to-pay anchors for DCE.",
              "Vendor landscape: awareness, consideration, differentiation for GE, Philips, Siemens Healthineers and others; selection drivers.",
              "KANO feature battery: classify must-haves, performance, delighters for AI diagnostic tool capabilities and services.",
              "Adoption baseline: current tools in use, pilot status, scale, satisfaction, maturity stage.",
              "Procurement models: preferences for perpetual/SaaS/subscription, per-study pricing, risk-sharing, and contracting terms.",
              "Model lifecycle expectations: update cadence, monitoring, bias mitigation, performance transparency, validation requirements.",
              "Training/change management: onboarding effort, support SLAs, champion networks, super-user models.",
              "Use cases: prioritize clinical areas and conditions with highest perceived value and feasibility.",
              "External influences: payer incentives, accreditation standards, clinical guidelines affecting adoption.",
              "Add quality controls: attention checks, role verification, and logic to terminate non-target respondents early."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Have you participated in any market research surve...' has poor objective coverage",
            "current_question": "Have you participated in any market research surveys about consumer products in the past 3 months?",
            "improvements": [
              "Screen for target population: Add role, organization type/size, and relevance to AI diagnostics (e.g., What is your role? Does your hospital have 100\u2013500 beds? Are you involved in evaluating/purchasing AI diagnostic tools?).",
              "Replace the current question with a research-screening module: Include recency and frequency of participation in market research specific to hospital technology/AI, to control for professional respondents and response bias.",
              "Add modules aligned to objectives: decision hierarchy mapping (roles, influence, RACI, stage-gates), budget thresholds/timelines, clinical acceptance drivers/barriers, privacy/data governance requirements, ROI metrics and evidence standards, integration and interoperability needs, regulatory requirements, vendor perceptions and selection criteria, KANO feature ratings, discrete choice tasks for pricing/trade-offs, procurement models, lifecycle governance, training/support needs, use-case prioritization, and payer/guideline impacts.",
              "If keeping this question, qualify it: Specify domain relevance (In the past 3 months, have you participated in any market research about hospital AI diagnostic tools or related clinical decision support?).",
              "Add follow-ups to mitigate bias: Number of studies, type (qual/quant), incentives received, confidentiality constraints\u2014use to weight or exclude over-surveyed respondents."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Which statement best describes your involvement in...' has poor objective coverage",
            "current_question": "Which statement best describes your involvement in choosing brands for everyday household products?",
            "improvements": [
              "Rewrite the question to target hospital decision contexts, e.g., \"Which statement best describes your role in evaluating and selecting AI-powered diagnostic tools at your hospital? (Options: ultimate decision maker; shared decision maker; recommender/influencer; evaluator; budget approver; technical gatekeeper; no involvement).\"",
              "Add a screener to qualify respondents from mid-sized hospitals (100\u2013500 beds) and target roles (C-suite, CIO, CMIO, CMO, department heads, IT/security).",
              "Include follow-ups to map hierarchy: \"Who else is typically involved at each stage (clinical evaluation, IT/security review, budget approval, final sign-off)?\"",
              "Incorporate budget items: \"What is the approval threshold for capital/opex purchases of AI tools and typical timelines?\"",
              "Add items on clinical acceptance: perceived benefits, barriers, and required evidence (e.g., workflow fit, accuracy, liability).",
              "Include privacy/governance and regulatory prompts: data flows, PHI handling, consent, IRB, FDA clearance expectations.",
              "Probe integration requirements: HIS/EMR interfaces, standards (HL7/FHIR/DICOM), security reviews, sandbox/pilot needs.",
              "Collect ROI/economic criteria: required KPIs (diagnostic accuracy uplift, turnaround time, LOS, readmissions), payback period, budget source.",
              "Assess vendor perceptions: ratings and differentiation of GE Healthcare, Philips, Siemens Healthineers, and others.",
              "Add feature prioritization items suitable for KANO and design a DCE block for price/feature trade-offs.",
              "Benchmark current adoption, pilots, contract models (SaaS, per-study, enterprise), and support/training expectations.",
              "Map external influences: payer incentives, professional society guidelines, and health system policies."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Please select the number four from the list below....' has poor objective coverage",
            "current_question": "Please select the number four from the list below.",
            "improvements": [
              "Replace with a screening flow to qualify respondents (role, hospital size, geography) to meet sampling objectives",
              "Add modules aligned to each objective, e.g., decision-making RACI for AI diagnostics; budget thresholds, timeline, and funding sources",
              "Include clinician acceptance items using validated scales (e.g., TAM constructs: perceived usefulness, ease of use, trust, workflow fit)",
              "Add privacy/data governance questions on PHI use, de-identification, data residency, consent, and security certifications",
              "Gather ROI criteria: required payback period, NPV/IRR thresholds, clinical KPIs, and evidence standards",
              "Assess integration: current HIS/EMR, interfaces (HL7/FHIR/DICOM), IT resources, security review steps, sandbox/testing needs",
              "Regulatory: required documentation (FDA/CE status), validation evidence, post-market surveillance expectations",
              "Competitive perceptions: familiarity, trials, satisfaction, strengths/weaknesses of GE, Philips, Siemens, and others",
              "KANO battery on feature set (must-have, one-dimensional, attractive, indifferent) for prioritized features",
              "Discrete choice/conjoint design with price, deployment model, integration depth, support SLAs, regulatory status",
              "Profile decision-makers and segment by attitudes, risk tolerance, innovation maturity, and budget authority",
              "Procurement/contracting: preferred models (per-study, per-user, enterprise, outcome-based), contract length, and terms",
              "Lifecycle expectations: update cadence, monitoring dashboards, bias audits, model cards, and performance transparency",
              "Training/change management: onboarding hours, formats, super-user models, vendor support expectations",
              "Use cases: rank clinical areas by value and readiness (radiology, cardiology, pathology, ED triage, sepsis alerts, etc.)",
              "External factors: impact of payer reimbursement, guidelines (e.g., ACR, FDA action plans), and liability concerns",
              "Benchmark adoption: current deployment stage, pilots vs. production, number of tools in use, and maturity model stage"
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'What is your gender?...' has poor objective coverage",
            "current_question": "What is your gender?",
            "improvements": [
              "Include role/position, department, seniority, and decision influence questions (e.g., RACI for AI diagnostic tool adoption).",
              "Add budget authority, approval thresholds, funding sources, and timeline questions.",
              "Include clinician acceptance items (Likert scales on usefulness, trust, workflow fit; barriers/drivers).",
              "Add privacy/data governance items (PHI use, de-identification, data residency, audit trails, consent).",
              "Include ROI/value criteria, required evidence, and payback expectations.",
              "Add integration and interoperability questions (HIS/EMR vendors, standards used, API requirements, IT constraints).",
              "Include regulatory readiness and compliance pathway questions (FDA/CE status, documentation expectations).",
              "Add vendor perception and selection criteria items for GE, Philips, Siemens Healthineers, and others.",
              "Include KANO-style feature classification questions and discrete choice experiments for pricing/feature trade-offs.",
              "Collect adoption status, stage, and maturity indicators.",
              "Ask about procurement and contracting models (CapEx vs OpEx, subscriptions, outcome-based, pilots).",
              "Include model lifecycle management expectations (updates, monitoring, bias, transparency, performance SLAs).",
              "Add training/change management/support needs and preferred delivery formats.",
              "Identify high-priority clinical areas/use cases and perceived impact.",
              "Ask about influence of external guidelines and payer incentives on adoption decisions.",
              "If gender is retained, clarify response options to be inclusive and explain its analytic purpose (e.g., for demographic weighting) with options such as: Male, Female, Non-binary, Prefer to self-describe: __, Prefer not to say."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'What is your approximate annual household income b...' has poor objective coverage",
            "current_question": "What is your approximate annual household income before taxes?",
            "improvements": [
              "Replace or complement household income with hospital/department budget parameters: annual capital and operating budget ranges for diagnostics/IT, typical approval thresholds, and spending authority by role.",
              "Add decision-making and governance items: roles involved, RACI across stages (identification, evaluation, pilot, procurement), and committee participation (value analysis, IT governance, privacy).",
              "Include budget approval mechanics: steps, timelines, sign-off levels, threshold amounts, and funding sources (capital, operating, grants, payer programs).",
              "Measure clinician acceptance: perceived usefulness, trust, workflow fit, and barriers (liability, usability, alert fatigue), using Likert scales.",
              "Assess privacy/data governance: PHI handling, de-identification, data sharing policies, required safeguards, and acceptable data residency.",
              "Capture ROI criteria: required payback period, hurdle rates, clinical outcomes prioritized, and evidence types needed.",
              "Evaluate integration requirements: EHR/HIS vendors, interface standards (HL7, FHIR, DICOM), SSO, audit, and performance requirements.",
              "Map regulatory expectations: required certifications, validation evidence, and post-market surveillance expectations.",
              "Add vendor perception modules and competitive comparisons for GE, Philips, Siemens, and others; measure differentiation drivers.",
              "Include KANO-style feature battery with functional/dysfunctional phrasing to classify must-haves, satisfiers, and delighters.",
              "Design DCE attributes/levels for pricing and features; household income should be replaced by organizational budget constraints and WTP proxies.",
              "Profile respondents by role, department, hospital size (beds 100\u2013500), ownership type, region, EHR system, and adoption stage.",
              "Benchmark adoption maturity: current deployments, pilots, timelines, and scale.",
              "Probe procurement preferences: purchase vs subscription, risk-sharing, pilot-to-contract pathways, and contracting barriers.",
              "Assess lifecycle expectations: update cadence, performance monitoring, bias audits, and transparency reports.",
              "Include training/change management needs: onboarding time, preferred formats, support SLAs, and success metrics."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'What is the highest level of education you have co...' has poor objective coverage",
            "current_question": "What is the highest level of education you have completed?",
            "improvements": [
              "Add role and authority: What is your current role/title? Which of the following decisions are you directly involved in for AI diagnostics (influencer, recommender, approver, final signer)?",
              "Add organizational context: Which department do you primarily represent? How many beds does your hospital have? Is your organization part of an IDN?",
              "Add budget/review thresholds: What is the maximum purchase amount you can approve? What committees must review AI diagnostic purchases and typical review timelines?",
              "Add adoption/attitudes: Rate your agreement with statements on AI clinical value, workflow impact, and risks; list top drivers/barriers.",
              "Add privacy/governance: Who is responsible for data governance? What safeguards and compliance frameworks are required (HIPAA, SOC 2, ISO 27001, ONC HTI-1, state laws)?",
              "Add ROI/evaluation: Which metrics are required for approval (diagnostic accuracy, LOS reduction, readmission rates, cost per case, NPV payback)? Minimum evidence thresholds?",
              "Add integration: What EMR/HIS systems are in use? Required interoperability standards (HL7 v2, FHIR, DICOM, SSO/OIDC, audit logs)? Key integration pain points?",
              "Add regulatory: What regulatory clearances are required (FDA class, 510(k)/De Novo), documentation needs, and post-market surveillance expectations?",
              "Add competitive perceptions: Rate familiarity and preference for GE, Philips, Siemens, and others; key differentiators and concerns.",
              "Add KANO inputs: Classify potential features as must-have, performance, attractive, indifferent, or reverse.",
              "Add DCE inputs: Present choice tasks varying features, pricing, deployment model (SaaS vs on-prem), and support to estimate WTP.",
              "Add adoption baseline: Current deployment stage of AI diagnostics and number of live use cases.",
              "Add procurement models: Preferred contracting (subscription, usage-based, per-study, enterprise license), term length, and risk-sharing.",
              "Add lifecycle expectations: Requirements for model updates, monitoring, bias audits, version transparency, and performance reporting.",
              "Add enablement: Training modalities, change management support, SLAs, and success metrics.",
              "Add use cases: Rank clinical areas where AI delivers highest value (radiology triage, cardiology echo, pathology, ED, ICU, etc.).",
              "Add external levers: Impact of payer incentives, quality programs, and professional society guidelines on prioritization.",
              "Retain education but contextualize: Ask highest education AND field of study/clinical background to improve persona segmentation."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Which categories of consumer products have you pur...' has poor objective coverage",
            "current_question": "Which categories of consumer products have you purchased in the past 3 months? Personal care, Household cleaning, Packaged food and beverages, Paper goods, Laundry products.",
            "improvements": [
              "Screen respondents to ensure they work in mid-sized hospitals (100\u2013500 beds) and hold relevant roles (C-suite, CIO, CMIO, CMO, department heads, IT, procurement, compliance).",
              "Add questions mapping decision-making hierarchy: influencers, decision-makers, committees involved, and stage-gates in the adoption process.",
              "Include budget and funding items: typical budget owners, approval thresholds, cycle timelines, capex vs opex preferences, and sources of funds.",
              "Measure clinician acceptance: Likert scales on willingness to use, perceived usefulness, trust, required evidence, and barriers (workflow impact, liability, false positives).",
              "Assess privacy and governance: data types processed, de-identification, PHI flows, consent, data residency, retention, auditability, and governance committees\u2019 requirements.",
              "Capture ROI criteria: required clinical endpoints, cost savings, throughput gains, payback period, NPV/IRR thresholds, and evidence standards.",
              "Probe integration: current HIS/EMR vendors, interoperability standards (HL7 v2/FHIR/DICOM), SSO, PACS/VNA, latency, uptime, and IT validation requirements.",
              "Address regulatory: expectations for FDA/CE status, post-market surveillance, model transparency, documentation, and validation evidence.",
              "Evaluate vendors: perception of GE, Philips, Siemens Healthineers and others; strengths/weaknesses; selection drivers and objection handlers.",
              "Include KANO items: classify key features into must-have, performance, delighters with functional/dysfunctional pair questions.",
              "Design a discrete choice experiment: vary price, integration level, performance metrics (sensitivity/specificity), deployment model, support SLAs, and regulatory status.",
              "Profile and segment: role, department, decision authority, risk tolerance, innovation orientation, budget control, and strategic priorities.",
              "Benchmark adoption: current usage, pilots, maturity stage, deployment scale, and outcomes achieved.",
              "Procurement model preferences: purchase vs subscription vs usage-based, enterprise vs departmental, trial/pilot terms, contracting constraints.",
              "Model lifecycle expectations: update cadence, monitoring dashboards, bias assessments, performance drift alerts, rollback, and human-in-the-loop.",
              "Training and change management: required training formats, time, super-user models, support SLAs, and go-live assistance.",
              "Prioritize use cases: departments (radiology, cardiology, ED, ICU, pathology), workflows, and perceived value/urgency.",
              "External factors: payer incentives, reimbursement codes, professional society guidelines, malpractice and liability considerations.",
              "Include quotas and verification items to reach 150+ qualified respondents and validate role/hospital size."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Thinking about the category you purchase most ofte...' has poor objective coverage",
            "current_question": "Thinking about the category you purchase most often, how frequently do you buy products in that category?",
            "improvements": [
              "Reframe to the healthcare AI context and role-targeting. Example: Which best describes your organization\u2019s current stage of adoption for AI-powered diagnostic tools? (Not evaluating, evaluating/piloting, limited deployment, scaled deployment, no plans).",
              "Add decision-making hierarchy items. Example: Who initiates, influences, and makes final decisions for AI diagnostic tool adoption in your hospital? (Select roles and indicate level of influence).",
              "Capture budget and approval mechanics. Example: What is the typical budget threshold requiring board approval for diagnostic technology purchases? What is the average time from business case submission to final approval?",
              "Assess clinician acceptance. Example: Please rate your clinical staff\u2019s willingness to use AI diagnostic tools and top drivers/barriers (list).",
              "Address privacy and governance. Example: Which data governance requirements must be satisfied for AI diagnostics (HIPAA, SOC 2, PHI de-identification, on-prem data retention, auditability)?",
              "Measure ROI criteria. Example: Which metrics are required to justify investment (diagnostic accuracy improvement, throughput, LOS reduction, reimbursement uplift, total cost of ownership)?",
              "Probe integration. Example: What interoperability standards and integrations are required (HL7 v2, FHIR, DICOM, PACS/RIS/EMR)? What are the top integration challenges?",
              "Regulatory pathway. Example: Which regulatory clearances/certifications are necessary (FDA 510(k)/De Novo, CE MDR)? What documentation/validation is required?",
              "Vendor perceptions. Example: Please rate GE Healthcare, Philips, Siemens Healthineers, and others on trust, performance, integration ease, service, and pricing; indicate preferred vendor and reasons.",
              "KANO inputs. Example: Classify listed features (must-have, performance, delighter, indifferent, reverse) for AI diagnostic tools.",
              "Discrete choice readiness. Example: Present conjoint-style choice sets varying price, accuracy uplift, integration effort, privacy features, service SLAs, regulatory status.",
              "Segmentation and personas. Example: Identify your role (CIO, CMO, Radiology Director, CFO, etc.), hospital size, region, and strategic stance toward AI.",
              "Procurement models. Example: Preferred contracting options (capital purchase, subscription/SaaS, usage-based, risk-share/outcomes-based).",
              "Lifecycle expectations. Example: Expectations for model updates, monitoring, bias evaluation, explainability, and performance reporting cadence.",
              "Training and change management. Example: Required training modalities, go-live support, and ongoing service levels.",
              "Use cases. Example: Rank AI diagnostic use cases by perceived value (e.g., radiology triage, cardiology imaging analysis, sepsis prediction).",
              "External incentives. Example: Impact of payer reimbursement, quality measures, and professional society guidelines on adoption priority.",
              "Sampling control. Example: Screeners to ensure respondents are decision-makers in mid-sized hospitals (100\u2013500 beds) and involved in AI or diagnostic technology decisions."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How familiar are you with brands in your most-purc...' has poor objective coverage",
            "current_question": "How familiar are you with brands in your most-purchased category?",
            "improvements": [
              "Consider LLM-powered analysis for detailed insights"
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'When choosing products in your most-purchased cate...' has poor objective coverage",
            "current_question": "When choosing products in your most-purchased category, how important are the following factors? Price, Quality, Brand reputation, Sustainability, Convenience, Promotions or discounts.",
            "improvements": [
              "Contextualize to AI diagnostics in mid-sized hospitals and specify the decision context (evaluation/selection of AI diagnostic tools).",
              "Replace generic factors with enterprise-relevant attributes and define levels for modeling: price/total cost (CapEx, SaaS, per-study), integration effort (HL7/FHIR readiness, EMR compatibility), clinical performance (sensitivity/specificity vs. standard of care), workflow impact (time to result, automation), data/privacy safeguards (PHI handling, de-identification, on-prem/cloud), regulatory status (FDA/CE class, validation evidence), vendor support (training, uptime SLAs), and procurement model.",
              "Add role-targeted questions to map decision hierarchy: identify initiators, influencers, decision-makers, and approvers; capture committee structures and stage-gates.",
              "Insert budget process items: approval thresholds, budget cycles, funding sources, and typical timelines.",
              "Include clinician adoption scales: perceived usefulness, ease of use, trust, explainability needs, and required conditions for use.",
              "Add privacy/data governance items: HIPAA policies, data residency, audit/logging, model monitoring, bias management, and DUA/BAA requirements.",
              "Capture integration/interoperability: current HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), IT constraints, and security certifications.",
              "Vendor landscape module: unaided/aided awareness, consideration, differentiation, satisfaction with GE/Philips/Siemens and others.",
              "Design a discrete choice experiment or conjoint with realistic attribute levels and price points; supplement with Gabor-Granger/Van Westendorp for WTP bounds.",
              "Include KANO classification questions for prioritized features (must-have, performance, delighters).",
              "Profile respondents: role, department, hospital size (beds 100\u2013500), teaching status, ownership, region; segment by attitudes and needs.",
              "Benchmark adoption: current use, pilot status, number of tools, maturity, and clinical areas in use.",
              "Procurement preferences: contracting models, risk-sharing/outcomes-based options, trial/pilot terms.",
              "Lifecycle expectations: update cadence, validation transparency, performance dashboards, human-in-the-loop requirements.",
              "Training/change management: preferred formats, time investment, super-user models, and post-go-live support.",
              "Add external environment: impact of payer incentives, guidelines, and accreditation requirements on adoption priority."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Based on the concept you just reviewed, how appeal...' has poor objective coverage",
            "current_question": "Based on the concept you just reviewed, how appealing is this product overall?",
            "improvements": [
              "Add respondent role and involvement: Which of the following best describes your role in AI diagnostic tool decisions? and What level of influence do you have? (7-point scale).",
              "Budget and approval flow: What is the typical budget threshold requiring C-suite approval? and What is the usual approval timeline? (ranges).",
              "ROI criteria: Please rate importance of each metric (diagnostic accuracy delta, LOS reduction, readmission reduction, throughput, total cost of ownership, payback period).",
              "Privacy/governance: How concerned are you about each privacy risk? Which safeguards are required? (HIPAA compliance evidence, de-identification, on-prem processing, BAA, audit logs).",
              "Integration: Indicate required integrations (HL7, FHIR, DICOM, single sign-on, PACS, EMR order/result, API). Rate perceived integration difficulty.",
              "Regulatory: Which validations are necessary? (FDA clearance class, clinical validation level, post-market surveillance).",
              "Competitive perception: Rate familiarity and perceived strengths/weaknesses of GE, Philips, Siemens, and other vendors. Include open-end on differentiation.",
              "KANO feature battery: For each proposed feature, ask functional/dysfunctional KANO questions to classify must-have, performance, delighters.",
              "Pricing/DCE: Implement a discrete choice experiment varying price, deployment model (SaaS, on-prem), integration depth, regulatory status, support SLAs, and key features.",
              "Segmentation: Attitudinal batteries (innovation readiness, risk tolerance, data governance strictness) to cluster personas across C-suite, CIO, CMO, department heads.",
              "Adoption benchmark: What best describes your current stage with AI diagnostics? (not considering \u2192 piloting \u2192 scaled).",
              "Procurement models: Preferred contracting options (subscription per study, per device, enterprise license, outcome-based).",
              "Lifecycle expectations: Requirements for model updates, monitoring, bias assessments, performance dashboards, rollback processes.",
              "Training/change management: Required training formats, hours, roles, and vendor support expectations.",
              "Use cases: Rank clinical areas/use cases by value and urgency (radiology triage, cardiology imaging, sepsis prediction, pathology, etc.).",
              "External levers: Influence of payer incentives and professional guidelines on adoption priority.",
              "Revise the overall-appeal item to be role- and context-specific: How appealing is this product for your organization given your role\u2019s priorities? followed by Why? (open-end) to capture drivers/barriers."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How likely are you to consider purchasing this pro...' has poor objective coverage",
            "current_question": "How likely are you to consider purchasing this product within the next month?",
            "improvements": [
              "Add role/decision influence items: e.g., Which roles initiate, influence, and approve AI diagnostic purchases? Use RACI or staged approval matrices.",
              "Include budget and approval thresholds: approval limits by role, annual budget cycles, CAPEX vs OPEX, timeline from proposal to approval.",
              "Measure clinician acceptance: Likert scales on perceived usefulness, ease of use, workflow fit, and specific barriers (liability, alert fatigue, trust).",
              "Privacy and governance: items on PHI use, de-identification, data residency, consent, audit, and security certifications required.",
              "ROI and evaluation criteria: required clinical endpoints, payback period, IRR/NPV thresholds, total cost components considered.",
              "Integration requirements: HIS/EMR vendors in use, standards (HL7, FHIR, DICOM), SSO, data pipelines, IT resource constraints.",
              "Regulatory: required clearances (FDA Class, CE), validation evidence, post-market surveillance expectations.",
              "Competitive perceptions: rating and selection drivers for GE/Philips/Siemens and other vendors; awareness and shortlist dynamics.",
              "KANO items: classify feature set using functional/dysfunctional pairs to identify must-haves, performance, delighters.",
              "Discrete choice modules: design DCE with price, deployment model, integration depth, regulatory status, performance claims, support SLAs.",
              "Segmentation: collect demographics (role, department, hospital size, region), attitudes toward innovation, risk tolerance.",
              "Adoption benchmarking: current deployment stage, number of tools live/piloted, years of use, volume of cases touched by AI.",
              "Procurement models: preferences for subscription vs perpetual, usage-based, risk-sharing/outcome-based contracts, marketplace purchasing.",
              "Lifecycle and governance: expectations for model updates, drift monitoring, bias assessments, transparency dashboards, change logs.",
              "Training and support: required training hours, modalities, super-user programs, go-live support, ongoing success metrics.",
              "Use cases: rank clinical areas and specific diagnostic tasks by perceived value and urgency.",
              "External environment: effect of payer incentives, guidelines, malpractice insurers, and accreditation bodies.",
              "Refine the intent question itself: add timeframe relevance by role and stage, e.g., Likelihood to recommend for evaluation, pilot, or purchase in next 3/6/12 months; include response options aligned to funnel stages rather than a single generic purchase likelihood."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How does this concept perform on the following asp...' has poor objective coverage",
            "current_question": "How does this concept perform on the following aspects? Clarity of benefits, Uniqueness, Fit with your needs, Trustworthiness, Likelihood to replace current brand.",
            "improvements": [
              "Add respondent role, department, hospital size, and decision influence questions to map decision-making hierarchy.",
              "Include budget process items: capex/opex, approval thresholds, timeline, committee involvement, and funding sources.",
              "Add ROI/economic criteria batteries (clinical outcomes, LOS reduction, throughput, readmissions, cost offsets) and expected payback/IRR thresholds.",
              "Insert privacy/data governance items: PHI handling, de-identification, data residency, access controls, audit trails, DPIA requirements, HIPAA/GDPR compliance evidence.",
              "Expand integration/interoperability: EHR vendor, interfaces (HL7/FHIR/DICOM), SSO, workflow embedding, IT resourcing, and validation in test environments.",
              "Regulatory evidence needs: FDA/CE status, predicate devices, post-market surveillance, cybersecurity attestations (e.g., SBOM), and required documentation.",
              "KANO feature set: list concrete features and capture Must-have/One-dimensional/Attractive/Indifferent/Reverse using functional/dysfunctional pairs.",
              "Discrete choice/conjoint: construct choice sets with price, deployment model, performance metrics, integration level, support, regulatory status, and vendor.",
              "Clinical acceptance: measure perceived usefulness, ease of use, explainability, override controls, liability concerns, and required training, with barriers/drivers.",
              "Model lifecycle expectations: update cadence, drift monitoring, bias audits, performance transparency, human-in-the-loop, and service-level metrics.",
              "Competitive benchmarking: vendor-specific ratings on trust, service, integration, pricing, roadmap, references, and switching costs; include open-ends.",
              "Adoption maturity: current usage, pilot status, number of use cases live, and near-term plans by department.",
              "Procurement models: preferences for SaaS, per-study, enterprise license, risk-sharing/outcomes-based, and contract length.",
              "Sampling/qualification: screen for mid-sized hospitals (100\u2013500 beds) and target roles (C-suite, CIO, CMO, department head) with purchase influence.",
              "Refine current question\u2019s aspects: split 'Fit with your needs' into clinical workflow fit, IT fit, and compliance fit; separate 'Trustworthiness' into model transparency, data security, and vendor credibility; define 'Likelihood to replace current brand' by time horizon and preconditions."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Please allocate 100 points across the following be...' has poor objective coverage",
            "current_question": "Please allocate 100 points across the following benefits to reflect their importance to you: Better performance, Better value for money, Eco-friendly materials, Convenient packaging.",
            "improvements": [
              "Replace benefits with healthcare AI\u2013relevant value drivers (e.g., diagnostic accuracy/sensitivity/specificity, time-to-result, workflow integration with EMR/PACS, total cost of ownership, data security/PHI compliance, explainability/auditability, clinical validation evidence, uptime/support SLAs).",
              "Tailor the allocation exercise by role: ask each respondent to allocate points across value drivers from their functional perspective (clinical, IT, finance, compliance) to inform decision hierarchy and cross-functional weighting.",
              "Add items tied to ROI and purchasing (e.g., impact on LOS, readmissions, throughput, staff productivity, reimbursement impact, capital vs. operating expense flexibility).",
              "Include integration and lifecycle items (HL7/FHIR interoperability, model monitoring, bias management, update cadence, vendor transparency).",
              "Include privacy/regulatory items (HIPAA compliance, data residency, de-identification, FDA clearance/AI SaMD evidence, audit trails).",
              "Screen respondents to target C-suite, CIOs, CMOs, radiology/lab heads, and procurement; capture their role in decision stages.",
              "Use multiple tasks: a point-allocation for high-level value drivers, a KANO battery for features, and a discrete choice/conjoint module for price-feature trade-offs.",
              "Add questions on budget thresholds, approval gates, timelines, and procurement models (subscription, per-study, enterprise license, risk-share).",
              "Include vendor perception items to compare GE, Philips, Siemens Healthineers, and others on trust, integration, support, and innovation.",
              "Include use-case prioritization to identify clinical areas with highest perceived value (e.g., radiology triage, sepsis prediction, cardiology imaging).",
              "Add items to capture external influences (payer incentives, accreditation guidelines, system-level mandates)."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Assuming the product includes the features describ...' has poor objective coverage",
            "current_question": "Assuming the product includes the features described, what is the highest price you would be willing to pay for one unit? Please enter a price in your local currency.",
            "improvements": [
              "Specify purchase model in the question (e.g., annual subscription per site, per-study fee, perpetual license + maintenance) and ask WTP per that model.",
              "Collect role and decision-involvement first, then ask WTP from the perspective of their influence/authority.",
              "Add price sensitivity meter (PSM/Van Westendorp) items alongside the WTP point estimate to mitigate outliers and derive acceptable price ranges.",
              "Use discrete choice/choice-based conjoint tasks presenting realistic feature bundles, integration/service options, and price to estimate trade-offs and WTP more robustly.",
              "Anchor currency and units explicitly (local currency code auto-filled; clarify per site/year, per scanner, per department, or per user).",
              "Include budget context questions: typical approval thresholds, who approves at given price bands, budget cycle timing, and funding sources.",
              "Link WTP to ROI metrics by asking which outcomes would justify the stated price (e.g., reduction in length of stay, throughput gain, diagnostic accuracy uplift) and required evidence levels.",
              "Include KANO items for key features (must-have, performance, excitement) to connect features to satisfaction and pricing.",
              "Add items on integration requirements (HIS/EMR, PACS/VNA, HL7/FHIR standards), deployment model (on-prem, private cloud), and data governance expectations.",
              "Capture procurement preferences (pilot-to-scale, RFP timelines, contracting model, term length, SLAs, risk-sharing).",
              "Assess clinician acceptance: perceived usefulness, workflow fit, training needs, and barriers; tie to WTP by department/use case.",
              "Gather regulatory/compliance expectations (FDA/CE class, validation evidence, post-market monitoring) and impact on purchase likelihood/price tolerance.",
              "Benchmark current adoption and maturity and relate to WTP (adopters vs non-adopters).",
              "Include competitive perception questions and willingness-to-switch at different price points vs GE/Philips/Siemens.",
              "Ask for maximum affordable price under current budget constraints vs ideal price under proven ROI to separate budget ceiling from value ceiling."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'At what price would you consider this product so e...' has poor objective coverage",
            "current_question": "At what price would you consider this product so expensive that you would not consider buying it? Please enter a price in your local currency.",
            "improvements": [
              "Use the full Van Westendorp Price Sensitivity Meter: ask four price points (too expensive, too cheap, expensive but considered, bargain/good value) and specify the unit of purchase (e.g., annual SaaS license per site, per modality, per bed).",
              "If running DCM/conjoint, collect feature\u2013price trade-offs: define attributes (e.g., integration level, validation evidence, support SLAs, deployment model, data governance features) with realistic price levels.",
              "Anchor responses to the hospital purchasing unit and time horizon (e.g., annual enterprise license for a 300-bed hospital) and capture currency explicitly.",
              "Add budget and approval questions: budget owner, approval thresholds, CAPEX vs OPEX, fiscal cycle timing, and typical procurement duration.",
              "Include role and segmentation items: respondent role, department, decision influence, attitudes toward AI risk/benefit, current adoption stage.",
              "Measure clinical acceptance and barriers: perceived usefulness, workflow impact, required accuracy/validation thresholds, liability concerns.",
              "Capture privacy and governance: data residency, PHI handling, de-identification, auditability, model monitoring and bias controls.",
              "Assess integration and lifecycle: EMR/HIS interfaces, standards (HL7/FHIR/DICOM), IT resources, update cadence, performance transparency.",
              "Evaluate ROI and evaluation criteria: target outcomes (throughput, LOS, diagnostic accuracy), payback period, hurdle rates, TCO components.",
              "Probe procurement models: subscription vs usage-based, outcomes-based contracting, pilots, and proof-of-value requirements.",
              "Benchmark adoption: current tools in use, maturity level, satisfaction, and expansion plans.",
              "Include competitive perception items covering GE, Philips, Siemens Healthineers and other vendors: strengths, weaknesses, and selection drivers.",
              "Add KANO-style feature questions to classify must-have, performance, and delighter features.",
              "Specify guardrails and ranges for price entry to reduce outliers and improve data quality; include an option for 'not applicable/no purchase under any price' to avoid forced numeric entries."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'At what price would you consider this product to b...' has poor objective coverage",
            "current_question": "At what price would you consider this product to be priced so low that you would question its quality? Please enter a price in your local currency.",
            "improvements": [
              "Add the full Van Westendorp Price Sensitivity Meter set: too cheap, cheap/good value, expensive/high side, too expensive, plus a purchase likelihood at given price points.",
              "Incorporate a Gabor-Granger or DCM module that varies price and key features/integration/support terms to estimate WTP and elasticities.",
              "Capture role and influence: ask respondent\u2019s role, department, and decision authority (recommender, influencer, approver, final decision).",
              "Add budget and process items: typical budget holder, approval thresholds, committee involvement, fiscal timing, and capital vs operating budget constraints.",
              "Include clinical adoption drivers/barriers: perceived usefulness, workflow fit, trust, and required evidence levels.",
              "Add privacy/data governance requirements: PHI handling, de-identification, on-prem vs cloud constraints, security certifications, and data-sharing policies.",
              "Include integration questions: required standards (HL7/FHIR/DICOM), EMR/PACS vendors, single sign-on, and IT resources for deployment.",
              "Add regulatory/compliance expectations: needed validations, FDA/CE status, post-market monitoring, and documentation requirements.",
              "Assess vendor perceptions: shortlist vendors, differentiation attributes, and selection criteria.",
              "Include KANO questions to classify features (must-have, performance, delighters) across prioritized use cases.",
              "Profile procurement preferences: pricing/contracting models (subscription, per-study, enterprise license), term length, SLAs, and risk-sharing.",
              "Capture ROI criteria: economic and clinical outcomes required, payback period, threshold ICER, and evaluation metrics used by committees.",
              "Benchmark current state: current tools in use, stage of adoption, pilots vs production, and satisfaction.",
              "Assess training/change management needs: onboarding, super-user models, and vendor support expectations.",
              "Segment by hospital size within 100\u2013500 beds, teaching status, and geography to enable meaningful comparisons."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How acceptable are the following price points for ...' has poor objective coverage",
            "current_question": "How acceptable are the following price points for one unit of the product? $4.99, $6.99, $8.99, $10.99, $12.99.",
            "improvements": [
              "Define the pricing unit explicitly (e.g., per-study, per-reader per-month, per-site annual license, per-bed per-year) and align price ranges to realistic enterprise levels.",
              "Use a choice-based conjoint or discrete choice experiment that varies price with key attributes (integration effort, validated accuracy, turnaround time impact, privacy/security certifications, support/SLA, contracting model) to estimate WTP and price elasticity.",
              "Add questions on budget ownership, approval thresholds, and timeline (e.g., capital vs. operating budget, who signs at $50k/$250k/$1M, cycle length).",
              "Segment by role (C-suite, CIO, CMIO, CMO, department heads) and tailor pricing perspectives accordingly.",
              "Include ROI criteria items: target outcome improvements, payback period, total cost of ownership components, reimbursement impacts.",
              "Capture procurement preferences: subscription vs. usage-based vs. enterprise license, pilot terms, risk-sharing/outcomes-based contracts.",
              "Integrate items on data governance, PHI handling, model monitoring, auditability, and regulatory documentation requirements.",
              "Add integration/interoperability measures: EHR/HIS compatibility, standards (HL7/FHIR/DICOM), IT effort estimates, and workflow fit.",
              "Include KANO-style feature questions to classify must-haves, performance, and delighters.",
              "Benchmark current adoption/maturity and identify top clinical use cases by perceived value.",
              "Assess vendor perceptions and differentiators for GE, Philips, Siemens Healthineers, and others.",
              "Calibrate price ranges to hospital-scale budgets (e.g., $10k\u2013$1M+ per year) and include sensitivity checks across tiers."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Please evaluate how each feature would influence y...' has poor objective coverage",
            "current_question": "Please evaluate how each feature would influence your likelihood to buy. Recyclable packaging, Fragrance-free formula, Family-size pack, Subscription discount available.",
            "improvements": [
              "Rewrite attributes to be domain-relevant (e.g., EMR integration level [FHIR/HL7 support], on-prem vs. cloud deployment, PHI de-identification, audit logging, model performance metrics, explainability, FDA/CE status, cybersecurity certifications, pricing model, uptime/SLA, workflow integration, training/support).",
              "Add role screening and routing to capture decision hierarchy (e.g., C-suite, CIO, CMIO, department head, IT security, procurement) and ask about their influence and decision stages.",
              "For KANO, use feature-specific functional/dysfunctional questions to classify must-be, performance, and delighters for AI diagnostic features.",
              "For pricing and trade-offs, implement a discrete choice or conjoint exercise with realistic levels (e.g., sensitivity/specificity ranges, integration effort, deployment model, price per study/license, SLA, compliance status).",
              "Include items on budget thresholds, approval steps, committees involved, and typical timelines.",
              "Add modules on clinician acceptance: perceived usefulness, ease of use, workflow impact, liability concerns, alert fatigue, required training.",
              "Include privacy and governance questions: data residency, HIPAA compliance, access controls, retention policies, model monitoring, bias mitigation, auditability.",
              "Assess integration challenges: current HIS/EMR vendors, interface engines, IT resources, API standards, data types supported, validation and sandbox testing needs.",
              "Capture ROI criteria: clinical outcomes, turnaround time reduction, readmission impacts, cost offsets, payor/reimbursement impacts; ask for minimum acceptable thresholds.",
              "Measure vendor perceptions and selection drivers for GE, Philips, Siemens Healthineers, and others; include brand trust, service quality, integration history.",
              "Ask about procurement/contracting preferences: CapEx vs. OpEx, subscription vs. per-study, risk-sharing, pilots/POCs.",
              "Benchmark current adoption and maturity: tools in use, departments, scale, satisfaction, expansion plans.",
              "Segment by hospital size (beds), teaching status, ownership, and region to ensure representativeness."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Which of the following best describes why you sele...' has poor objective coverage",
            "current_question": "Which of the following best describes why you selected your answer to purchase intent?",
            "improvements": [
              "Specify the referent decision and timeframe: e.g., \u201cThinking about adopting AI diagnostic tools in your hospital within the next 12 months\u2026\u201d",
              "Use a multi-select, factorized list for reasons behind purchase intent covering clinical efficacy, workflow impact, integration effort, data privacy/security, regulatory clearance, ROI/total cost of ownership, budget status, stakeholder support, vendor trust, and external incentives; include \u2018other\u2019 with text.",
              "Add role/context screens: capture respondent\u2019s role, department, influence/decision authority, and committee participation to map hierarchy.",
              "Include budget and procurement items: approval thresholds, funding source, current budget availability, contracting model preferences, and timeline gates.",
              "Embed privacy/governance: PHI handling, data residency, de-identification, consent, auditability, and compliance frameworks required.",
              "Add integration specifics: named HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), IT lift, cybersecurity review, and sandbox/pilot needs.",
              "Capture ROI criteria: target payback period, clinical outcomes metrics, throughput, readmission/LOS, cost offsets, and evidence requirements.",
              "Include clinician adoption drivers/barriers: usability, sensitivity/specificity expectations, trust/explainability, autonomy impact, training needs.",
              "Add regulatory pathway perceptions: FDA class/clearance expectations, post-market monitoring, documentation needs.",
              "Collect vendor perceptions: likelihood to consider GE/Philips/Siemens vs others, differentiation drivers, and trust factors.",
              "Enable KANO tagging by asking respondents to rate candidate features as must-have, performance, attractive, indifferent, reverse.",
              "Support pricing research by following with a discrete choice exercise or Gabor-Granger/van Westendorp and feature bundles.",
              "Benchmark adoption: current deployment stage, number of tools in use, departments, and maturity level.",
              "Segment by personas: attitudes toward innovation, risk tolerance, data governance strictness, and budget flexibility.",
              "Offer an open-ended follow-up to capture nuanced rationale not covered by fixed options."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How likely are you to recommend this product conce...' has poor objective coverage",
            "current_question": "How likely are you to recommend this product concept to a friend or colleague?",
            "improvements": [
              "Add role/decision-influence questions: 'Which of the following roles are involved in evaluating/approving AI diagnostics at your hospital? Please indicate influence vs final decision.'",
              "Budget process items: 'What is the typical capital/OPEX approval threshold for AI tools? What is the approval timeline and required documentation?'",
              "Clinical acceptance battery: 'Rate your likelihood to use for specific use cases and indicate top drivers/barriers (workflow fit, accuracy, liability, trust, alert fatigue, explainability).' ",
              "Privacy/governance items: 'Which data types would be processed? Required safeguards (de-identification, on-prem processing, BAAs, audit trails)? Who oversees data governance?'",
              "ROI/economic metrics: 'What ROI/payback period is required? Which metrics matter most (reduced LOS, readmissions, throughput, staffing efficiency)? Evidence required?'",
              "Integration/interoperability: 'Which EHR/HIS systems are in place? Required standards (HL7, FHIR, DICOM, SMART on FHIR)? Integration pain points and IT resourcing?'",
              "Regulatory: 'What certifications/evidence are required (FDA/CE, IEC 62304, ISO 27001, SOC 2)? Post-market surveillance expectations?'",
              "Competitive perceptions: 'Rate familiarity and trust in GE/Philips/Siemens vs emerging vendors; key differentiators; shortlist and elimination criteria.'",
              "KANO feature battery: Classify features as must-have/one-dimensional/attractive/indifferent/reverse via paired functional/dysfunctional questions for key capabilities.",
              "Discrete choice experiments: Construct DCE with attributes (price, deployment model, integration level, explainability, workflow automation, validation evidence) to estimate WTP.",
              "Segmentation: Collect demographics and psychographics (risk tolerance, innovation posture, budget authority) to build personas (CIO, CMO, department head).",
              "Adoption maturity and benchmarking: 'Which AI tools are currently in use? Stage (pilot/scale), usage frequency, measured outcomes.'",
              "Procurement models: 'Preference for SaaS subscription, per-study fee, capital purchase with maintenance, or outcomes-based; contracting constraints.'",
              "Lifecycle expectations: 'Model update cadence, monitoring KPIs, bias detection/reporting, human-in-the-loop, rollback procedures, transparency needs.'",
              "Training/change management: 'Required training hours/modalities, super-user programs, vendor support SLAs, go-live support expectations.'",
              "Use-case prioritization: 'Rank clinical areas by expected value (radiology triage, sepsis prediction, cardiology imaging, pathology) and rationale.'",
              "External drivers: 'Impact of payer incentives, guidelines (AHA, CMS, FDA) on prioritization and timelines.'",
              "Refine the recommendation question: specify respondent role and context (e.g., 'Based on your hospital\u2019s needs and constraints, how likely are you to recommend this AI diagnostic concept for adoption in your department?') and follow with 'Why?' open-end to capture drivers/barriers."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'How confident are you that you understood the prod...' has poor objective coverage",
            "current_question": "How confident are you that you understood the product concept correctly?",
            "improvements": [
              "Reframe to comprehension check plus content probes: pair the confidence item with objective measures (e.g., a few true/false statements about the concept and a short summary recall) to validate understanding before substantive questions.",
              "Add role and organization screener items to ensure target sample (hospital size, respondent role, department, decision influence).",
              "Insert modules aligned to each objective: decision-making map (who initiates, evaluates, approves; RACI-style questions), budget thresholds/timelines, clinical acceptance (Likert drivers/barriers), privacy/data governance requirements, ROI metrics and target payback, integration and interoperability specifics, regulatory evidence needs, vendor perceptions and shortlists, KANO feature ratings, DCE choice sets with price/feature trade-offs, procurement models, lifecycle governance, training/support requirements, use-case prioritization, influence of guidelines/reimbursement, and differentiators beyond top vendors.",
              "If retaining a confidence item, anchor it to specific facets (e.g., confidence in data sources, workflow impact, integration model, pricing, regulatory status) to be diagnostically useful.",
              "Use validated scales where possible (e.g., technology acceptance constructs, privacy concern indices) and structured matrices for decision stages and stakeholders.",
              "Include benchmarking items on current adoption stage, pilots, and planned timelines.",
              "Add quality controls: comprehension gate, attention checks, and consistency checks across modules."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Please indicate how closely the following statemen...' has poor objective coverage",
            "current_question": "Please indicate how closely the following statements describe your typical shopping behavior. I look for the lowest price, I prefer sustainable options, I am loyal to specific brands, I try new products frequently.",
            "improvements": [
              "Anchor the question in the AI diagnostics enterprise purchase context; replace consumer heuristics with hospital-relevant decision criteria (e.g., clinical efficacy, workflow impact, integration effort, regulatory risk, data security, total cost of ownership).",
              "Use role-specific batteries: separate versions for executive leadership, IT, clinical leadership, and procurement to map decision influence and priorities.",
              "Add items to map decision-making hierarchy and stages (awareness, evaluation, pilot, committee review, CFO approval, contracting). Include who initiates, who evaluates, who approves, and veto points.",
              "Include budget process questions: approval thresholds, capital vs. OpEx, cycle timelines, sources of funding, committee cadence.",
              "Add clinician acceptance items: perceived usefulness, trust in AI, explainability needs, impact on workload, training needs, liability concerns.",
              "Insert privacy/data governance items: PHI handling, de-identification, data residency, audit trails, SOC2/HITRUST, HIPAA, GDPR where applicable.",
              "Add integration and interoperability items: required standards (HL7/FHIR/DICOM), SSO, data pipelines, IT resources, sandbox/pilot capabilities.",
              "Include ROI/economic evaluation items: payback period, NPV/IRR thresholds, clinical and operational KPIs, reimbursement impacts.",
              "Add vendor perception and selection criteria items covering GE, Philips, Siemens Healthineers and others; measure trust, support quality, roadmap alignment, pricing models.",
              "Design Kano-style feature questions: classify must-haves, performance features, and delighters across explainability, bias monitoring, calibration, auto-documentation, and integration utilities.",
              "Prepare attributes/levels for discrete choice or conjoint tasks: price/licensing model, integration effort, accuracy lift, explainability features, support SLAs, compliance certifications.",
              "Measure adoption maturity: current use, pilots, number of departments, outcomes achieved, barriers faced.",
              "Assess preferred procurement and contracting models: subscription vs. perpetual, risk-sharing, outcome-based, enterprise vs. departmental licensing.",
              "Capture data lifecycle expectations: model updates cadence, monitoring dashboards, drift/bias alerts, validation transparency, rollback procedures.",
              "Add items on external guidelines and payer incentives: awareness, perceived impact on prioritization, specific programs influencing adoption.",
              "Refine the attitudinal battery to healthcare-relevant frames (e.g., I prioritize evidence strength; I avoid tools without clear accountability; I prefer vendors with proven integrations in our EMR; I value outcome-based pricing).",
              "Include demographic/screener variables: role, department, hospital bed size (confirm 100\u2013500), EMR vendor, existing AI deployments, regional regulations."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Programmer note: Randomize the order of features i...' has poor objective coverage",
            "current_question": "Programmer note: Randomize the order of features in Q19 and Q24 and anchor the first and last options in all Likert scales.",
            "improvements": [
              "Provide the actual survey questions/items for Q19, Q24, and any Likert scales so they can be mapped to objectives.",
              "For each objective, include at least one targeted question block, e.g.:",
              "- Decision-making hierarchy: role-specific influence/decision matrices and process flow items.",
              "- Budget approval: thresholds, approvers, timelines, funding sources, fiscal year cadence.",
              "- Clinical acceptance: Likert items on perceived usefulness, trust, workflow fit, safety, change readiness.",
              "- Privacy/data governance: items on HIPAA, data residency, consent, de-identification, audit trails, DUA/BAA requirements.",
              "- ROI/economic criteria: total cost components, payback period, NPV/IRR use, clinical outcomes thresholds.",
              "- Integration/interoperability: specific standards (HL7 v2, FHIR, DICOM), SSO, order/result flows, IT effort.",
              "- Regulatory: FDA/CE status importance, validation documentation, post-market surveillance needs.",
              "- Competitive landscape: awareness, consideration, preference, perceived strengths/weaknesses for GE, Philips, Siemens and others.",
              "- KANO: functional/dysfunctional paired items for prioritized features.",
              "- Discrete choice: conjoint tasks with price and feature levels tailored to AI diagnostics.",
              "- Profiling/segmentation: role, department, bed size, EMR, adoption stage, attitudes.",
              "- Procurement models: CapEx vs OpEx, subscription, per-study, outcomes-based, pilots.",
              "- Lifecycle expectations: update cadence, monitoring, bias mitigation, transparency, explainability.",
              "- Training/support: onboarding, CME/CE, super-user programs, vendor SLAs.",
              "- Use cases: ranked clinical areas (radiology, cardiology, pathology, ED triage, sepsis, stroke, etc.).",
              "- External guidelines/payer incentives: awareness and impact of CMS reimbursement, professional society guidance.",
              "- Differentiators beyond top vendors: openness, extensibility, TCO, service quality, local support.",
              "Maintain the programmer note as a survey programming instruction attached to relevant questions, but do not treat it as a standalone question.",
              "Ensure randomization and anchoring are applied where appropriate: randomize feature lists for KANO and DCM tasks; anchor endpoints in Likert scales to reduce response bias."
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Programmer note: Apply soft quotas to balance age ...' has poor objective coverage",
            "current_question": "Programmer note: Apply soft quotas to balance age and gender to census distributions within country where feasible.",
            "improvements": [
              "Replace or supplement the programmer note with actual survey questions aligned to each objective (e.g., decision authority matrix, RACI items, and process flow for AI tool adoption)",
              "Add screening and profiling items to ensure respondents are target roles (C-suite, CIO, CMO, department heads) at mid-sized hospitals (100\u2013500 beds)",
              "Include modules for: budget thresholds/approval timelines; clinical acceptance (drivers/barriers, use scenarios); privacy/data governance policies; ROI/economic criteria; integration/interoperability with HIS/EMR; regulatory documentation and validation needs",
              "Add competitive perception batteries for GE Healthcare, Philips, Siemens Healthineers, and other vendors; capture differentiators and selection drivers",
              "Design KANO questions (functional/dysfunctional paired items) for prioritized AI features",
              "Embed a discrete choice experiment (conjoint) with price and feature attributes to estimate WTP and sensitivity",
              "Include items on procurement/contracting models (CAPEX vs OPEX, subscription, outcomes-based), support/training/change management requirements, and lifecycle expectations (updates, monitoring, bias, transparency)",
              "Add benchmarking questions on current adoption, deployment scale, and maturity",
              "Refine sampling plan and quotas to target hospital size and roles; consider additional soft quotas by role and region rather than only age/gender",
              "Retain the programmer note as a sampling instruction but move it to the sample plan/specifications section, not as a survey question"
            ],
            "expected_impact": "medium"
          },
          {
            "type": "improve_question",
            "priority": "medium",
            "issue": "Question 'Programmer note: Implement validation for constant...' has poor objective coverage",
            "current_question": "Programmer note: Implement validation for constant sum to equal 100 in Q19 and require numeric entries greater than zero for pricing questions.",
            "improvements": [
              "Replace the programmer note with actual survey items tied to objectives; keep validation instructions separate in a survey spec or as field notes.",
              "For decision-making hierarchy: add role-selection grids and influence/decision authority matrices (e.g., RACI-style) and process flow questions.",
              "For budgets: include questions on budget owners, approval thresholds, timing windows, and funding sources (Opex/Capex, grants).",
              "For clinician acceptance: add Likert scales on perceived usefulness, ease of use, trust, and barriers; include open-ends for concerns.",
              "For privacy/governance: include items on HIPAA, data retention, de-identification, PHI handling, data residency, and required safeguards.",
              "For ROI: ask required payback period, acceptable total cost of ownership, and clinical/economic outcomes used in business cases.",
              "For integration: measure current HIS/EMR vendors, interface standards (HL7, FHIR, DICOM), SSO/IDM needs, and workflow integration points.",
              "For regulatory: ask required evidence (FDA clearance class, performance validation), documentation, and internal review bodies.",
              "For competitive landscape: add brand familiarity, consideration, perceived strengths/weaknesses of GE, Philips, Siemens, and others.",
              "For KANO: include functional/dysfunctional pair items for target features to classify must-be, performance, and delighters.",
              "For pricing/WTP: implement discrete choice/conjoint tasks with price, features, and service levels; keep numeric validation rules as programming notes.",
              "For profiling/segmentation: capture role, department, tenure, hospital size (beds 100\u2013500), and attitudes toward innovation/risk.",
              "For adoption triggers/barriers: include max-diff or rating of triggers (e.g., reimbursement, clinical champions) and barriers (IT constraints, privacy).",
              "For benchmarking: ask current deployment status, number of use cases live, and maturity level.",
              "For procurement models: include preferences for subscription vs. perpetual, per-study vs. enterprise, and contracting constraints.",
              "For lifecycle expectations: items on update cadence, monitoring, bias audits, model explainability, and transparency dashboards.",
              "For training/support: measure desired training formats, change management support, SLAs, and post-go-live support needs.",
              "For clinical use cases: rate value by department (radiology, pathology, cardiology, ED triage) and anticipated ROI/time-to-value.",
              "For external incentives: assess impact of payer reimbursement codes, guidelines, and accreditation requirements.",
              "For differentiation: ask which features/services beyond top vendors would drive switching or selection."
            ],
            "expected_impact": "medium"
          }
        ],
        "confidence_score": 0.9999999999999999,
        "evaluation_metadata": {
          "evaluation_timestamp": "2025-10-11T21:54:13.957318",
          "llm_powered": true,
          "rules_context_used": false,
          "objectives_extracted": 20,
          "questions_analyzed": 31,
          "critical_gaps_found": 10
        }
      },
      "methodological_rigor": {
        "overall_score": 0.3582258064516129,
        "reasoning_chain": [
          "STEP 1: Performing advanced multi-type bias detection with severity assessment",
          "STEP 2: Analyzing question sequencing and logical flow",
          "STEP 3: Evaluating methodology implementation compliance",
          "STEP 4: Assessing statistical power and sampling adequacy",
          "STEP 5: Generating specific methodological improvement recommendations"
        ],
        "bias_analysis": [
          {
            "bias_type": "double_barreled",
            "question_id": "q1",
            "question_text": "Which of the following best describes your role in household shopping for everyday consumer products such as personal care, cleaning, and packaged goods?",
            "severity": "medium",
            "specific_issue": "Combines multiple product categories under one role; respondents may have different roles by category (e.g., leads cleaning but not personal care).",
            "suggested_fix": "Which of the following best describes your role in household shopping for everyday consumer products overall? If your role differs by category, please answer based on your typical overall role.",
            "confidence": 0.74
          },
          {
            "bias_type": "framing",
            "question_id": "q1",
            "question_text": "Which of the following best describes your role in household shopping for everyday consumer products such as personal care, cleaning, and packaged goods?",
            "severity": "low",
            "specific_issue": "Providing examples may narrow interpretation and exclude other relevant categories (e.g., pet care).",
            "suggested_fix": "Which of the following best describes your role in household shopping for everyday consumer products? (Examples: personal care, cleaning, packaged goods, etc.)",
            "confidence": 0.62
          },
          {
            "bias_type": "double_barreled",
            "question_id": "q2",
            "question_text": "How often do you purchase consumer products like personal care, cleaning, or packaged goods?",
            "severity": "medium",
            "specific_issue": "Frequency can vary by category; a single frequency may not accurately represent behavior across categories.",
            "suggested_fix": "Thinking about everyday consumer products overall, how often do you make purchases for these items? If it varies by category, choose the option that best reflects your overall typical frequency.",
            "confidence": 0.71
          },
          {
            "bias_type": "response_order",
            "question_id": "q3",
            "question_text": "In which country do you currently reside?",
            "severity": "low",
            "specific_issue": "If country list is long and not randomized/alphabetized, primacy or recency effects may occur.",
            "suggested_fix": "Display countries in alphabetical order and include a searchable dropdown.",
            "confidence": 0.68
          },
          {
            "bias_type": "response_order",
            "question_id": "q4",
            "question_text": "What is your age?",
            "severity": "medium",
            "specific_issue": "If age is asked as categories without balanced bins or with top-coding, it can skew distributions and induce order effects.",
            "suggested_fix": "Collect age as an open numeric field with validation (e.g., 18\u201399). If categories are required, use balanced, non-overlapping bins and display ascending order.",
            "confidence": 0.76
          },
          {
            "bias_type": "social_desirability",
            "question_id": "q5",
            "question_text": "Which of the following industries do you or a close family member work in?",
            "severity": "low",
            "specific_issue": "Potential sensitivity about disclosing employment of family members could lead to underreporting.",
            "suggested_fix": "Which of the following industries do you or an immediate family member work in? Your response is confidential and used only for screening.",
            "confidence": 0.63
          },
          {
            "bias_type": "framing",
            "question_id": "q6",
            "question_text": "Have you participated in any market research surveys about consumer products in the past 3 months?",
            "severity": "low",
            "specific_issue": "Timeframe of 3 months may not align with goals and could trigger recall bias if not clearly defined.",
            "suggested_fix": "In the past 3 months, have you completed any market research surveys specifically about consumer products?",
            "confidence": 0.58
          },
          {
            "bias_type": "double_barreled",
            "question_id": "q7",
            "question_text": "Which statement best describes your involvement in choosing brands for everyday household products?",
            "severity": "medium",
            "specific_issue": "Involvement may vary by product category; a single statement may not capture nuanced roles.",
            "suggested_fix": "Which statement best describes your overall involvement in choosing brands for everyday household products?",
            "confidence": 0.66
          },
          {
            "bias_type": "framing",
            "question_id": "q8",
            "question_text": "Please select the number four from the list below.",
            "severity": "low",
            "specific_issue": "As an attention check, direct instruction could cue gaming if overused; minimal bias risk but may increase dropout for genuine respondents with accessibility needs.",
            "suggested_fix": "Attention check: Please select the number 4 from the list below.",
            "confidence": 0.55
          },
          {
            "bias_type": "social_desirability",
            "question_id": "q9",
            "question_text": "What is your gender?",
            "severity": "high",
            "specific_issue": "Gender can be sensitive and identity-based; limited options can force misclassification and induce discomfort or socially desirable responding.",
            "suggested_fix": "What is your gender? Options: Woman; Man; Non-binary; Another gender (please specify); Prefer not to say.",
            "confidence": 0.86
          },
          {
            "bias_type": "response_order",
            "question_id": "q10",
            "question_text": "What is your approximate annual household income before taxes?",
            "severity": "medium",
            "specific_issue": "If categories are uneven, top-coded, or ordered to imply desirability, responses can be biased by anchoring and social desirability.",
            "suggested_fix": "Use balanced, inflation-adjusted brackets with clear before-tax framing; include Prefer not to say; present ascending order.",
            "confidence": 0.8
          },
          {
            "bias_type": "social_desirability",
            "question_id": "q11",
            "question_text": "What is the highest level of education you have completed?",
            "severity": "low",
            "specific_issue": "Education is status-laden; without Prefer not to say or standardized categories, may prompt socially desirable responses.",
            "suggested_fix": "Use standard education categories for the country, include Prefer not to say, and clarify completed vs currently enrolled.",
            "confidence": 0.67
          },
          {
            "bias_type": "double_barreled",
            "question_id": "q12",
            "question_text": "Which categories of consumer products have you purchased in the past 3 months? Personal care, Household cleaning, Packaged food and beverages, Paper goods, Laundry products.",
            "severity": "low",
            "specific_issue": "Combines food and beverages into one; recall period is clear but categories may overlap (e.g., paper goods vs household cleaning).",
            "suggested_fix": "Select all you purchased in the past 3 months: Personal care; Household cleaning; Packaged food; Packaged beverages; Paper goods; Laundry products.",
            "confidence": 0.7
          },
          {
            "bias_type": "framing",
            "question_id": "q13",
            "question_text": "Thinking about the category you purchase most often, how frequently do you buy products in that category?",
            "severity": "low",
            "specific_issue": "Focusing on most-often category emphasizes higher-frequency behavior and may inflate overall frequency impressions.",
            "suggested_fix": "Thinking about the category you purchase most often, how frequently do you buy products in that category? (This question is only about your most-purchased category.)",
            "confidence": 0.61
          },
          {
            "bias_type": "response_order",
            "question_id": "q14",
            "question_text": "How familiar are you with brands in your most-purchased category?",
            "severity": "low",
            "specific_issue": "If Likert scale lacks balanced anchors or is not clearly labeled, may induce acquiescence or midpoint bias.",
            "suggested_fix": "Use a 5-point scale with fully labeled, balanced anchors: Not at all familiar; Slightly; Moderately; Very; Extremely.",
            "confidence": 0.72
          },
          {
            "bias_type": "acquiescence",
            "question_id": "q15",
            "question_text": "When choosing products in your most-purchased category, how important are the following factors? Price, Quality, Brand reputation, Sustainability, Convenience, Promotions or discounts.",
            "severity": "medium",
            "specific_issue": "All attributes are positively valenced, encouraging higher ratings across the board (yea-saying).",
            "suggested_fix": "Use a balanced importance scale and include a mix of positively and neutrally valenced items; include a Not applicable option.",
            "confidence": 0.78
          },
          {
            "bias_type": "framing",
            "question_id": "q16",
            "question_text": "Based on the concept you just reviewed, how appealing is this product overall?",
            "severity": "low",
            "specific_issue": "The term 'appealing' is positively framed and may inflate positivity compared to neutral wording.",
            "suggested_fix": "Based on the concept you just reviewed, how would you rate this product overall?",
            "confidence": 0.6
          },
          {
            "bias_type": "confirmation",
            "question_id": "q17",
            "question_text": "How likely are you to consider purchasing this product within the next month?",
            "severity": "medium",
            "specific_issue": "Specifies a short time horizon, nudging to immediate intent and possibly overstating short-term purchase consideration.",
            "suggested_fix": "How likely are you to consider purchasing this product in the near future (e.g., within the next 1\u20133 months)?",
            "confidence": 0.62
          },
          {
            "bias_type": "acquiescence",
            "question_id": "q18",
            "question_text": "How does this concept perform on the following aspects? Clarity of benefits, Uniqueness, Fit with your needs, Trustworthiness, Likelihood to replace current brand.",
            "severity": "medium",
            "specific_issue": "All aspects imply positive performance evaluation; may prompt yea-saying and halo effects.",
            "suggested_fix": "Ask for agreement with balanced statements including negatives (e.g., The benefits are unclear) or use performance scales anchored at Poor/Excellent.",
            "confidence": 0.77
          },
          {
            "bias_type": "framing",
            "question_id": "q19",
            "question_text": "Please allocate 100 points across the following benefits to reflect their importance to you: Better performance, Better value for money, Eco-friendly materials, Convenient packaging.",
            "severity": "medium",
            "specific_issue": "All options are positive benefits, potentially inflating perceived importance; constant-sum forces trade-offs that may not reflect absolute importance.",
            "suggested_fix": "Retain constant-sum but preface with neutrality: Allocate 100 points across the following possible product attributes to reflect their relative importance to you.",
            "confidence": 0.7
          },
          {
            "bias_type": "framing",
            "question_id": "q20",
            "question_text": "Assuming the product includes the features described, what is the highest price you would be willing to pay for one unit? Please enter a price in your local currency.",
            "severity": "low",
            "specific_issue": "Wording may anchor on inclusion of all features as described; still standard WTP question with minimal bias.",
            "suggested_fix": "Considering only the features described (no additional features), what is the highest price you would be willing to pay for one unit? Enter a price in your local currency.",
            "confidence": 0.58
          },
          {
            "bias_type": "framing",
            "question_id": "q21",
            "question_text": "At what price would you consider this product so expensive that you would not consider buying it? Please enter a price in your local currency.",
            "severity": "low",
            "specific_issue": "Van Westendorp 'Too expensive' anchor may prime high threshold if asked before 'Too cheap' and 'Expensive' bounds.",
            "suggested_fix": "Ask Van Westendorp in standard sequence or randomize order: Too cheap, Cheap, Expensive, Too expensive.",
            "confidence": 0.75
          },
          {
            "bias_type": "framing",
            "question_id": "q22",
            "question_text": "At what price would you consider this product to be priced so low that you would question its quality? Please enter a price in your local currency.",
            "severity": "low",
            "specific_issue": "Wording suggests low price implies poor quality, which could reinforce price\u2013quality heuristic.",
            "suggested_fix": "At what price would this product be so low that you would doubt it meets your expectations? Enter a price in your local currency.",
            "confidence": 0.66
          },
          {
            "bias_type": "response_order",
            "question_id": "q23",
            "question_text": "How acceptable are the following price points for one unit of the product? $4.99, $6.99, $8.99, $10.99, $12.99.",
            "severity": "high",
            "specific_issue": "Fixed dollar anchors create anchoring effects across countries; order can bias toward midpoints if not randomized; currency mismatch for non-USD respondents.",
            "suggested_fix": "Localize to respondent currency and adjust levels accordingly; display prices in ascending order and consider randomizing block order across respondents.",
            "confidence": 0.88
          },
          {
            "bias_type": "acquiescence",
            "question_id": "q24",
            "question_text": "Please evaluate how each feature would influence your likelihood to buy. Recyclable packaging, Fragrance-free formula, Family-size pack, Subscription discount available.",
            "severity": "medium",
            "specific_issue": "Features are framed positively; without a negative option or Not applicable, respondents may overstate positive influence.",
            "suggested_fix": "Use a bipolar influence scale with Not applicable: Strongly decreases; Slightly decreases; No impact; Slightly increases; Strongly increases; Not applicable.",
            "confidence": 0.79
          },
          {
            "bias_type": "confirmation",
            "question_id": "q25",
            "question_text": "Which of the following best describes why you selected your answer to purchase intent?",
            "severity": "medium",
            "specific_issue": "If options emphasize positive reasons, it can rationalize intent and confirm prior responses.",
            "suggested_fix": "Provide a balanced list including positive, neutral, and negative reasons, plus Other (specify).",
            "confidence": 0.72
          },
          {
            "bias_type": "social_desirability",
            "question_id": "q26",
            "question_text": "How likely are you to recommend this product concept to a friend or colleague?",
            "severity": "low",
            "specific_issue": "NPS-style recommendation may trigger positivity bias due to social desirability and hypothetical nature.",
            "suggested_fix": "Use standard 0\u201310 likelihood scale with clear anchors and include Prefer not to answer.",
            "confidence": 0.63
          },
          {
            "bias_type": "acquiescence",
            "question_id": "q27",
            "question_text": "How confident are you that you understood the product concept correctly?",
            "severity": "medium",
            "specific_issue": "Self-assessed understanding tends to be inflated; wording implies there is a correct understanding.",
            "suggested_fix": "How confident are you in your understanding of the product concept? Use a 5-point scale with Not at all to Extremely, and include I did not understand it.",
            "confidence": 0.7
          },
          {
            "bias_type": "acquiescence",
            "question_id": "q28",
            "question_text": "Please indicate how closely the following statements describe your typical shopping behavior. I look for the lowest price, I prefer sustainable options, I am loyal to specific brands, I try new products frequently.",
            "severity": "high",
            "specific_issue": "All items are socially acceptable or desirable in different ways; without reverse-coded or neutral statements, yea-saying and social desirability can inflate agreement.",
            "suggested_fix": "Balance with reverse-coded/neutral items (e.g., I rarely compare prices; I usually stick to the first acceptable option) and randomize item order; include Doesn\u2019t describe me.",
            "confidence": 0.86
          },
          {
            "bias_type": "response_order",
            "question_id": "q29",
            "question_text": "Programmer note: Randomize the order of features in Q19 and Q24 and anchor the first and last options in all Likert scales.",
            "severity": "low",
            "specific_issue": "Anchoring first and last options can reduce but not eliminate order bias; no mention of randomizing scale direction across respondents.",
            "suggested_fix": "Randomize item order; keep consistent left-to-right polarity; consider counterbalancing scale direction in pilot tests only.",
            "confidence": 0.59
          },
          {
            "bias_type": "framing",
            "question_id": "q30",
            "question_text": "Programmer note: Apply soft quotas to balance age and gender to census distributions within country where feasible.",
            "severity": "low",
            "specific_issue": "Quotas reduce sampling bias but may introduce nonresponse bias if hard to fill cells lead to over-targeting specific groups.",
            "suggested_fix": "Monitor recruitment sources to avoid over-targeting; document weighting plan and report unfilled cells.",
            "confidence": 0.6
          },
          {
            "bias_type": "framing",
            "question_id": "q31",
            "question_text": "Programmer note: Implement validation for constant sum to equal 100 in Q19 and require numeric entries greater than zero for pricing questions.",
            "severity": "low",
            "specific_issue": "Forcing >0 for pricing may exclude legitimate zero WTP; constant-sum strictness may induce satisficing.",
            "suggested_fix": "Allow zero for WTP where appropriate; allow minor rounding tolerance in constant sum (e.g., 98\u2013102) with an auto-normalize option.",
            "confidence": 0.83
          }
        ],
        "question_flow_analysis": [
          {
            "question_id": "q1",
            "position": 1,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Question topic (household consumer shopping) is misaligned with RFQ target (AI diagnostics in hospitals).",
              "Not a screen for B2B healthcare decision-makers; risks admitting unqualified respondents.",
              "Opening question does not build rapport for the correct audience."
            ],
            "optimal_position": null,
            "reasoning": "This survey is for mid-sized hospital stakeholders about AI diagnostics. Q1 is irrelevant and should be removed entirely. Replace with screeners on role (C-suite, CIO, CMO, dept head), hospital size, and AI/HIS exposure."
          },
          {
            "question_id": "q2",
            "position": 2,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Irrelevant consumer purchase frequency for B2B healthcare audience.",
              "Continues an off-topic path, increasing drop-off among target executives."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace early content with screeners on decision-making authority and involvement with diagnostic imaging/AI tools."
          },
          {
            "question_id": "q3",
            "position": 3,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Country is a demographic and should be placed later after screening.",
              "Without proper screeners, geo data does not ensure target sample compliance."
            ],
            "optimal_position": 26,
            "reasoning": "Retain country as a demographic but move to the end block. Early questions should confirm hospital role and eligibility."
          },
          {
            "question_id": "q4",
            "position": 4,
            "flow_score": 0.1,
            "sequencing_issues": [
              "Age is a personal demographic generally reserved for the end.",
              "Potentially sensitive and not relevant for screening eligibility."
            ],
            "optimal_position": 27,
            "reasoning": "Move to demographics at the end to prevent early abandonment and avoid priming effects."
          },
          {
            "question_id": "q5",
            "position": 5,
            "flow_score": 0.1,
            "sequencing_issues": [
              "Industry affiliation as framed is consumer-survey style and unrelated to hospital/AI context.",
              "If intended as a conflict-of-interest screen, wording is off-target."
            ],
            "optimal_position": null,
            "reasoning": "Remove or replace with a targeted screener: current employer type (hospital/health system), bed size, role, department, and whether respondent works in radiology, lab, IT, or procurement."
          },
          {
            "question_id": "q6",
            "position": 6,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Past participation in consumer research is irrelevant.",
              "If used as a quality/survey fatigue screen, it should be reframed to healthcare tech research."
            ],
            "optimal_position": null,
            "reasoning": "Remove or rewrite to: 'Have you participated in research on AI in healthcare in the last 3 months?' Place early if used to avoid professional respondents."
          },
          {
            "question_id": "q7",
            "position": 7,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Still consumer household brand-choice oriented.",
              "Does not help qualify or profile hospital decision-makers."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with involvement in technology/vendor selection and budget approval process."
          },
          {
            "question_id": "q8",
            "position": 8,
            "flow_score": 0.5,
            "sequencing_issues": [
              "Attention check is acceptable, but better after engagement and before key trade-off tasks.",
              "Single attention check early may screen out rushed respondents prematurely among executives."
            ],
            "optimal_position": 15,
            "reasoning": "Keep one attention check around the transition into core evaluation modules to protect data quality without harming early rapport."
          },
          {
            "question_id": "q9",
            "position": 9,
            "flow_score": 0.1,
            "sequencing_issues": [
              "Gender is a demographic and should be later.",
              "Not useful for screening eligibility."
            ],
            "optimal_position": 28,
            "reasoning": "Move to the demographics section at the end."
          },
          {
            "question_id": "q10",
            "position": 10,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Household income is not relevant to B2B hospital procurement.",
              "Sensitive and early placement is inappropriate."
            ],
            "optimal_position": null,
            "reasoning": "Remove. If any financial profiling is needed, capture organization-level budget authority and capex/opex bands, not personal income."
          },
          {
            "question_id": "q11",
            "position": 11,
            "flow_score": 0.3,
            "sequencing_issues": [
              "Education belongs to end demographics.",
              "For this audience, role/title and years in role are more informative earlier."
            ],
            "optimal_position": 29,
            "reasoning": "Move to end. Use early screeners for title and clinical/IT experience instead."
          },
          {
            "question_id": "q12",
            "position": 12,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Consumer categories irrelevant to AI diagnostics context.",
              "Prolongs off-topic content and increases attrition."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with clinical domains using AI diagnostics (radiology, pathology, cardiology, ED triage) in the hospital."
          },
          {
            "question_id": "q13",
            "position": 13,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Continues consumer product theme.",
              "No link to RFQ objectives."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Insert questions on purchase/upgrade cycles for diagnostic tools and EMR/HIS integration cadence."
          },
          {
            "question_id": "q14",
            "position": 14,
            "flow_score": 0.0,
            "sequencing_issues": [
              "Consumer brand familiarity not applicable.",
              "Misses opportunity to measure awareness of GE, Philips, Siemens Healthineers."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Add vendor awareness and consideration for GE Healthcare, Philips, Siemens Healthineers, and others."
          },
          {
            "question_id": "q15",
            "position": 15,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Attributes are consumer-oriented (price, promotions) vs. enterprise drivers (clinical accuracy, workflow integration, data security, ROI).",
              "Matrix placed before establishing context of AI diagnostic tools."
            ],
            "optimal_position": null,
            "reasoning": "Remove or completely rewrite as enterprise attribute importance. If retained in rewritten form, place after context-setting and role profiling."
          },
          {
            "question_id": "q16",
            "position": 16,
            "flow_score": 0.1,
            "sequencing_issues": [
              "References 'concept you just reviewed' but no healthcare AI concept is provided.",
              "Consumer product appeal question misaligned with B2B decision-making."
            ],
            "optimal_position": null,
            "reasoning": "Remove. If testing AI tool concepts, place a structured concept read with relevant outcomes (sensitivity/specificity, workflow, regulatory status) before evaluation."
          },
          {
            "question_id": "q17",
            "position": 17,
            "flow_score": 0.1,
            "sequencing_issues": [
              "Consumer purchase intent framing inappropriate for hospital procurement cycles.",
              "Timing 'next month' ignores budgeting and approval timelines."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with likelihood to evaluate/pilot/purchase within specified budget cycles (e.g., next 6-12 months) and contingent on approvals."
          },
          {
            "question_id": "q18",
            "position": 18,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Generic concept diagnostics without healthcare-specific criteria (clinical validity, interoperability, cybersecurity, HIPAA).",
              "Placed without proper concept stimulus."
            ],
            "optimal_position": null,
            "reasoning": "Remove or rewrite to healthcare-specific evaluation and place after a clear AI-tool concept stimulus."
          },
          {
            "question_id": "q19",
            "position": 19,
            "flow_score": 0.3,
            "sequencing_issues": [
              "Benefits are consumer product oriented.",
              "Constant-sum method is fine, but items should reflect enterprise value drivers."
            ],
            "optimal_position": null,
            "reasoning": "Remove or rewrite to constant-sum across hospital-relevant benefits (diagnostic accuracy uplift, reduced turnaround time, clinician adoption, integration ease, total cost of ownership, compliance). Place after attribute intro."
          },
          {
            "question_id": "q20",
            "position": 20,
            "flow_score": 0.2,
            "sequencing_issues": [
              "WTP for 'one unit' of consumer product does not translate to enterprise licensing/capex.",
              "Numeric open without anchoring to pricing model (SaaS, per-study, per-modality) will be noisy."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with discrete choice or Gabor-Granger tailored to enterprise pricing models and budget holders; place after feature definitions."
          },
          {
            "question_id": "q21",
            "position": 21,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Van Westendorp item framed for consumer goods; lacks enterprise context.",
              "No price metric clarity."
            ],
            "optimal_position": null,
            "reasoning": "Remove or reframe within Van Westendorp using enterprise pricing unit (per site per year license, per modality, per study). Place within pricing module after value framing."
          },
          {
            "question_id": "q22",
            "position": 22,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Same as Q21; consumer framing and unclear unit."
            ],
            "optimal_position": null,
            "reasoning": "Remove or reframe as part of a coherent enterprise Van Westendorp block."
          },
          {
            "question_id": "q23",
            "position": 23,
            "flow_score": 0.1,
            "sequencing_issues": [
              "Fixed consumer price points inappropriate.",
              "Currency and unit mismatch for global hospital audience."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with price levels relevant to AI diagnostics (e.g., $50k-$500k capex, $X per study, $Y per bed per year) within a DCE or price ladder."
          },
          {
            "question_id": "q24",
            "position": 24,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Features are consumer-centric (recyclable packaging, fragrance-free).",
              "No linkage to AI diagnostic tool features."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with features like PACS/RIS integration, FDA/CE status, audit trails, on-prem vs cloud, model explainability, IT admin controls, cybersecurity certifications, SLA."
          },
          {
            "question_id": "q25",
            "position": 25,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Tied to earlier consumer purchase intent; irrelevant.",
              "Misses reasons tied to hospital procurement (clinical outcomes, reimbursement, IT fit, training)."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with 'drivers and barriers' for adoption, mapped to decision stakeholders."
          },
          {
            "question_id": "q26",
            "position": 26,
            "flow_score": 0.2,
            "sequencing_issues": [
              "NPS on a consumer concept; not meaningful for enterprise procurement.",
              "If used at all, place at end after concept evaluation."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Consider an advocacy/endorsement likelihood within professional context, but priority is adoption likelihood within org."
          },
          {
            "question_id": "q27",
            "position": 27,
            "flow_score": 0.5,
            "sequencing_issues": [
              "Concept comprehension check is good but earlier concept is missing.",
              "Placed late; should accompany concept evaluations."
            ],
            "optimal_position": 18,
            "reasoning": "Retain a comprehension check immediately after any AI-tool concept read and before evaluation/joint tasks to filter misreads."
          },
          {
            "question_id": "q28",
            "position": 28,
            "flow_score": 0.2,
            "sequencing_issues": [
              "Behavioral statements are consumer shopping oriented.",
              "Not relevant to hospital decision criteria."
            ],
            "optimal_position": null,
            "reasoning": "Remove. Replace with organizational decision style statements (risk tolerance, innovation adoption, standardization vs best-of-breed, data governance posture)."
          },
          {
            "question_id": "q29",
            "position": 29,
            "flow_score": 0.7,
            "sequencing_issues": [
              "Programming notes are fine but reference removed consumer items.",
              "Anchoring Likerts is okay; ensure randomization in feature/DCE blocks."
            ],
            "optimal_position": 99,
            "reasoning": "Keep programming notes but update to reflect healthcare-specific attributes and DCE tasks. Position is flexible/not respondent-facing."
          },
          {
            "question_id": "q30",
            "position": 30,
            "flow_score": 0.7,
            "sequencing_issues": [
              "Soft quotas on age/gender not aligned with B2B sampling needs.",
              "Better to quota by role, hospital size, region, and department."
            ],
            "optimal_position": 99,
            "reasoning": "Revise quotas to align with target universe: role (C-suite/CIO/CMO/Dept head), bed size (100\u2013500), region/country, and department (IT, Radiology, Pathology)."
          },
          {
            "question_id": "q31",
            "position": 31,
            "flow_score": 0.8,
            "sequencing_issues": [
              "Validation instruction is fine but tied to consumer constant-sum and pricing questions slated for replacement."
            ],
            "optimal_position": 99,
            "reasoning": "Retain validation guidance but adapt to new tasks (e.g., DCE design, Van Westendorp enterprise units, numeric validations on budgets). Programming note position is fine."
          }
        ],
        "methodology_compliance": [],
        "statistical_power_assessment": {
          "overall_adequacy_score": 0.05,
          "sample_size_evaluation": "Target Responses is 0, which is insufficient for any inferential statistics or descriptive reliability. For a 31-question survey aimed at C-suite/CIO/CMO/department heads with analyses including discrete choice (conjoint), MaxDiff, and segmentation across hospital sizes (100\u2013500 beds) and roles, a minimum of 200\u2013300 completes is typically required for robust utilities and stable subgroup estimates. With 0 responses, sampling error is undefined, confidence intervals cannot be computed, and no power exists to detect any effect.",
          "methodology_alignment": 0.0,
          "detectable_effect_sizes": {
            "survey_metrics": "None. With n=0, no effects are detectable. For reference, if n were 150\u2013300 overall with balanced subgroups, typical detectable effects at 80% power and alpha=0.05 (two-tailed) might be: proportions (two-group comparison, equal groups): n=150 total (75/75) detects ~15\u201317 percentage point differences (e.g., 50% vs 67%); n=300 total (150/150) detects ~11\u201312 pp. Means (Likert composites, SD\u22481): n=150 detects Cohen\u2019s d\u22480.46\u20130.50; n=300 detects d\u22480.33\u20130.35. Within-subject changes require fewer, but still >100 for stable estimates."
          },
          "power_recommendations": [
            "Set a minimum overall target of 300 qualified completes to support conjoint/discrete choice utilities estimation and allow basic segmentation (role, hospital size, region).",
            "If doing MaxDiff, ensure at least 200 completes; for conjoint/discrete choice with 6\u20138 attributes and 3\u20134 levels, aim for 300\u2013500 completes to enable hierarchical Bayes estimation and subgroup comparisons.",
            "For price research: Van Westendorp requires \u2265100; Gabor\u2013Granger requires \u2265150 per price point. If testing 5 price points, aim for 750 total or use experimental design to balance exposures and ensure \u2265150 observations per price.",
            "For TURF analysis, target \u2265200\u2013300 completes to stabilize reach estimates, especially if evaluating many item combinations.",
            "Plan segmentation a priori. For two to four key segments (e.g., C-suite vs clinical leadership; 100\u2013299 vs 300\u2013500 beds), ensure \u2265100\u2013150 per segment for inferential testing; this implies 300\u2013600 total depending on the number of segments.",
            "Reduce methodology scope if recruitment is constrained: choose either MaxDiff or conjoint (not both), and prefer Van Westendorp over Gabor\u2013Granger when sample is <400.",
            "Implement quality controls (attention checks, speeders, straightlining) anticipating 10\u201320% exclusion; over-recruit accordingly.",
            "Pre-register key hypotheses and analysis plan to control alpha inflation given multiple endpoints (acceptance, ROI, privacy, integration, regulatory)."
          ],
          "risk_assessment": "With 0 completes, all analyses fail: no parameter estimates, no confidence intervals, and no external validity. Even small pilot data (<100) would be inadequate for conjoint utilities, unstable for MaxDiff, underpowered for subgroup tests, and invalid for Gabor\u2013Granger unless per-price exposures are met. Failure to meet per-method minimums risks biased utilities, wide CIs, non-convergent models, and misleading pricing recommendations. Business decisions (feature prioritization via KANO, pricing via DCM/PSM) would lack statistical credibility."
        },
        "sampling_adequacy_analysis": {
          "adequacy_score": 0.5,
          "target_responses": 0,
          "sampling_strategy": "Random sampling assumed",
          "representativeness_concerns": [
            "Low sample size may affect representativeness"
          ],
          "sampling_recommendations": [
            "Ensure representative sampling across target segments"
          ]
        },
        "specific_recommendations": [
          {
            "type": "flow_improvement",
            "priority": "high",
            "issue": "Poor question sequencing for q1",
            "current_position": 1,
            "suggested_position": null,
            "reasoning": "This survey is for mid-sized hospital stakeholders about AI diagnostics. Q1 is irrelevant and should be removed entirely. Replace with screeners on role (C-suite, CIO, CMO, dept head), hospital size, and AI/HIS exposure.",
            "expected_impact": "medium"
          },
          {
            "type": "flow_improvement",
            "priority": "high",
            "issue": "Poor question sequencing for q2",
            "current_position": 2,
            "suggested_position": null,
            "reasoning": "Remove. Replace early content with screeners on decision-making authority and involvement with diagnostic imaging/AI tools.",
            "expected_impact": "medium"
          },
          {
            "type": "flow_improvement",
            "priority": "high",
            "issue": "Poor question sequencing for q3",
            "current_position": 3,
            "suggested_position": 26,
            "reasoning": "Retain country as a demographic but move to the end block. Early questions should confirm hospital role and eligibility.",
            "expected_impact": "medium"
          },
          {
            "type": "sample_size_adjustment",
            "priority": "medium",
            "issue": "Insufficient sample size for reliable results",
            "power_concerns": "With 0 completes, all analyses fail: no parameter estimates, no confidence intervals, and no external validity. Even small pilot data (<100) would be inadequate for conjoint utilities, unstable for MaxDiff, underpowered for subgroup tests, and invalid for Gabor\u2013Granger unless per-price exposures are met. Failure to meet per-method minimums risks biased utilities, wide CIs, non-convergent models, and misleading pricing recommendations. Business decisions (feature prioritization via KANO, pricing via DCM/PSM) would lack statistical credibility.",
            "recommendations": [
              "Set a minimum overall target of 300 qualified completes to support conjoint/discrete choice utilities estimation and allow basic segmentation (role, hospital size, region).",
              "If doing MaxDiff, ensure at least 200 completes; for conjoint/discrete choice with 6\u20138 attributes and 3\u20134 levels, aim for 300\u2013500 completes to enable hierarchical Bayes estimation and subgroup comparisons.",
              "For price research: Van Westendorp requires \u2265100; Gabor\u2013Granger requires \u2265150 per price point. If testing 5 price points, aim for 750 total or use experimental design to balance exposures and ensure \u2265150 observations per price.",
              "For TURF analysis, target \u2265200\u2013300 completes to stabilize reach estimates, especially if evaluating many item combinations.",
              "Plan segmentation a priori. For two to four key segments (e.g., C-suite vs clinical leadership; 100\u2013299 vs 300\u2013500 beds), ensure \u2265100\u2013150 per segment for inferential testing; this implies 300\u2013600 total depending on the number of segments.",
              "Reduce methodology scope if recruitment is constrained: choose either MaxDiff or conjoint (not both), and prefer Van Westendorp over Gabor\u2013Granger when sample is <400.",
              "Implement quality controls (attention checks, speeders, straightlining) anticipating 10\u201320% exclusion; over-recruit accordingly.",
              "Pre-register key hypotheses and analysis plan to control alpha inflation given multiple endpoints (acceptance, ROI, privacy, integration, regulatory)."
            ],
            "expected_impact": "high"
          }
        ],
        "confidence_score": 1.0,
        "evaluation_metadata": {
          "evaluation_timestamp": "2025-10-11T21:57:14.438389",
          "llm_powered": true,
          "rules_context_used": false,
          "biases_detected": 32,
          "questions_analyzed": 31,
          "methodologies_evaluated": 0
        }
      },
      "clarity_comprehensibility": {
        "evaluation_focus": "Language accessibility and question wording effectiveness",
        "key_metrics": [
          "language_accessibility",
          "question_wording_quality",
          "ambiguity_check"
        ],
        "analysis_method": "LLM-based clarity assessment"
      },
      "structural_coherence": {
        "evaluation_focus": "Logical flow and question type appropriateness",
        "key_metrics": [
          "logical_flow",
          "question_type_appropriateness",
          "scale_consistency"
        ],
        "analysis_method": "LLM-based structural assessment"
      },
      "deployment_readiness": {
        "evaluation_focus": "Practical deployment considerations",
        "key_metrics": [
          "length_appropriateness",
          "time_reasonableness",
          "feasibility_assessment"
        ],
        "analysis_method": "LLM-based deployment assessment"
      }
    }
  }
}